id	sid	tid	token	lemma	pos
dpc-2577	1	1	dermatology	dermatology	NOUN
dpc-2577	1	2	:	:	PUNCT
dpc-2577	1	3	practical	practical	ADJ
dpc-2577	1	4	and	and	CCONJ
dpc-2577	1	5	conceptual	conceptual	ADJ
dpc-2577	1	6	original	original	ADJ
dpc-2577	1	7	article	article	NOUN
dpc-2577	1	8	|	|	ADV
dpc-2577	1	9	dermatol	dermatol	ADJ
dpc-2577	1	10	pract	pract	NOUN
dpc-2577	1	11	concept	concept	NOUN
dpc-2577	1	12	.	.	PUNCT
dpc-2577	2	1	2023;13(1):e2023056	2023;13(1):e2023056	NUM
dpc-2577	2	2	1	1	NUM
dpc-2577	2	3	characterization	characterization	NOUN
dpc-2577	2	4	of	of	ADP
dpc-2577	2	5	chronic	chronic	ADJ
dpc-2577	2	6	urticaria	urticaria	NOUN
dpc-2577	2	7	and	and	CCONJ
dpc-2577	2	8	associated	associated	ADJ
dpc-2577	2	9	conditions	condition	NOUN
dpc-2577	2	10	a	a	DET
dpc-2577	2	11	web	web	NOUN
dpc-2577	2	12	-	-	PUNCT
dpc-2577	2	13	based	base	VERB
dpc-2577	2	14	survey	survey	NOUN
dpc-2577	2	15	weronika	weronika	X
dpc-2577	2	16	zysk1	zysk1	PROPN
dpc-2577	2	17	,	,	PUNCT
dpc-2577	2	18	magdalena	magdalena	PROPN
dpc-2577	2	19	trzeciak2	trzeciak2	PROPN
dpc-2577	2	20	1	1	NUM
dpc-2577	2	21	dermatological	dermatological	ADJ
dpc-2577	2	22	students	student	NOUN
dpc-2577	2	23	scientific	scientific	ADJ
dpc-2577	2	24	association	association	NOUN
dpc-2577	2	25	,	,	PUNCT
dpc-2577	2	26	department	department	NOUN
dpc-2577	2	27	of	of	ADP
dpc-2577	2	28	dermatology	dermatology	NOUN
dpc-2577	2	29	,	,	PUNCT
dpc-2577	2	30	venereology	venereology	NOUN
dpc-2577	2	31	and	and	CCONJ
dpc-2577	2	32	allergology	allergology	NOUN
dpc-2577	2	33	,	,	PUNCT
dpc-2577	2	34	faculty	faculty	NOUN
dpc-2577	2	35	of	of	ADP
dpc-2577	2	36	medicine	medicine	NOUN
dpc-2577	2	37	,	,	PUNCT
dpc-2577	2	38	medical	medical	ADJ
dpc-2577	2	39	university	university	PROPN
dpc-2577	2	40	of	of	ADP
dpc-2577	2	41	gdansk	gdansk	PROPN
dpc-2577	2	42	,	,	PUNCT
dpc-2577	2	43	poland	poland	PROPN
dpc-2577	2	44	2	2	NUM
dpc-2577	2	45	department	department	NOUN
dpc-2577	2	46	of	of	ADP
dpc-2577	2	47	dermatology	dermatology	NOUN
dpc-2577	2	48	,	,	PUNCT
dpc-2577	2	49	venereology	venereology	NOUN
dpc-2577	2	50	and	and	CCONJ
dpc-2577	2	51	allergology	allergology	NOUN
dpc-2577	2	52	,	,	PUNCT
dpc-2577	2	53	faculty	faculty	NOUN
dpc-2577	2	54	of	of	ADP
dpc-2577	2	55	medicine	medicine	NOUN
dpc-2577	2	56	,	,	PUNCT
dpc-2577	2	57	medical	medical	ADJ
dpc-2577	2	58	university	university	PROPN
dpc-2577	2	59	of	of	ADP
dpc-2577	2	60	gdansk	gdansk	PROPN
dpc-2577	2	61	,	,	PUNCT
dpc-2577	2	62	poland	poland	PROPN
dpc-2577	2	63	key	key	ADJ
dpc-2577	2	64	words	word	NOUN
dpc-2577	2	65	:	:	PUNCT
dpc-2577	2	66	chronic	chronic	ADJ
dpc-2577	2	67	urticaria	urticaria	NOUN
dpc-2577	2	68	,	,	PUNCT
dpc-2577	2	69	autoimmune	autoimmune	ADJ
dpc-2577	2	70	urticaria	urticaria	NOUN
dpc-2577	2	71	,	,	PUNCT
dpc-2577	2	72	comorbidity	comorbidity	NOUN
dpc-2577	2	73	,	,	PUNCT
dpc-2577	2	74	angioedema	angioedema	VERB
dpc-2577	2	75	citation	citation	NOUN
dpc-2577	2	76	:	:	PUNCT
dpc-2577	2	77	zysk	zysk	PROPN
dpc-2577	2	78	w	w	PROPN
dpc-2577	2	79	,	,	PUNCT
dpc-2577	2	80	trzeciak	trzeciak	PROPN
dpc-2577	2	81	m.	m.	NOUN
dpc-2577	2	82	characterization	characterization	NOUN
dpc-2577	2	83	of	of	ADP
dpc-2577	2	84	chronic	chronic	ADJ
dpc-2577	2	85	urticaria	urticaria	NOUN
dpc-2577	2	86	and	and	CCONJ
dpc-2577	2	87	associated	associated	ADJ
dpc-2577	2	88	conditions	condition	NOUN
dpc-2577	2	89	a	a	DET
dpc-2577	2	90	web	web	NOUN
dpc-2577	2	91	-	-	PUNCT
dpc-2577	2	92	based	base	VERB
dpc-2577	2	93	survey	survey	NOUN
dpc-2577	2	94	.	.	PUNCT
dpc-2577	3	1	dermatol	dermatol	NOUN
dpc-2577	3	2	pract	pract	PROPN
dpc-2577	3	3	concept	concept	NOUN
dpc-2577	3	4	.	.	PUNCT
dpc-2577	4	1	2023;13(1):e2023056	2023;13(1):e2023056	X
dpc-2577	4	2	.	.	X
dpc-2577	4	3	doi	doi	PROPN
dpc-2577	4	4	:	:	PUNCT
dpc-2577	5	1	https://doi.org/10.5826/dpc.1301a56	https://doi.org/10.5826/dpc.1301a56	NOUN
dpc-2577	5	2	accepted	accept	VERB
dpc-2577	5	3	:	:	PUNCT
dpc-2577	5	4	may	may	AUX
dpc-2577	5	5	28	28	NUM
dpc-2577	5	6	,	,	PUNCT
dpc-2577	5	7	2022	2022	NUM
dpc-2577	5	8	;	;	PUNCT
dpc-2577	5	9	published	publish	VERB
dpc-2577	5	10	:	:	PUNCT
dpc-2577	5	11	january	january	NOUN
dpc-2577	5	12	2023	2023	NUM
dpc-2577	5	13	copyright	copyright	NOUN
dpc-2577	5	14	:	:	PUNCT
dpc-2577	6	1	©	©	PROPN
dpc-2577	6	2	2023	2023	NUM
dpc-2577	6	3	zysk	zysk	X
dpc-2577	6	4	et	et	PROPN
dpc-2577	6	5	al	al	PROPN
dpc-2577	6	6	.	.	PUNCT
dpc-2577	7	1	this	this	PRON
dpc-2577	7	2	is	be	AUX
dpc-2577	7	3	an	an	DET
dpc-2577	7	4	open	open	ADJ
dpc-2577	7	5	-	-	PUNCT
dpc-2577	7	6	access	access	NOUN
dpc-2577	7	7	article	article	NOUN
dpc-2577	7	8	distributed	distribute	VERB
dpc-2577	7	9	under	under	ADP
dpc-2577	7	10	the	the	DET
dpc-2577	7	11	terms	term	NOUN
dpc-2577	7	12	of	of	ADP
dpc-2577	7	13	the	the	DET
dpc-2577	7	14	creative	creative	ADJ
dpc-2577	7	15	commons	common	NOUN
dpc-2577	7	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-2577	7	17	license	license	NOUN
dpc-2577	7	18	(	(	PUNCT
dpc-2577	7	19	by	by	ADP
dpc-2577	7	20	-	-	PUNCT
dpc-2577	7	21	nc-4.0	nc-4.0	NOUN
dpc-2577	7	22	)	)	PUNCT
dpc-2577	7	23	,	,	PUNCT
dpc-2577	7	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-2577	7	25	,	,	PUNCT
dpc-2577	7	26	which	which	PRON
dpc-2577	7	27	permits	permit	VERB
dpc-2577	7	28	unrestricted	unrestricted	ADJ
dpc-2577	7	29	noncommercial	noncommercial	ADJ
dpc-2577	7	30	use	use	NOUN
dpc-2577	7	31	,	,	PUNCT
dpc-2577	7	32	distribution	distribution	NOUN
dpc-2577	7	33	,	,	PUNCT
dpc-2577	7	34	and	and	CCONJ
dpc-2577	7	35	reproduction	reproduction	NOUN
dpc-2577	7	36	in	in	ADP
dpc-2577	7	37	any	any	DET
dpc-2577	7	38	medium	medium	NOUN
dpc-2577	7	39	,	,	PUNCT
dpc-2577	7	40	provided	provide	VERB
dpc-2577	7	41	the	the	DET
dpc-2577	7	42	original	original	ADJ
dpc-2577	7	43	authors	author	NOUN
dpc-2577	7	44	and	and	CCONJ
dpc-2577	7	45	source	source	NOUN
dpc-2577	7	46	are	be	AUX
dpc-2577	7	47	credited	credit	VERB
dpc-2577	7	48	.	.	PUNCT
dpc-2577	8	1	funding	funding	NOUN
dpc-2577	8	2	:	:	PUNCT
dpc-2577	8	3	none	none	NOUN
dpc-2577	8	4	.	.	PUNCT
dpc-2577	9	1	competing	compete	VERB
dpc-2577	9	2	interests	interest	NOUN
dpc-2577	9	3	:	:	PUNCT
dpc-2577	9	4	none	none	NOUN
dpc-2577	9	5	.	.	PUNCT
dpc-2577	10	1	authorship	authorship	NOUN
dpc-2577	10	2	:	:	PUNCT
dpc-2577	10	3	all	all	DET
dpc-2577	10	4	authors	author	NOUN
dpc-2577	10	5	have	have	AUX
dpc-2577	10	6	contributed	contribute	VERB
dpc-2577	10	7	significantly	significantly	ADV
dpc-2577	10	8	to	to	ADP
dpc-2577	10	9	this	this	DET
dpc-2577	10	10	publication	publication	NOUN
dpc-2577	10	11	.	.	PUNCT
dpc-2577	11	1	corresponding	correspond	VERB
dpc-2577	11	2	author	author	NOUN
dpc-2577	11	3	:	:	PUNCT
dpc-2577	11	4	weronika	weronika	X
dpc-2577	11	5	zysk	zysk	ADV
dpc-2577	11	6	,	,	PUNCT
dpc-2577	11	7	dermatological	dermatological	ADJ
dpc-2577	11	8	students	student	NOUN
dpc-2577	11	9	scientific	scientific	ADJ
dpc-2577	11	10	association	association	NOUN
dpc-2577	11	11	,	,	PUNCT
dpc-2577	11	12	department	department	NOUN
dpc-2577	11	13	of	of	ADP
dpc-2577	11	14	dermatology	dermatology	NOUN
dpc-2577	11	15	,	,	PUNCT
dpc-2577	11	16	venerology	venerology	NOUN
dpc-2577	11	17	and	and	CCONJ
dpc-2577	11	18	allergology	allergology	NOUN
dpc-2577	11	19	,	,	PUNCT
dpc-2577	11	20	faculty	faculty	NOUN
dpc-2577	11	21	of	of	ADP
dpc-2577	11	22	medicine	medicine	NOUN
dpc-2577	11	23	,	,	PUNCT
dpc-2577	11	24	medical	medical	ADJ
dpc-2577	11	25	university	university	PROPN
dpc-2577	11	26	of	of	ADP
dpc-2577	11	27	gdansk	gdansk	PROPN
dpc-2577	11	28	,	,	PUNCT
dpc-2577	11	29	17	17	NUM
dpc-2577	11	30	smoluchowskiego	smoluchowskiego	PROPN
dpc-2577	11	31	st	st	PROPN
dpc-2577	11	32	,	,	PUNCT
dpc-2577	11	33	80	80	NUM
dpc-2577	11	34	-	-	SYM
dpc-2577	11	35	214	214	NUM
dpc-2577	11	36	gdansk	gdansk	PROPN
dpc-2577	11	37	,	,	PUNCT
dpc-2577	11	38	poland	poland	PROPN
dpc-2577	11	39	.	.	PUNCT
dpc-2577	12	1	e	e	X
dpc-2577	12	2	-	-	NOUN
dpc-2577	12	3	mail	mail	NOUN
dpc-2577	12	4	:	:	PUNCT
dpc-2577	12	5	weronikazysk@gumed.edu.pl	weronikazysk@gumed.edu.pl	NOUN
dpc-2577	12	6	introduction	introduction	NOUN
dpc-2577	12	7	:	:	PUNCT
dpc-2577	12	8	chronic	chronic	ADJ
dpc-2577	12	9	urticaria	urticaria	NOUN
dpc-2577	12	10	is	be	AUX
dpc-2577	12	11	a	a	DET
dpc-2577	12	12	common	common	ADJ
dpc-2577	12	13	disease	disease	NOUN
dpc-2577	12	14	,	,	PUNCT
dpc-2577	12	15	characterized	characterize	VERB
dpc-2577	12	16	by	by	ADP
dpc-2577	12	17	the	the	DET
dpc-2577	12	18	development	development	NOUN
dpc-2577	12	19	of	of	ADP
dpc-2577	12	20	wheals	wheal	NOUN
dpc-2577	12	21	,	,	PUNCT
dpc-2577	12	22	angioedema	angioedema	VERB
dpc-2577	12	23	,	,	PUNCT
dpc-2577	12	24	or	or	CCONJ
dpc-2577	12	25	both	both	PRON
dpc-2577	12	26	,	,	PUNCT
dpc-2577	12	27	which	which	PRON
dpc-2577	12	28	can	can	AUX
dpc-2577	12	29	be	be	AUX
dpc-2577	12	30	associated	associate	VERB
dpc-2577	12	31	with	with	ADP
dpc-2577	12	32	several	several	ADJ
dpc-2577	12	33	comorbidities	comorbiditie	NOUN
dpc-2577	12	34	.	.	PUNCT
dpc-2577	13	1	most	most	ADJ
dpc-2577	13	2	of	of	ADP
dpc-2577	13	3	the	the	DET
dpc-2577	13	4	available	available	ADJ
dpc-2577	13	5	studies	study	NOUN
dpc-2577	13	6	have	have	AUX
dpc-2577	13	7	focused	focus	VERB
dpc-2577	13	8	on	on	ADP
dpc-2577	13	9	specific	specific	ADJ
dpc-2577	13	10	common	common	ADJ
dpc-2577	13	11	comorbidities	comorbiditie	NOUN
dpc-2577	13	12	and	and	CCONJ
dpc-2577	13	13	their	their	PRON
dpc-2577	13	14	association	association	NOUN
dpc-2577	13	15	with	with	ADP
dpc-2577	13	16	cu	cu	PROPN
dpc-2577	13	17	,	,	PUNCT
dpc-2577	13	18	but	but	CCONJ
dpc-2577	13	19	have	have	AUX
dpc-2577	13	20	seldom	seldom	ADV
dpc-2577	13	21	reported	report	VERB
dpc-2577	13	22	the	the	DET
dpc-2577	13	23	overall	overall	ADJ
dpc-2577	13	24	burden	burden	NOUN
dpc-2577	13	25	of	of	ADP
dpc-2577	13	26	comorbidities	comorbiditie	NOUN
dpc-2577	13	27	.	.	PUNCT
dpc-2577	14	1	objectives	objective	NOUN
dpc-2577	14	2	:	:	PUNCT
dpc-2577	14	3	this	this	DET
dpc-2577	14	4	study	study	NOUN
dpc-2577	14	5	aimed	aim	VERB
dpc-2577	14	6	to	to	PART
dpc-2577	14	7	investigate	investigate	VERB
dpc-2577	14	8	and	and	CCONJ
dpc-2577	14	9	analyze	analyze	VERB
dpc-2577	14	10	self	self	NOUN
dpc-2577	14	11	-	-	PUNCT
dpc-2577	14	12	reported	report	VERB
dpc-2577	14	13	comorbidities	comorbiditie	NOUN
dpc-2577	14	14	in	in	ADP
dpc-2577	14	15	polish	polish	ADJ
dpc-2577	14	16	patients	patient	NOUN
dpc-2577	14	17	with	with	ADP
dpc-2577	14	18	cu	cu	PROPN
dpc-2577	15	1	.	.	PUNCT
dpc-2577	15	2	methods	method	NOUN
dpc-2577	15	3	:	:	PUNCT
dpc-2577	15	4	an	an	DET
dpc-2577	15	5	anonymous	anonymous	ADJ
dpc-2577	15	6	online	online	ADJ
dpc-2577	15	7	survey	survey	NOUN
dpc-2577	15	8	consisting	consist	VERB
dpc-2577	15	9	of	of	ADP
dpc-2577	15	10	20	20	NUM
dpc-2577	15	11	questions	question	NOUN
dpc-2577	15	12	was	be	AUX
dpc-2577	15	13	conducted	conduct	VERB
dpc-2577	15	14	on	on	ADP
dpc-2577	15	15	members	member	NOUN
dpc-2577	15	16	of	of	ADP
dpc-2577	15	17	an	an	DET
dpc-2577	15	18	urticaria	urticaria	NOUN
dpc-2577	15	19	group	group	NOUN
dpc-2577	15	20	on	on	ADP
dpc-2577	15	21	the	the	DET
dpc-2577	15	22	social	social	ADJ
dpc-2577	15	23	media	media	NOUN
dpc-2577	15	24	platform	platform	NOUN
dpc-2577	15	25	facebook	facebook	PROPN
dpc-2577	15	26	.	.	PUNCT
dpc-2577	16	1	a	a	DET
dpc-2577	16	2	total	total	NOUN
dpc-2577	16	3	of	of	ADP
dpc-2577	16	4	102	102	NUM
dpc-2577	16	5	people	people	NOUN
dpc-2577	16	6	took	take	VERB
dpc-2577	16	7	part	part	NOUN
dpc-2577	16	8	in	in	ADP
dpc-2577	16	9	this	this	DET
dpc-2577	16	10	survey	survey	NOUN
dpc-2577	16	11	.	.	PUNCT
dpc-2577	17	1	the	the	DET
dpc-2577	17	2	results	result	NOUN
dpc-2577	17	3	were	be	AUX
dpc-2577	17	4	analyzed	analyze	VERB
dpc-2577	17	5	in	in	ADP
dpc-2577	17	6	microsoft	microsoft	PROPN
dpc-2577	17	7	excel	excel	VERB
dpc-2577	17	8	2016	2016	NUM
dpc-2577	17	9	.	.	PUNCT
dpc-2577	18	1	results	result	NOUN
dpc-2577	18	2	:	:	PUNCT
dpc-2577	18	3	in	in	ADP
dpc-2577	18	4	the	the	DET
dpc-2577	18	5	group	group	NOUN
dpc-2577	18	6	,	,	PUNCT
dpc-2577	18	7	95.1	95.1	NUM
dpc-2577	18	8	%	%	NOUN
dpc-2577	18	9	were	be	AUX
dpc-2577	18	10	females	female	NOUN
dpc-2577	18	11	and	and	CCONJ
dpc-2577	18	12	4.9	4.9	NUM
dpc-2577	18	13	%	%	NOUN
dpc-2577	18	14	males	male	NOUN
dpc-2577	18	15	,	,	PUNCT
dpc-2577	18	16	with	with	ADP
dpc-2577	18	17	a	a	DET
dpc-2577	18	18	mean	mean	ADJ
dpc-2577	18	19	age	age	NOUN
dpc-2577	18	20	of	of	ADP
dpc-2577	18	21	33.8	33.8	NUM
dpc-2577	18	22	years	year	NOUN
dpc-2577	18	23	.	.	PUNCT
dpc-2577	19	1	the	the	DET
dpc-2577	19	2	most	most	ADV
dpc-2577	19	3	common	common	ADJ
dpc-2577	19	4	diagnosed	diagnose	VERB
dpc-2577	19	5	type	type	NOUN
dpc-2577	19	6	of	of	ADP
dpc-2577	19	7	urticaria	urticaria	NOUN
dpc-2577	19	8	was	be	AUX
dpc-2577	19	9	spontaneous	spontaneous	ADJ
dpc-2577	19	10	(	(	PUNCT
dpc-2577	19	11	52.9	52.9	NUM
dpc-2577	19	12	%	%	NOUN
dpc-2577	19	13	)	)	PUNCT
dpc-2577	19	14	.	.	PUNCT
dpc-2577	20	1	angioedema	angioedema	ADV
dpc-2577	20	2	accompanied	accompany	VERB
dpc-2577	20	3	urticaria	urticaria	NOUN
dpc-2577	20	4	in	in	ADP
dpc-2577	20	5	68.6	68.6	NUM
dpc-2577	20	6	%	%	NOUN
dpc-2577	20	7	of	of	ADP
dpc-2577	20	8	the	the	DET
dpc-2577	20	9	respondents	respondent	NOUN
dpc-2577	20	10	,	,	PUNCT
dpc-2577	20	11	mainly	mainly	ADV
dpc-2577	20	12	those	those	PRON
dpc-2577	20	13	with	with	ADP
dpc-2577	20	14	delayed	delay	VERB
dpc-2577	20	15	pressure	pressure	NOUN
dpc-2577	20	16	urticaria	urticaria	NOUN
dpc-2577	20	17	(	(	PUNCT
dpc-2577	20	18	86.4	86.4	NUM
dpc-2577	20	19	%	%	NOUN
dpc-2577	20	20	)	)	PUNCT
dpc-2577	20	21	.	.	PUNCT
dpc-2577	21	1	85.3	85.3	NUM
dpc-2577	21	2	%	%	NOUN
dpc-2577	21	3	of	of	ADP
dpc-2577	21	4	respondents	respondent	NOUN
dpc-2577	21	5	reported	report	VERB
dpc-2577	21	6	comorbidities	comorbiditie	NOUN
dpc-2577	21	7	,	,	PUNCT
dpc-2577	21	8	most	most	ADV
dpc-2577	21	9	often	often	ADV
dpc-2577	21	10	atopic	atopic	NOUN
dpc-2577	21	11	diseases	disease	NOUN
dpc-2577	21	12	and	and	CCONJ
dpc-2577	21	13	allergies	allergy	NOUN
dpc-2577	21	14	(	(	PUNCT
dpc-2577	21	15	49	49	NUM
dpc-2577	21	16	%	%	NOUN
dpc-2577	21	17	)	)	PUNCT
dpc-2577	21	18	,	,	PUNCT
dpc-2577	21	19	chronic	chronic	ADJ
dpc-2577	21	20	inflammation	inflammation	NOUN
dpc-2577	21	21	and	and	CCONJ
dpc-2577	21	22	infections	infection	NOUN
dpc-2577	21	23	(	(	PUNCT
dpc-2577	21	24	36.3	36.3	NUM
dpc-2577	21	25	%	%	NOUN
dpc-2577	21	26	)	)	PUNCT
dpc-2577	21	27	,	,	PUNCT
dpc-2577	21	28	thyroid	thyroid	NOUN
dpc-2577	21	29	(	(	PUNCT
dpc-2577	21	30	36.3	36.3	NUM
dpc-2577	21	31	%	%	NOUN
dpc-2577	21	32	)	)	PUNCT
dpc-2577	21	33	and	and	CCONJ
dpc-2577	21	34	psychiatric	psychiatric	ADJ
dpc-2577	21	35	disorders	disorder	NOUN
dpc-2577	21	36	(	(	PUNCT
dpc-2577	21	37	25.5	25.5	NUM
dpc-2577	21	38	%	%	NOUN
dpc-2577	21	39	)	)	PUNCT
dpc-2577	21	40	.	.	PUNCT
dpc-2577	22	1	moreover	moreover	ADV
dpc-2577	22	2	,	,	PUNCT
dpc-2577	22	3	in	in	ADP
dpc-2577	22	4	30.4	30.4	NUM
dpc-2577	22	5	%	%	NOUN
dpc-2577	22	6	of	of	ADP
dpc-2577	22	7	patients	patient	NOUN
dpc-2577	22	8	,	,	PUNCT
dpc-2577	22	9	at	at	ADV
dpc-2577	22	10	least	least	ADJ
dpc-2577	22	11	one	one	NUM
dpc-2577	22	12	autoimmune	autoimmune	ADJ
dpc-2577	22	13	disease	disease	NOUN
dpc-2577	22	14	was	be	AUX
dpc-2577	22	15	noted	note	VERB
dpc-2577	22	16	.	.	PUNCT
dpc-2577	23	1	as	as	SCONJ
dpc-2577	23	2	compared	compare	VERB
dpc-2577	23	3	to	to	ADP
dpc-2577	23	4	the	the	DET
dpc-2577	23	5	patients	patient	NOUN
dpc-2577	23	6	without	without	ADP
dpc-2577	23	7	autoimmune	autoimmune	ADJ
dpc-2577	23	8	urticaria	urticaria	NOUN
dpc-2577	23	9	,	,	PUNCT
dpc-2577	23	10	many	many	ADJ
dpc-2577	23	11	more	more	ADJ
dpc-2577	23	12	with	with	ADP
dpc-2577	23	13	autoimmune	autoimmune	ADJ
dpc-2577	23	14	urticaria	urticaria	NOUN
dpc-2577	23	15	had	have	VERB
dpc-2577	23	16	a	a	DET
dpc-2577	23	17	coexisting	coexist	VERB
dpc-2577	23	18	autoimmune	autoimmune	ADJ
dpc-2577	23	19	disease	disease	NOUN
dpc-2577	23	20	(	(	PUNCT
dpc-2577	23	21	50	50	NUM
dpc-2577	23	22	%	%	NOUN
dpc-2577	23	23	vs.	vs.	ADP
dpc-2577	23	24	23.7	23.7	NUM
dpc-2577	23	25	%	%	NOUN
dpc-2577	23	26	)	)	PUNCT
dpc-2577	23	27	.	.	PUNCT
dpc-2577	24	1	family	family	NOUN
dpc-2577	24	2	history	history	NOUN
dpc-2577	24	3	of	of	ADP
dpc-2577	24	4	autoimmune	autoimmune	ADJ
dpc-2577	24	5	diseases	disease	NOUN
dpc-2577	24	6	was	be	AUX
dpc-2577	24	7	positive	positive	ADJ
dpc-2577	24	8	in	in	ADP
dpc-2577	24	9	42.2	42.2	NUM
dpc-2577	24	10	%	%	NOUN
dpc-2577	24	11	,	,	PUNCT
dpc-2577	24	12	and	and	CCONJ
dpc-2577	24	13	the	the	DET
dpc-2577	24	14	familial	familial	ADJ
dpc-2577	24	15	history	history	NOUN
dpc-2577	24	16	of	of	ADP
dpc-2577	24	17	urticaria	urticaria	NOUN
dpc-2577	24	18	and	and	CCONJ
dpc-2577	24	19	atopy	atopy	NOUN
dpc-2577	24	20	was	be	AUX
dpc-2577	24	21	positive	positive	ADJ
dpc-2577	24	22	in	in	ADP
dpc-2577	24	23	7.8	7.8	NUM
dpc-2577	24	24	%	%	NOUN
dpc-2577	24	25	and	and	CCONJ
dpc-2577	24	26	25.5	25.5	NUM
dpc-2577	24	27	%	%	NOUN
dpc-2577	24	28	,	,	PUNCT
dpc-2577	24	29	respectively	respectively	ADV
dpc-2577	24	30	.	.	PUNCT
dpc-2577	25	1	conclusions	conclusion	NOUN
dpc-2577	25	2	:	:	PUNCT
dpc-2577	25	3	the	the	DET
dpc-2577	25	4	knowledge	knowledge	NOUN
dpc-2577	25	5	of	of	ADP
dpc-2577	25	6	comorbidities	comorbiditie	NOUN
dpc-2577	25	7	of	of	ADP
dpc-2577	25	8	chronic	chronic	ADJ
dpc-2577	25	9	urticaria	urticaria	NOUN
dpc-2577	25	10	may	may	AUX
dpc-2577	25	11	support	support	VERB
dpc-2577	25	12	clinicians	clinician	NOUN
dpc-2577	25	13	to	to	PART
dpc-2577	25	14	manage	manage	VERB
dpc-2577	25	15	and	and	CCONJ
dpc-2577	25	16	treat	treat	VERB
dpc-2577	25	17	patients	patient	NOUN
dpc-2577	25	18	with	with	ADP
dpc-2577	25	19	this	this	DET
dpc-2577	25	20	common	common	ADJ
dpc-2577	25	21	condition	condition	NOUN
dpc-2577	25	22	.	.	PUNCT
dpc-2577	26	1	abstract	abstract	ADJ
dpc-2577	26	2	2	2	NUM
dpc-2577	26	3	original	original	ADJ
dpc-2577	26	4	article	article	NOUN
dpc-2577	26	5	|	|	ADV
dpc-2577	26	6	dermatol	dermatol	ADJ
dpc-2577	26	7	pract	pract	NOUN
dpc-2577	26	8	concept	concept	NOUN
dpc-2577	26	9	.	.	PUNCT
dpc-2577	27	1	2023;13(1):e2023056	2023;13(1):e2023056	NUM
dpc-2577	27	2	introduction	introduction	NOUN
dpc-2577	27	3	chronic	chronic	ADJ
dpc-2577	27	4	urticaria	urticaria	NOUN
dpc-2577	27	5	(	(	PUNCT
dpc-2577	27	6	cu	cu	PROPN
dpc-2577	27	7	)	)	PUNCT
dpc-2577	27	8	,	,	PUNCT
dpc-2577	27	9	affecting	affect	VERB
dpc-2577	27	10	0.5%–1	0.5%–1	NUM
dpc-2577	27	11	%	%	NOUN
dpc-2577	27	12	of	of	ADP
dpc-2577	27	13	the	the	DET
dpc-2577	27	14	general	general	ADJ
dpc-2577	27	15	population	population	NOUN
dpc-2577	27	16	,	,	PUNCT
dpc-2577	27	17	is	be	AUX
dpc-2577	27	18	defined	define	VERB
dpc-2577	27	19	by	by	ADP
dpc-2577	27	20	the	the	DET
dpc-2577	27	21	repeated	repeat	VERB
dpc-2577	27	22	occurrence	occurrence	NOUN
dpc-2577	27	23	of	of	ADP
dpc-2577	27	24	itchy	itchy	ADJ
dpc-2577	27	25	hives	hive	NOUN
dpc-2577	27	26	,	,	PUNCT
dpc-2577	27	27	angioedema	angioedema	VERB
dpc-2577	27	28	,	,	PUNCT
dpc-2577	27	29	or	or	CCONJ
dpc-2577	27	30	both	both	PRON
dpc-2577	27	31	,	,	PUNCT
dpc-2577	27	32	for	for	ADP
dpc-2577	27	33	6	6	NUM
dpc-2577	27	34	weeks	week	NOUN
dpc-2577	27	35	or	or	CCONJ
dpc-2577	27	36	more	more	ADJ
dpc-2577	27	37	.	.	PUNCT
dpc-2577	28	1	according	accord	VERB
dpc-2577	28	2	to	to	ADP
dpc-2577	28	3	current	current	ADJ
dpc-2577	28	4	guidelines	guideline	NOUN
dpc-2577	28	5	,	,	PUNCT
dpc-2577	28	6	cu	cu	PROPN
dpc-2577	28	7	can	can	AUX
dpc-2577	28	8	be	be	AUX
dpc-2577	28	9	divided	divide	VERB
dpc-2577	28	10	into	into	ADP
dpc-2577	28	11	chronic	chronic	ADJ
dpc-2577	28	12	spontaneous	spontaneous	ADJ
dpc-2577	28	13	urticaria	urticaria	NOUN
dpc-2577	28	14	(	(	PUNCT
dpc-2577	28	15	csu	csu	PROPN
dpc-2577	28	16	)	)	PUNCT
dpc-2577	28	17	and	and	CCONJ
dpc-2577	28	18	chronic	chronic	ADJ
dpc-2577	28	19	inducible	inducible	ADJ
dpc-2577	28	20	urticaria	urticaria	NOUN
dpc-2577	28	21	(	(	PUNCT
dpc-2577	28	22	cindu	cindu	NOUN
dpc-2577	28	23	)	)	PUNCT
dpc-2577	28	24	with	with	ADP
dpc-2577	28	25	several	several	ADJ
dpc-2577	28	26	subgroups	subgroup	NOUN
dpc-2577	28	27	.	.	PUNCT
dpc-2577	29	1	both	both	DET
dpc-2577	29	2	cu	cu	PROPN
dpc-2577	29	3	types	type	NOUN
dpc-2577	29	4	can	can	AUX
dpc-2577	29	5	occur	occur	VERB
dpc-2577	29	6	concomitantly	concomitantly	ADV
dpc-2577	29	7	in	in	ADP
dpc-2577	29	8	the	the	DET
dpc-2577	29	9	same	same	ADJ
dpc-2577	29	10	patient	patient	NOUN
dpc-2577	29	11	[	[	X
dpc-2577	29	12	1	1	NUM
dpc-2577	29	13	]	]	PUNCT
dpc-2577	29	14	.	.	PUNCT
dpc-2577	30	1	cu	cu	PROPN
dpc-2577	30	2	develops	develop	VERB
dpc-2577	30	3	more	more	ADV
dpc-2577	30	4	frequently	frequently	ADV
dpc-2577	30	5	in	in	ADP
dpc-2577	30	6	adults	adult	NOUN
dpc-2577	30	7	,	,	PUNCT
dpc-2577	30	8	in	in	ADP
dpc-2577	30	9	the	the	DET
dpc-2577	30	10	third	third	ADJ
dpc-2577	30	11	to	to	PART
dpc-2577	30	12	fifth	fifth	ADJ
dpc-2577	30	13	decade	decade	NOUN
dpc-2577	30	14	of	of	ADP
dpc-2577	30	15	life	life	NOUN
dpc-2577	30	16	,	,	PUNCT
dpc-2577	30	17	and	and	CCONJ
dpc-2577	30	18	females	female	NOUN
dpc-2577	30	19	are	be	AUX
dpc-2577	30	20	affected	affect	VERB
dpc-2577	30	21	at	at	ADP
dpc-2577	30	22	least	least	ADV
dpc-2577	30	23	twice	twice	ADV
dpc-2577	30	24	as	as	ADV
dpc-2577	30	25	often	often	ADV
dpc-2577	30	26	as	as	ADP
dpc-2577	30	27	males	male	NOUN
dpc-2577	30	28	[	[	X
dpc-2577	30	29	2	2	NUM
dpc-2577	30	30	]	]	PUNCT
dpc-2577	30	31	.	.	PUNCT
dpc-2577	31	1	several	several	ADJ
dpc-2577	31	2	studies	study	NOUN
dpc-2577	31	3	reported	report	VERB
dpc-2577	31	4	that	that	SCONJ
dpc-2577	31	5	patients	patient	NOUN
dpc-2577	31	6	with	with	ADP
dpc-2577	31	7	cu	cu	NOUN
dpc-2577	31	8	frequently	frequently	ADV
dpc-2577	31	9	exhibit	exhibit	VERB
dpc-2577	31	10	comorbidities	comorbiditie	NOUN
dpc-2577	31	11	.	.	PUNCT
dpc-2577	32	1	the	the	DET
dpc-2577	32	2	association	association	NOUN
dpc-2577	32	3	of	of	ADP
dpc-2577	32	4	cu	cu	PROPN
dpc-2577	32	5	with	with	ADP
dpc-2577	32	6	psychiatric	psychiatric	ADJ
dpc-2577	32	7	disorders	disorder	NOUN
dpc-2577	32	8	,	,	PUNCT
dpc-2577	32	9	including	include	VERB
dpc-2577	32	10	depression	depression	NOUN
dpc-2577	32	11	,	,	PUNCT
dpc-2577	32	12	anxiety	anxiety	NOUN
dpc-2577	32	13	and	and	CCONJ
dpc-2577	32	14	behavioral	behavioral	ADJ
dpc-2577	32	15	problems	problem	NOUN
dpc-2577	32	16	,	,	PUNCT
dpc-2577	32	17	atopic	atopic	NOUN
dpc-2577	32	18	disorders	disorder	NOUN
dpc-2577	32	19	,	,	PUNCT
dpc-2577	32	20	autoimmune	autoimmune	ADJ
dpc-2577	32	21	disorders	disorder	NOUN
dpc-2577	32	22	,	,	PUNCT
dpc-2577	32	23	hypertension	hypertension	NOUN
dpc-2577	32	24	,	,	PUNCT
dpc-2577	32	25	osteoporosis	osteoporosis	NOUN
dpc-2577	32	26	,	,	PUNCT
dpc-2577	32	27	and	and	CCONJ
dpc-2577	32	28	infections	infection	NOUN
dpc-2577	32	29	,	,	PUNCT
dpc-2577	32	30	has	have	AUX
dpc-2577	32	31	been	be	AUX
dpc-2577	32	32	reported	report	VERB
dpc-2577	32	33	previously	previously	ADV
dpc-2577	32	34	[	[	X
dpc-2577	32	35	3	3	NUM
dpc-2577	32	36	-	-	SYM
dpc-2577	32	37	7	7	NUM
dpc-2577	32	38	]	]	PUNCT
dpc-2577	32	39	.	.	PUNCT
dpc-2577	33	1	most	most	ADJ
dpc-2577	33	2	of	of	ADP
dpc-2577	33	3	these	these	DET
dpc-2577	33	4	studies	study	NOUN
dpc-2577	33	5	have	have	AUX
dpc-2577	33	6	focused	focus	VERB
dpc-2577	33	7	on	on	ADP
dpc-2577	33	8	specific	specific	ADJ
dpc-2577	33	9	common	common	ADJ
dpc-2577	33	10	comorbidities	comorbiditie	NOUN
dpc-2577	33	11	and	and	CCONJ
dpc-2577	33	12	their	their	PRON
dpc-2577	33	13	association	association	NOUN
dpc-2577	33	14	with	with	ADP
dpc-2577	33	15	cu	cu	PROPN
dpc-2577	33	16	,	,	PUNCT
dpc-2577	33	17	but	but	CCONJ
dpc-2577	33	18	have	have	AUX
dpc-2577	33	19	seldom	seldom	ADV
dpc-2577	33	20	reported	report	VERB
dpc-2577	33	21	the	the	DET
dpc-2577	33	22	overall	overall	ADJ
dpc-2577	33	23	burden	burden	NOUN
dpc-2577	33	24	of	of	ADP
dpc-2577	33	25	comorbidities	comorbiditie	NOUN
dpc-2577	33	26	.	.	PUNCT
dpc-2577	34	1	objectives	objective	NOUN
dpc-2577	34	2	this	this	DET
dpc-2577	34	3	study	study	NOUN
dpc-2577	34	4	aimed	aim	VERB
dpc-2577	34	5	to	to	PART
dpc-2577	34	6	investigate	investigate	VERB
dpc-2577	34	7	and	and	CCONJ
dpc-2577	34	8	analyze	analyze	VERB
dpc-2577	34	9	self	self	NOUN
dpc-2577	34	10	-	-	PUNCT
dpc-2577	34	11	reported	report	VERB
dpc-2577	34	12	comorbidities	comorbiditie	NOUN
dpc-2577	34	13	in	in	ADP
dpc-2577	34	14	polish	polish	ADJ
dpc-2577	34	15	patients	patient	NOUN
dpc-2577	34	16	with	with	ADP
dpc-2577	34	17	cu	cu	PROPN
dpc-2577	34	18	.	.	PROPN
dpc-2577	34	19	material	material	PROPN
dpc-2577	34	20	and	and	CCONJ
dpc-2577	34	21	methods	method	NOUN
dpc-2577	34	22	the	the	DET
dpc-2577	34	23	study	study	NOUN
dpc-2577	34	24	was	be	AUX
dpc-2577	34	25	based	base	VERB
dpc-2577	34	26	on	on	ADP
dpc-2577	34	27	an	an	DET
dpc-2577	34	28	anonymously	anonymously	ADV
dpc-2577	34	29	filled	fill	VERB
dpc-2577	34	30	online	online	ADJ
dpc-2577	34	31	survey	survey	NOUN
dpc-2577	34	32	prepared	prepare	VERB
dpc-2577	34	33	by	by	ADP
dpc-2577	34	34	the	the	DET
dpc-2577	34	35	authors	author	NOUN
dpc-2577	34	36	.	.	PUNCT
dpc-2577	35	1	individuals	individual	NOUN
dpc-2577	35	2	with	with	ADP
dpc-2577	35	3	cu	cu	PROPN
dpc-2577	35	4	and	and	CCONJ
dpc-2577	35	5	parents	parent	NOUN
dpc-2577	35	6	of	of	ADP
dpc-2577	35	7	children	child	NOUN
dpc-2577	35	8	with	with	ADP
dpc-2577	35	9	cu	cu	PROPN
dpc-2577	35	10	were	be	AUX
dpc-2577	35	11	recruited	recruit	VERB
dpc-2577	35	12	for	for	ADP
dpc-2577	35	13	participation	participation	NOUN
dpc-2577	35	14	in	in	ADP
dpc-2577	35	15	the	the	DET
dpc-2577	35	16	study	study	NOUN
dpc-2577	35	17	through	through	ADP
dpc-2577	35	18	closed	close	VERB
dpc-2577	35	19	membership	membership	NOUN
dpc-2577	35	20	cu	cu	PROPN
dpc-2577	35	21	support	support	NOUN
dpc-2577	35	22	groups	group	NOUN
dpc-2577	35	23	found	find	VERB
dpc-2577	35	24	on	on	ADP
dpc-2577	35	25	social	social	ADJ
dpc-2577	35	26	media	medium	NOUN
dpc-2577	35	27	platforms	platform	NOUN
dpc-2577	35	28	(	(	PUNCT
dpc-2577	35	29	facebook	facebook	PROPN
dpc-2577	35	30	)	)	PUNCT
dpc-2577	35	31	.	.	PUNCT
dpc-2577	36	1	individuals	individual	NOUN
dpc-2577	36	2	interested	interested	ADJ
dpc-2577	36	3	in	in	ADP
dpc-2577	36	4	participating	participate	VERB
dpc-2577	36	5	in	in	ADP
dpc-2577	36	6	the	the	DET
dpc-2577	36	7	survey	survey	NOUN
dpc-2577	36	8	were	be	AUX
dpc-2577	36	9	directed	direct	VERB
dpc-2577	36	10	through	through	ADP
dpc-2577	36	11	an	an	DET
dpc-2577	36	12	introduction	introduction	NOUN
dpc-2577	36	13	and	and	CCONJ
dpc-2577	36	14	implicit	implicit	ADJ
dpc-2577	36	15	consent	consent	NOUN
dpc-2577	36	16	into	into	ADP
dpc-2577	36	17	google	google	PROPN
dpc-2577	36	18	forms	form	NOUN
dpc-2577	36	19	.	.	PUNCT
dpc-2577	37	1	the	the	DET
dpc-2577	37	2	questionnaire	questionnaire	NOUN
dpc-2577	37	3	consisted	consist	VERB
dpc-2577	37	4	of	of	ADP
dpc-2577	37	5	20	20	NUM
dpc-2577	37	6	questions	question	NOUN
dpc-2577	37	7	:	:	PUNCT
dpc-2577	37	8	7	7	NUM
dpc-2577	37	9	single	single	ADJ
dpc-2577	37	10	-	-	PUNCT
dpc-2577	37	11	choice	choice	NOUN
dpc-2577	37	12	and	and	CCONJ
dpc-2577	37	13	13	13	NUM
dpc-2577	37	14	multiple	multiple	ADJ
dpc-2577	37	15	-	-	PUNCT
dpc-2577	37	16	choice	choice	NOUN
dpc-2577	37	17	.	.	PUNCT
dpc-2577	38	1	single	single	ADJ
dpc-2577	38	2	-	-	PUNCT
dpc-2577	38	3	choice	choice	NOUN
dpc-2577	38	4	questions	question	NOUN
dpc-2577	38	5	concerned	concern	VERB
dpc-2577	38	6	basic	basic	ADJ
dpc-2577	38	7	demographic	demographic	ADJ
dpc-2577	38	8	information	information	NOUN
dpc-2577	38	9	,	,	PUNCT
dpc-2577	38	10	presence	presence	NOUN
dpc-2577	38	11	of	of	ADP
dpc-2577	38	12	angioedema	angioedema	SYM
dpc-2577	38	13	,	,	PUNCT
dpc-2577	38	14	age	age	NOUN
dpc-2577	38	15	of	of	ADP
dpc-2577	38	16	the	the	DET
dpc-2577	38	17	first	first	ADJ
dpc-2577	38	18	episode	episode	NOUN
dpc-2577	38	19	of	of	ADP
dpc-2577	38	20	cu	cu	PROPN
dpc-2577	38	21	,	,	PUNCT
dpc-2577	38	22	and	and	CCONJ
dpc-2577	38	23	frequency	frequency	NOUN
dpc-2577	38	24	of	of	ADP
dpc-2577	38	25	cu	cu	PROPN
dpc-2577	38	26	symptoms	symptom	NOUN
dpc-2577	38	27	.	.	PUNCT
dpc-2577	39	1	multiple	multiple	ADJ
dpc-2577	39	2	-	-	PUNCT
dpc-2577	39	3	choice	choice	NOUN
dpc-2577	39	4	questions	question	NOUN
dpc-2577	39	5	concerned	concern	VERB
dpc-2577	39	6	information	information	NOUN
dpc-2577	39	7	about	about	ADP
dpc-2577	39	8	diagnosed	diagnose	VERB
dpc-2577	39	9	types	type	NOUN
dpc-2577	39	10	of	of	ADP
dpc-2577	39	11	cu	cu	PROPN
dpc-2577	39	12	,	,	PUNCT
dpc-2577	39	13	localization	localization	NOUN
dpc-2577	39	14	of	of	ADP
dpc-2577	39	15	angioedema	angioedema	ADJ
dpc-2577	39	16	,	,	PUNCT
dpc-2577	39	17	family	family	NOUN
dpc-2577	39	18	history	history	NOUN
dpc-2577	39	19	of	of	ADP
dpc-2577	39	20	urticaria	urticaria	NOUN
dpc-2577	39	21	and	and	CCONJ
dpc-2577	39	22	atopy	atopy	NOUN
dpc-2577	39	23	,	,	PUNCT
dpc-2577	39	24	family	family	NOUN
dpc-2577	39	25	history	history	NOUN
dpc-2577	39	26	of	of	ADP
dpc-2577	39	27	autoimmune	autoimmune	ADJ
dpc-2577	39	28	diseases	disease	NOUN
dpc-2577	39	29	,	,	PUNCT
dpc-2577	39	30	the	the	DET
dpc-2577	39	31	coexistence	coexistence	NOUN
dpc-2577	39	32	of	of	ADP
dpc-2577	39	33	connective	connective	ADJ
dpc-2577	39	34	tissue	tissue	NOUN
dpc-2577	39	35	,	,	PUNCT
dpc-2577	39	36	thyroid	thyroid	NOUN
dpc-2577	39	37	gland	gland	NOUN
dpc-2577	39	38	,	,	PUNCT
dpc-2577	39	39	digestive	digestive	ADJ
dpc-2577	39	40	system	system	NOUN
dpc-2577	39	41	,	,	PUNCT
dpc-2577	39	42	inflammatory	inflammatory	ADJ
dpc-2577	39	43	diseases	disease	NOUN
dpc-2577	39	44	,	,	PUNCT
dpc-2577	39	45	metabolic	metabolic	NOUN
dpc-2577	39	46	and	and	CCONJ
dpc-2577	39	47	cardiovascular	cardiovascular	ADJ
dpc-2577	39	48	diseases	disease	NOUN
dpc-2577	39	49	,	,	PUNCT
dpc-2577	39	50	skin	skin	NOUN
dpc-2577	39	51	diseases	disease	NOUN
dpc-2577	39	52	,	,	PUNCT
dpc-2577	39	53	allergic	allergic	ADJ
dpc-2577	39	54	diseases	disease	NOUN
dpc-2577	39	55	,	,	PUNCT
dpc-2577	39	56	mental	mental	ADJ
dpc-2577	39	57	disorders	disorder	NOUN
dpc-2577	39	58	,	,	PUNCT
dpc-2577	39	59	neoplasm	neoplasm	ADJ
dpc-2577	39	60	diseases	disease	NOUN
dpc-2577	39	61	,	,	PUNCT
dpc-2577	39	62	and	and	CCONJ
dpc-2577	39	63	others	other	NOUN
dpc-2577	39	64	that	that	SCONJ
dpc-2577	39	65	individuals	individual	NOUN
dpc-2577	39	66	could	could	AUX
dpc-2577	39	67	add	add	VERB
dpc-2577	39	68	in	in	ADP
dpc-2577	39	69	a	a	DET
dpc-2577	39	70	designated	designate	VERB
dpc-2577	39	71	place	place	NOUN
dpc-2577	39	72	.	.	PUNCT
dpc-2577	40	1	data	datum	NOUN
dpc-2577	40	2	about	about	ADP
dpc-2577	40	3	family	family	NOUN
dpc-2577	40	4	history	history	NOUN
dpc-2577	40	5	of	of	ADP
dpc-2577	40	6	atopy	atopy	NOUN
dpc-2577	40	7	was	be	AUX
dpc-2577	40	8	defined	define	VERB
dpc-2577	40	9	as	as	ADP
dpc-2577	40	10	the	the	DET
dpc-2577	40	11	presence	presence	NOUN
dpc-2577	40	12	of	of	ADP
dpc-2577	40	13	asthma	asthma	NOUN
dpc-2577	40	14	,	,	PUNCT
dpc-2577	40	15	eczema	eczema	NOUN
dpc-2577	40	16	,	,	PUNCT
dpc-2577	40	17	allergic	allergic	ADJ
dpc-2577	40	18	rhinitis	rhinitis	NOUN
dpc-2577	40	19	,	,	PUNCT
dpc-2577	40	20	or	or	CCONJ
dpc-2577	40	21	rhino	rhino	NOUN
dpc-2577	40	22	conjunctivitis	conjunctivitis	NOUN
dpc-2577	40	23	,	,	PUNCT
dpc-2577	40	24	whereas	whereas	SCONJ
dpc-2577	40	25	autoimmune	autoimmune	ADJ
dpc-2577	40	26	diseases	disease	NOUN
dpc-2577	40	27	were	be	AUX
dpc-2577	40	28	defined	define	VERB
dpc-2577	40	29	as	as	ADP
dpc-2577	40	30	hashimoto	hashimoto	NOUN
dpc-2577	40	31	’s	’s	PART
dpc-2577	40	32	thyroiditis	thyroiditis	NOUN
dpc-2577	40	33	,	,	PUNCT
dpc-2577	40	34	systemic	systemic	ADJ
dpc-2577	40	35	lupus	lupus	PROPN
dpc-2577	40	36	erythematosus	erythematosus	NOUN
dpc-2577	40	37	,	,	PUNCT
dpc-2577	40	38	pernicious	pernicious	ADJ
dpc-2577	40	39	anemia	anemia	NOUN
dpc-2577	40	40	,	,	PUNCT
dpc-2577	40	41	vitiligo	vitiligo	VERB
dpc-2577	40	42	,	,	PUNCT
dpc-2577	40	43	graves	grave	NOUN
dpc-2577	40	44	’	'	PUNCT
dpc-2577	40	45	disease	disease	NOUN
dpc-2577	40	46	,	,	PUNCT
dpc-2577	40	47	rheumatoid	rheumatoid	NOUN
dpc-2577	40	48	arthritis	arthritis	NOUN
dpc-2577	40	49	,	,	PUNCT
dpc-2577	40	50	celiac	celiac	ADJ
dpc-2577	40	51	disease	disease	NOUN
dpc-2577	40	52	,	,	PUNCT
dpc-2577	40	53	alopecia	alopecia	NOUN
dpc-2577	40	54	areata	areata	NOUN
dpc-2577	40	55	,	,	PUNCT
dpc-2577	40	56	sclerosis	sclerosis	NOUN
dpc-2577	40	57	multiplex	multiplex	PROPN
dpc-2577	40	58	,	,	PUNCT
dpc-2577	40	59	scleroderma	scleroderma	NOUN
dpc-2577	40	60	,	,	PUNCT
dpc-2577	40	61	diabetes	diabetes	NOUN
dpc-2577	40	62	mellitus	mellitus	NOUN
dpc-2577	40	63	type	type	VERB
dpc-2577	40	64	1	1	NUM
dpc-2577	40	65	,	,	PUNCT
dpc-2577	40	66	crohn	crohn	NOUN
dpc-2577	40	67	’	'	PUNCT
dpc-2577	40	68	disease	disease	NOUN
dpc-2577	40	69	and	and	CCONJ
dpc-2577	40	70	ulcerative	ulcerative	ADJ
dpc-2577	40	71	colitis	colitis	NOUN
dpc-2577	40	72	.	.	PUNCT
dpc-2577	41	1	a	a	DET
dpc-2577	41	2	total	total	NOUN
dpc-2577	41	3	of	of	ADP
dpc-2577	41	4	102	102	NUM
dpc-2577	41	5	people	people	NOUN
dpc-2577	41	6	(	(	PUNCT
dpc-2577	41	7	97	97	NUM
dpc-2577	41	8	women	woman	NOUN
dpc-2577	41	9	and	and	CCONJ
dpc-2577	41	10	5	5	NUM
dpc-2577	41	11	men	man	NOUN
dpc-2577	41	12	)	)	PUNCT
dpc-2577	41	13	took	take	VERB
dpc-2577	41	14	part	part	NOUN
dpc-2577	41	15	in	in	ADP
dpc-2577	41	16	this	this	DET
dpc-2577	41	17	survey	survey	NOUN
dpc-2577	41	18	.	.	PUNCT
dpc-2577	42	1	the	the	DET
dpc-2577	42	2	average	average	ADJ
dpc-2577	42	3	age	age	NOUN
dpc-2577	42	4	of	of	ADP
dpc-2577	42	5	patients	patient	NOUN
dpc-2577	42	6	was	be	AUX
dpc-2577	42	7	33.8	33.8	NUM
dpc-2577	42	8	years	year	NOUN
dpc-2577	42	9	(	(	PUNCT
dpc-2577	42	10	range	range	NOUN
dpc-2577	42	11	,	,	PUNCT
dpc-2577	42	12	9	9	NUM
dpc-2577	42	13	-	-	SYM
dpc-2577	42	14	57	57	NUM
dpc-2577	42	15	years	year	NOUN
dpc-2577	42	16	)	)	PUNCT
dpc-2577	42	17	.	.	PUNCT
dpc-2577	43	1	the	the	DET
dpc-2577	43	2	results	result	NOUN
dpc-2577	43	3	were	be	AUX
dpc-2577	43	4	analyzed	analyze	VERB
dpc-2577	43	5	in	in	ADP
dpc-2577	43	6	microsoft	microsoft	PROPN
dpc-2577	43	7	excel	excel	VERB
dpc-2577	43	8	2016	2016	NUM
dpc-2577	43	9	and	and	CCONJ
dpc-2577	43	10	presented	present	VERB
dpc-2577	43	11	on	on	ADP
dpc-2577	43	12	a	a	DET
dpc-2577	43	13	percentage	percentage	NOUN
dpc-2577	43	14	scale	scale	NOUN
dpc-2577	43	15	.	.	PUNCT
dpc-2577	44	1	the	the	DET
dpc-2577	44	2	study	study	NOUN
dpc-2577	44	3	was	be	AUX
dpc-2577	44	4	approved	approve	VERB
dpc-2577	44	5	by	by	ADP
dpc-2577	44	6	the	the	DET
dpc-2577	44	7	independent	independent	ADJ
dpc-2577	44	8	bioethics	bioethics	PROPN
dpc-2577	44	9	committee	committee	NOUN
dpc-2577	44	10	for	for	ADP
dpc-2577	44	11	scientific	scientific	ADJ
dpc-2577	44	12	research	research	NOUN
dpc-2577	44	13	at	at	ADP
dpc-2577	44	14	the	the	DET
dpc-2577	44	15	medical	medical	ADJ
dpc-2577	44	16	university	university	PROPN
dpc-2577	44	17	of	of	ADP
dpc-2577	44	18	gdansk	gdansk	PROPN
dpc-2577	44	19	(	(	PUNCT
dpc-2577	44	20	nkbbn/833/2021	nkbbn/833/2021	PROPN
dpc-2577	44	21	)	)	PUNCT
dpc-2577	44	22	.	.	PUNCT
dpc-2577	45	1	results	result	VERB
dpc-2577	45	2	the	the	DET
dpc-2577	45	3	majority	majority	NOUN
dpc-2577	45	4	of	of	ADP
dpc-2577	45	5	cu	cu	PROPN
dpc-2577	45	6	patients	patient	NOUN
dpc-2577	45	7	were	be	AUX
dpc-2577	45	8	19–39	19–39	NUM
dpc-2577	45	9	years	year	NOUN
dpc-2577	45	10	old	old	ADJ
dpc-2577	45	11	(	(	PUNCT
dpc-2577	45	12	59.8	59.8	NUM
dpc-2577	45	13	%	%	NOUN
dpc-2577	45	14	)	)	PUNCT
dpc-2577	45	15	,	,	PUNCT
dpc-2577	45	16	followed	follow	VERB
dpc-2577	45	17	by	by	ADP
dpc-2577	45	18	patients	patient	NOUN
dpc-2577	45	19	aged	age	VERB
dpc-2577	45	20	≥40	≥40	PROPN
dpc-2577	45	21	years	year	NOUN
dpc-2577	45	22	old	old	ADJ
dpc-2577	45	23	(	(	PUNCT
dpc-2577	45	24	33.3	33.3	NUM
dpc-2577	45	25	%	%	NOUN
dpc-2577	45	26	)	)	PUNCT
dpc-2577	45	27	,	,	PUNCT
dpc-2577	45	28	while	while	SCONJ
dpc-2577	45	29	a	a	DET
dpc-2577	45	30	small	small	ADJ
dpc-2577	45	31	proportion	proportion	NOUN
dpc-2577	45	32	,	,	PUNCT
dpc-2577	45	33	6.9	6.9	NUM
dpc-2577	45	34	%	%	NOUN
dpc-2577	45	35	of	of	ADP
dpc-2577	45	36	patients	patient	NOUN
dpc-2577	45	37	were	be	AUX
dpc-2577	45	38	≤18	≤18	ADJ
dpc-2577	45	39	years	year	NOUN
dpc-2577	45	40	old	old	ADJ
dpc-2577	45	41	.	.	PUNCT
dpc-2577	46	1	the	the	DET
dpc-2577	46	2	vast	vast	ADJ
dpc-2577	46	3	majority	majority	NOUN
dpc-2577	46	4	of	of	ADP
dpc-2577	46	5	the	the	DET
dpc-2577	46	6	respondents	respondent	NOUN
dpc-2577	46	7	(	(	PUNCT
dpc-2577	46	8	80.4	80.4	NUM
dpc-2577	46	9	%	%	NOUN
dpc-2577	46	10	)	)	PUNCT
dpc-2577	46	11	lived	live	VERB
dpc-2577	46	12	in	in	ADP
dpc-2577	46	13	cities	city	NOUN
dpc-2577	46	14	,	,	PUNCT
dpc-2577	46	15	the	the	DET
dpc-2577	46	16	remaining	remain	VERB
dpc-2577	46	17	19.6	19.6	NUM
dpc-2577	46	18	%	%	NOUN
dpc-2577	46	19	lived	live	VERB
dpc-2577	46	20	in	in	ADP
dpc-2577	46	21	villages	village	NOUN
dpc-2577	46	22	.	.	PUNCT
dpc-2577	47	1	more	more	ADJ
dpc-2577	47	2	than	than	ADP
dpc-2577	47	3	half	half	NOUN
dpc-2577	47	4	of	of	ADP
dpc-2577	47	5	the	the	DET
dpc-2577	47	6	respondents	respondent	NOUN
dpc-2577	47	7	(	(	PUNCT
dpc-2577	47	8	63.7	63.7	NUM
dpc-2577	47	9	%	%	NOUN
dpc-2577	47	10	)	)	PUNCT
dpc-2577	47	11	reported	report	VERB
dpc-2577	47	12	higher	high	ADJ
dpc-2577	47	13	education	education	NOUN
dpc-2577	47	14	,	,	PUNCT
dpc-2577	47	15	17.6	17.6	NUM
dpc-2577	47	16	%	%	NOUN
dpc-2577	47	17	secondary	secondary	ADJ
dpc-2577	47	18	,	,	PUNCT
dpc-2577	47	19	and	and	CCONJ
dpc-2577	47	20	3.9	3.9	NUM
dpc-2577	47	21	%	%	NOUN
dpc-2577	47	22	vocational	vocational	ADJ
dpc-2577	47	23	.	.	PUNCT
dpc-2577	48	1	nearly	nearly	ADV
dpc-2577	48	2	16	16	NUM
dpc-2577	48	3	%	%	NOUN
dpc-2577	48	4	of	of	ADP
dpc-2577	48	5	respondents	respondent	NOUN
dpc-2577	48	6	were	be	AUX
dpc-2577	48	7	studying	study	VERB
dpc-2577	48	8	.	.	PUNCT
dpc-2577	49	1	the	the	DET
dpc-2577	49	2	mean	mean	ADJ
dpc-2577	49	3	age	age	NOUN
dpc-2577	49	4	at	at	ADP
dpc-2577	49	5	disease	disease	NOUN
dpc-2577	49	6	onset	onset	NOUN
dpc-2577	49	7	was	be	AUX
dpc-2577	49	8	27.5	27.5	NUM
dpc-2577	49	9	years	year	NOUN
dpc-2577	49	10	(	(	PUNCT
dpc-2577	49	11	range	range	NOUN
dpc-2577	49	12	,	,	PUNCT
dpc-2577	49	13	3–55	3–55	PROPN
dpc-2577	49	14	years	year	NOUN
dpc-2577	49	15	)	)	PUNCT
dpc-2577	49	16	.	.	PUNCT
dpc-2577	50	1	among	among	ADP
dpc-2577	50	2	all	all	DET
dpc-2577	50	3	patients	patient	NOUN
dpc-2577	50	4	,	,	PUNCT
dpc-2577	50	5	the	the	DET
dpc-2577	50	6	most	most	ADV
dpc-2577	50	7	frequent	frequent	ADJ
dpc-2577	50	8	type	type	NOUN
dpc-2577	50	9	of	of	ADP
dpc-2577	50	10	cu	cu	PROPN
dpc-2577	50	11	was	be	AUX
dpc-2577	50	12	csu	csu	VERB
dpc-2577	50	13	,	,	PUNCT
dpc-2577	50	14	diagnosed	diagnose	VERB
dpc-2577	50	15	in	in	ADP
dpc-2577	50	16	78.4	78.4	NUM
dpc-2577	50	17	%	%	NOUN
dpc-2577	50	18	.	.	PUNCT
dpc-2577	51	1	autoimmune	autoimmune	ADJ
dpc-2577	51	2	urticaria	urticaria	PROPN
dpc-2577	51	3	,	,	PUNCT
dpc-2577	51	4	which	which	PRON
dpc-2577	51	5	is	be	AUX
dpc-2577	51	6	a	a	DET
dpc-2577	51	7	subtype	subtype	NOUN
dpc-2577	51	8	of	of	ADP
dpc-2577	51	9	csu	csu	PROPN
dpc-2577	51	10	,	,	PUNCT
dpc-2577	51	11	was	be	AUX
dpc-2577	51	12	diagnosed	diagnose	VERB
dpc-2577	51	13	in	in	ADP
dpc-2577	51	14	25.5	25.5	NUM
dpc-2577	51	15	%	%	NOUN
dpc-2577	51	16	.	.	PUNCT
dpc-2577	52	1	among	among	ADP
dpc-2577	52	2	all	all	DET
dpc-2577	52	3	patients	patient	NOUN
dpc-2577	52	4	with	with	ADP
dpc-2577	52	5	cu	cu	PROPN
dpc-2577	52	6	,	,	PUNCT
dpc-2577	52	7	59.8	59.8	NUM
dpc-2577	52	8	%	%	NOUN
dpc-2577	52	9	were	be	AUX
dpc-2577	52	10	diagnosed	diagnose	VERB
dpc-2577	52	11	with	with	ADP
dpc-2577	52	12	csu	csu	PROPN
dpc-2577	52	13	only	only	ADV
dpc-2577	52	14	,	,	PUNCT
dpc-2577	52	15	21.6	21.6	NUM
dpc-2577	52	16	%	%	NOUN
dpc-2577	52	17	were	be	AUX
dpc-2577	52	18	diagnosed	diagnose	VERB
dpc-2577	52	19	with	with	ADP
dpc-2577	52	20	isolated	isolated	ADJ
dpc-2577	52	21	cindu	cindu	NOUN
dpc-2577	52	22	only	only	ADV
dpc-2577	52	23	and	and	CCONJ
dpc-2577	52	24	the	the	DET
dpc-2577	52	25	remaining	remain	VERB
dpc-2577	52	26	18.6	18.6	NUM
dpc-2577	52	27	%	%	NOUN
dpc-2577	52	28	had	have	VERB
dpc-2577	52	29	a	a	DET
dpc-2577	52	30	combination	combination	NOUN
dpc-2577	52	31	of	of	ADP
dpc-2577	52	32	both	both	DET
dpc-2577	52	33	types	type	NOUN
dpc-2577	52	34	.	.	PUNCT
dpc-2577	53	1	the	the	DET
dpc-2577	53	2	most	most	ADV
dpc-2577	53	3	common	common	ADJ
dpc-2577	53	4	subtypes	subtype	NOUN
dpc-2577	53	5	of	of	ADP
dpc-2577	53	6	cindu	cindu	NOUN
dpc-2577	53	7	were	be	AUX
dpc-2577	53	8	delayed	delay	VERB
dpc-2577	53	9	pressure	pressure	NOUN
dpc-2577	53	10	urticaria	urticaria	NOUN
dpc-2577	53	11	(	(	PUNCT
dpc-2577	53	12	21.6	21.6	NUM
dpc-2577	53	13	%	%	NOUN
dpc-2577	53	14	)	)	PUNCT
dpc-2577	53	15	,	,	PUNCT
dpc-2577	53	16	symptomatic	symptomatic	ADJ
dpc-2577	53	17	dermographism	dermographism	NOUN
dpc-2577	53	18	(	(	PUNCT
dpc-2577	53	19	14.7	14.7	NUM
dpc-2577	53	20	%	%	NOUN
dpc-2577	53	21	)	)	PUNCT
dpc-2577	53	22	,	,	PUNCT
dpc-2577	53	23	and	and	CCONJ
dpc-2577	53	24	cholinergic	cholinergic	ADJ
dpc-2577	53	25	urticaria	urticaria	NOUN
dpc-2577	53	26	(	(	PUNCT
dpc-2577	53	27	8.8	8.8	NUM
dpc-2577	53	28	%	%	NOUN
dpc-2577	53	29	;	;	PUNCT
dpc-2577	53	30	fig	fig	NOUN
dpc-2577	53	31	1	1	NUM
dpc-2577	53	32	)	)	PUNCT
dpc-2577	53	33	.	.	PUNCT
dpc-2577	54	1	angioedema	angioedema	NOUN
dpc-2577	54	2	symptoms	symptom	NOUN
dpc-2577	54	3	were	be	AUX
dpc-2577	54	4	reported	report	VERB
dpc-2577	54	5	by	by	ADP
dpc-2577	54	6	70	70	NUM
dpc-2577	54	7	patients	patient	NOUN
dpc-2577	54	8	(	(	PUNCT
dpc-2577	54	9	68.6	68.6	NUM
dpc-2577	54	10	%	%	NOUN
dpc-2577	54	11	)	)	PUNCT
dpc-2577	54	12	and	and	CCONJ
dpc-2577	54	13	occurred	occur	VERB
dpc-2577	54	14	mainly	mainly	ADV
dpc-2577	54	15	in	in	ADP
dpc-2577	54	16	patients	patient	NOUN
dpc-2577	54	17	with	with	ADP
dpc-2577	54	18	delayed	delay	VERB
dpc-2577	54	19	pressure	pressure	NOUN
dpc-2577	54	20	urticaria	urticaria	NOUN
dpc-2577	54	21	(	(	PUNCT
dpc-2577	54	22	86.4	86.4	NUM
dpc-2577	54	23	%	%	NOUN
dpc-2577	54	24	;	;	PUNCT
dpc-2577	54	25	fig	fig	NOUN
dpc-2577	54	26	2	2	NUM
dpc-2577	54	27	)	)	PUNCT
dpc-2577	54	28	.	.	PUNCT
dpc-2577	55	1	of	of	ADP
dpc-2577	55	2	the	the	DET
dpc-2577	55	3	70	70	NUM
dpc-2577	55	4	patients	patient	NOUN
dpc-2577	55	5	who	who	PRON
dpc-2577	55	6	experienced	experience	VERB
dpc-2577	55	7	symptoms	symptom	NOUN
dpc-2577	55	8	of	of	ADP
dpc-2577	55	9	angioedema	angioedema	NOUN
dpc-2577	55	10	,	,	PUNCT
dpc-2577	55	11	the	the	DET
dpc-2577	55	12	most	most	ADV
dpc-2577	55	13	frequently	frequently	ADV
dpc-2577	55	14	reported	report	VERB
dpc-2577	55	15	locations	location	NOUN
dpc-2577	55	16	for	for	ADP
dpc-2577	55	17	angioedema	angioedema	NOUN
dpc-2577	55	18	were	be	AUX
dpc-2577	55	19	non	non	ADJ
dpc-2577	55	20	-	-	ADJ
dpc-2577	55	21	facial	facial	ADJ
dpc-2577	55	22	body	body	NOUN
dpc-2577	55	23	areas	area	NOUN
dpc-2577	55	24	(	(	PUNCT
dpc-2577	55	25	82.9	82.9	NUM
dpc-2577	55	26	%	%	NOUN
dpc-2577	55	27	)	)	PUNCT
dpc-2577	55	28	,	,	PUNCT
dpc-2577	55	29	most	most	ADV
dpc-2577	55	30	commonly	commonly	ADV
dpc-2577	55	31	the	the	DET
dpc-2577	55	32	hands	hand	NOUN
dpc-2577	55	33	(	(	PUNCT
dpc-2577	55	34	68.6	68.6	NUM
dpc-2577	55	35	%	%	NOUN
dpc-2577	55	36	)	)	PUNCT
dpc-2577	55	37	,	,	PUNCT
dpc-2577	55	38	feet	foot	NOUN
dpc-2577	55	39	(	(	PUNCT
dpc-2577	55	40	57.1	57.1	NUM
dpc-2577	55	41	%	%	NOUN
dpc-2577	55	42	)	)	PUNCT
dpc-2577	55	43	,	,	PUNCT
dpc-2577	55	44	over	over	ADP
dpc-2577	55	45	joints	joint	NOUN
dpc-2577	55	46	(	(	PUNCT
dpc-2577	55	47	35.7	35.7	NUM
dpc-2577	55	48	%	%	NOUN
dpc-2577	55	49	)	)	PUNCT
dpc-2577	55	50	,	,	PUNCT
dpc-2577	55	51	and	and	CCONJ
dpc-2577	55	52	trunk	trunk	NOUN
dpc-2577	55	53	(	(	PUNCT
dpc-2577	55	54	5.7	5.7	NUM
dpc-2577	55	55	%	%	NOUN
dpc-2577	55	56	)	)	PUNCT
dpc-2577	55	57	.	.	PUNCT
dpc-2577	56	1	17.1	17.1	NUM
dpc-2577	56	2	%	%	NOUN
dpc-2577	56	3	of	of	ADP
dpc-2577	56	4	patients	patient	NOUN
dpc-2577	56	5	reported	report	VERB
dpc-2577	56	6	experiencing	experience	VERB
dpc-2577	56	7	swelling	swell	VERB
dpc-2577	56	8	symptoms	symptom	NOUN
dpc-2577	56	9	over	over	ADP
dpc-2577	56	10	the	the	DET
dpc-2577	56	11	whole	whole	ADJ
dpc-2577	56	12	body	body	NOUN
dpc-2577	56	13	.	.	PUNCT
dpc-2577	57	1	on	on	ADP
dpc-2577	57	2	the	the	DET
dpc-2577	57	3	face	face	NOUN
dpc-2577	57	4	,	,	PUNCT
dpc-2577	57	5	angioedema	angioedema	VERB
dpc-2577	57	6	occurred	occur	VERB
dpc-2577	57	7	in	in	ADP
dpc-2577	57	8	68.6	68.6	NUM
dpc-2577	57	9	%	%	NOUN
dpc-2577	57	10	of	of	ADP
dpc-2577	57	11	patients	patient	NOUN
dpc-2577	57	12	:	:	PUNCT
dpc-2577	57	13	the	the	DET
dpc-2577	57	14	areas	area	NOUN
dpc-2577	57	15	around	around	ADP
dpc-2577	57	16	the	the	DET
dpc-2577	57	17	eyes	eye	NOUN
dpc-2577	57	18	were	be	AUX
dpc-2577	57	19	affected	affect	VERB
dpc-2577	57	20	in	in	ADP
dpc-2577	57	21	67.1	67.1	NUM
dpc-2577	57	22	%	%	NOUN
dpc-2577	57	23	of	of	ADP
dpc-2577	57	24	cases	case	NOUN
dpc-2577	57	25	,	,	PUNCT
dpc-2577	57	26	the	the	DET
dpc-2577	57	27	lips	lip	NOUN
dpc-2577	57	28	in	in	ADP
dpc-2577	57	29	65.7	65.7	NUM
dpc-2577	57	30	%	%	NOUN
dpc-2577	57	31	,	,	PUNCT
dpc-2577	57	32	the	the	DET
dpc-2577	57	33	oral	oral	ADJ
dpc-2577	57	34	mucosa	mucosa	NOUN
dpc-2577	57	35	in	in	ADP
dpc-2577	57	36	12.9	12.9	NUM
dpc-2577	57	37	%	%	NOUN
dpc-2577	57	38	,	,	PUNCT
dpc-2577	57	39	and	and	CCONJ
dpc-2577	57	40	the	the	DET
dpc-2577	57	41	tongue	tongue	NOUN
dpc-2577	57	42	in	in	ADP
dpc-2577	57	43	11.4	11.4	NUM
dpc-2577	57	44	%	%	NOUN
dpc-2577	57	45	.	.	PUNCT
dpc-2577	58	1	in	in	ADP
dpc-2577	58	2	more	more	ADJ
dpc-2577	58	3	than	than	ADP
dpc-2577	58	4	half	half	NOUN
dpc-2577	58	5	of	of	ADP
dpc-2577	58	6	the	the	DET
dpc-2577	58	7	cases	case	NOUN
dpc-2577	58	8	(	(	PUNCT
dpc-2577	58	9	59.8	59.8	NUM
dpc-2577	58	10	%	%	NOUN
dpc-2577	58	11	)	)	PUNCT
dpc-2577	58	12	,	,	PUNCT
dpc-2577	58	13	hives	hive	NOUN
dpc-2577	58	14	appear	appear	VERB
dpc-2577	58	15	every	every	DET
dpc-2577	58	16	day	day	NOUN
dpc-2577	58	17	,	,	PUNCT
dpc-2577	58	18	in	in	ADP
dpc-2577	58	19	16.7	16.7	NUM
dpc-2577	58	20	%	%	NOUN
dpc-2577	58	21	several	several	ADJ
dpc-2577	58	22	times	time	NOUN
dpc-2577	58	23	a	a	DET
dpc-2577	58	24	week	week	NOUN
dpc-2577	58	25	,	,	PUNCT
dpc-2577	58	26	in	in	ADP
dpc-2577	58	27	8.8	8.8	NUM
dpc-2577	58	28	%	%	NOUN
dpc-2577	58	29	several	several	ADJ
dpc-2577	58	30	times	time	NOUN
dpc-2577	58	31	a	a	DET
dpc-2577	58	32	month	month	NOUN
dpc-2577	58	33	,	,	PUNCT
dpc-2577	58	34	in	in	ADP
dpc-2577	58	35	10.8	10.8	NUM
dpc-2577	58	36	%	%	NOUN
dpc-2577	58	37	several	several	ADJ
dpc-2577	58	38	times	time	NOUN
dpc-2577	58	39	a	a	DET
dpc-2577	58	40	year	year	NOUN
dpc-2577	58	41	,	,	PUNCT
dpc-2577	58	42	and	and	CCONJ
dpc-2577	58	43	in	in	ADP
dpc-2577	58	44	3.9	3.9	NUM
dpc-2577	58	45	%	%	NOUN
dpc-2577	58	46	less	less	ADV
dpc-2577	58	47	frequently	frequently	ADV
dpc-2577	58	48	.	.	PUNCT
dpc-2577	59	1	we	we	PRON
dpc-2577	59	2	examined	examine	VERB
dpc-2577	59	3	the	the	DET
dpc-2577	59	4	prevalence	prevalence	NOUN
dpc-2577	59	5	of	of	ADP
dpc-2577	59	6	reported	report	VERB
dpc-2577	59	7	comorbid	comorbid	NOUN
dpc-2577	59	8	diseases	disease	NOUN
dpc-2577	59	9	by	by	ADP
dpc-2577	59	10	cu	cu	PROPN
dpc-2577	59	11	patients	patient	NOUN
dpc-2577	59	12	,	,	PUNCT
dpc-2577	59	13	grouping	group	VERB
dpc-2577	59	14	them	they	PRON
dpc-2577	59	15	into	into	ADP
dpc-2577	59	16	10	10	NUM
dpc-2577	59	17	disease	disease	NOUN
dpc-2577	59	18	categories	category	NOUN
dpc-2577	59	19	.	.	PUNCT
dpc-2577	60	1	the	the	DET
dpc-2577	60	2	data	datum	NOUN
dpc-2577	60	3	presented	present	VERB
dpc-2577	60	4	in	in	ADP
dpc-2577	60	5	table	table	NOUN
dpc-2577	60	6	1	1	NUM
dpc-2577	60	7	summarize	summarize	VERB
dpc-2577	60	8	the	the	DET
dpc-2577	60	9	comorbidity	comorbidity	NOUN
dpc-2577	60	10	profile	profile	NOUN
dpc-2577	60	11	of	of	ADP
dpc-2577	60	12	cu	cu	PROPN
dpc-2577	60	13	patients	patient	NOUN
dpc-2577	60	14	.	.	PUNCT
dpc-2577	61	1	of	of	ADP
dpc-2577	61	2	102	102	NUM
dpc-2577	61	3	cu	cu	PROPN
dpc-2577	61	4	patients	patient	NOUN
dpc-2577	61	5	,	,	PUNCT
dpc-2577	61	6	85.3	85.3	NUM
dpc-2577	61	7	%	%	NOUN
dpc-2577	61	8	had	have	VERB
dpc-2577	61	9	one	one	NUM
dpc-2577	61	10	or	or	CCONJ
dpc-2577	61	11	more	more	ADV
dpc-2577	61	12	concomitant	concomitant	ADJ
dpc-2577	61	13	diseases	disease	NOUN
dpc-2577	61	14	.	.	PUNCT
dpc-2577	62	1	almost	almost	ADV
dpc-2577	62	2	50	50	NUM
dpc-2577	62	3	%	%	NOUN
dpc-2577	62	4	of	of	ADP
dpc-2577	62	5	patients	patient	NOUN
dpc-2577	62	6	had	have	VERB
dpc-2577	62	7	at	at	ADV
dpc-2577	62	8	least	least	ADV
dpc-2577	62	9	one	one	NUM
dpc-2577	62	10	atopic	atopic	NOUN
dpc-2577	62	11	disease	disease	NOUN
dpc-2577	62	12	or	or	CCONJ
dpc-2577	62	13	allergy	allergy	NOUN
dpc-2577	62	14	and	and	CCONJ
dpc-2577	62	15	it	it	PRON
dpc-2577	62	16	was	be	AUX
dpc-2577	62	17	the	the	DET
dpc-2577	62	18	most	most	ADV
dpc-2577	62	19	original	original	ADJ
dpc-2577	62	20	article	article	NOUN
dpc-2577	62	21	|	|	ADV
dpc-2577	62	22	dermatol	dermatol	ADJ
dpc-2577	62	23	pract	pract	NOUN
dpc-2577	62	24	concept	concept	NOUN
dpc-2577	62	25	.	.	PUNCT
dpc-2577	63	1	2023;13(1):e2023056	2023;13(1):e2023056	NUM
dpc-2577	63	2	3	3	NUM
dpc-2577	63	3	commonly	commonly	ADV
dpc-2577	63	4	reported	report	VERB
dpc-2577	63	5	group	group	NOUN
dpc-2577	63	6	of	of	ADP
dpc-2577	63	7	comorbidities	comorbiditie	NOUN
dpc-2577	63	8	,	,	PUNCT
dpc-2577	63	9	followed	follow	VERB
dpc-2577	63	10	by	by	ADP
dpc-2577	63	11	chronic	chronic	ADJ
dpc-2577	63	12	inflammation	inflammation	NOUN
dpc-2577	63	13	and	and	CCONJ
dpc-2577	63	14	infections	infection	NOUN
dpc-2577	63	15	(	(	PUNCT
dpc-2577	63	16	36.3	36.3	NUM
dpc-2577	63	17	%	%	NOUN
dpc-2577	63	18	)	)	PUNCT
dpc-2577	63	19	,	,	PUNCT
dpc-2577	63	20	  	  	SPACE
dpc-2577	63	21	thyroid	thyroid	NOUN
dpc-2577	63	22	disorders	disorder	NOUN
dpc-2577	63	23	(	(	PUNCT
dpc-2577	63	24	36.3	36.3	NUM
dpc-2577	63	25	%	%	NOUN
dpc-2577	63	26	)	)	PUNCT
dpc-2577	63	27	,	,	PUNCT
dpc-2577	63	28	psychiatric	psychiatric	ADJ
dpc-2577	63	29	disorders	disorder	NOUN
dpc-2577	63	30	(	(	PUNCT
dpc-2577	63	31	36.3	36.3	NUM
dpc-2577	63	32	%	%	NOUN
dpc-2577	63	33	)	)	PUNCT
dpc-2577	63	34	,	,	PUNCT
dpc-2577	63	35	skin	skin	NOUN
dpc-2577	63	36	diseases	disease	NOUN
dpc-2577	63	37	(	(	PUNCT
dpc-2577	63	38	18.6	18.6	NUM
dpc-2577	63	39	%	%	NOUN
dpc-2577	63	40	)	)	PUNCT
dpc-2577	63	41	,	,	PUNCT
dpc-2577	63	42	gastrointestinal	gastrointestinal	ADJ
dpc-2577	63	43	diseases	disease	NOUN
dpc-2577	63	44	(	(	PUNCT
dpc-2577	63	45	18.6	18.6	NUM
dpc-2577	63	46	%	%	NOUN
dpc-2577	63	47	)	)	PUNCT
dpc-2577	63	48	,	,	PUNCT
dpc-2577	63	49	cardiometabolic	cardiometabolic	NOUN
dpc-2577	63	50	diseases	disease	NOUN
dpc-2577	63	51	(	(	PUNCT
dpc-2577	63	52	10.8	10.8	NUM
dpc-2577	63	53	%	%	NOUN
dpc-2577	63	54	)	)	PUNCT
dpc-2577	63	55	,	,	PUNCT
dpc-2577	63	56	rheumatic	rheumatic	ADJ
dpc-2577	63	57	diseases	disease	NOUN
dpc-2577	63	58	(	(	PUNCT
dpc-2577	63	59	6.9	6.9	NUM
dpc-2577	63	60	%	%	NOUN
dpc-2577	63	61	)	)	PUNCT
dpc-2577	63	62	,	,	PUNCT
dpc-2577	63	63	malignancies	malignancy	NOUN
dpc-2577	63	64	(	(	PUNCT
dpc-2577	63	65	2.0	2.0	NUM
dpc-2577	63	66	%	%	NOUN
dpc-2577	63	67	)	)	PUNCT
dpc-2577	63	68	,	,	PUNCT
dpc-2577	63	69	and	and	CCONJ
dpc-2577	63	70	others	other	NOUN
dpc-2577	63	71	included	include	VERB
dpc-2577	63	72	migraine	migraine	NOUN
dpc-2577	63	73	,	,	PUNCT
dpc-2577	63	74	endometriosis	endometriosis	NOUN
dpc-2577	63	75	,	,	PUNCT
dpc-2577	63	76	pernicious	pernicious	ADJ
dpc-2577	63	77	anemia	anemia	NOUN
dpc-2577	63	78	and	and	CCONJ
dpc-2577	63	79	epilepsy	epilepsy	NOUN
dpc-2577	63	80	.	.	PUNCT
dpc-2577	64	1	among	among	ADP
dpc-2577	64	2	all	all	DET
dpc-2577	64	3	comorbidities	comorbiditie	NOUN
dpc-2577	64	4	reported	report	VERB
dpc-2577	64	5	by	by	ADP
dpc-2577	64	6	patients	patient	NOUN
dpc-2577	64	7	,	,	PUNCT
dpc-2577	64	8	we	we	PRON
dpc-2577	64	9	determined	determine	VERB
dpc-2577	64	10	autoimmune	autoimmune	ADJ
dpc-2577	64	11	diseases	disease	NOUN
dpc-2577	64	12	.	.	PUNCT
dpc-2577	65	1	of	of	ADP
dpc-2577	65	2	102	102	NUM
dpc-2577	65	3	cu	cu	PROPN
dpc-2577	65	4	patients	patient	NOUN
dpc-2577	65	5	,	,	PUNCT
dpc-2577	65	6	31	31	NUM
dpc-2577	65	7	(	(	PUNCT
dpc-2577	65	8	30.4	30.4	NUM
dpc-2577	65	9	%	%	NOUN
dpc-2577	65	10	)	)	PUNCT
dpc-2577	65	11	had	have	VERB
dpc-2577	65	12	one	one	NUM
dpc-2577	65	13	or	or	CCONJ
dpc-2577	65	14	more	more	ADJ
dpc-2577	65	15	comorbid	comorbid	ADJ
dpc-2577	65	16	autoimmune	autoimmune	ADJ
dpc-2577	65	17	diseases	disease	NOUN
dpc-2577	65	18	(	(	PUNCT
dpc-2577	65	19	table	table	NOUN
dpc-2577	65	20	2	2	NUM
dpc-2577	65	21	)	)	PUNCT
dpc-2577	65	22	.	.	PUNCT
dpc-2577	66	1	the	the	DET
dpc-2577	66	2	most	most	ADV
dpc-2577	66	3	prevalent	prevalent	ADJ
dpc-2577	66	4	were	be	AUX
dpc-2577	66	5	autoimmune	autoimmune	ADJ
dpc-2577	66	6	thyroid	thyroid	NOUN
dpc-2577	66	7	diseases	disease	NOUN
dpc-2577	66	8	(	(	PUNCT
dpc-2577	66	9	24.5	24.5	NUM
dpc-2577	66	10	%	%	NOUN
dpc-2577	66	11	,	,	PUNCT
dpc-2577	66	12	mostly	mostly	ADV
dpc-2577	66	13	ht	ht	X
dpc-2577	66	14	in	in	ADP
dpc-2577	66	15	22.5	22.5	NUM
dpc-2577	66	16	%	%	NOUN
dpc-2577	66	17	)	)	PUNCT
dpc-2577	66	18	.	.	PUNCT
dpc-2577	67	1	other	other	ADJ
dpc-2577	67	2	common	common	ADJ
dpc-2577	67	3	autoimmune	autoimmune	ADJ
dpc-2577	67	4	comorbidities	comorbiditie	NOUN
dpc-2577	67	5	included	include	VERB
dpc-2577	67	6	systemic	systemic	ADJ
dpc-2577	67	7	lupus	lupus	NOUN
dpc-2577	67	8	erythematosus	erythematosus	NOUN
dpc-2577	67	9	(	(	PUNCT
dpc-2577	67	10	2.9	2.9	NUM
dpc-2577	67	11	%	%	NOUN
dpc-2577	67	12	)	)	PUNCT
dpc-2577	67	13	and	and	CCONJ
dpc-2577	67	14	rheumatoid	rheumatoid	VERB
dpc-2577	67	15	arthritis	arthritis	NOUN
dpc-2577	67	16	(	(	PUNCT
dpc-2577	67	17	2.9	2.9	NUM
dpc-2577	67	18	%	%	NOUN
dpc-2577	67	19	)	)	PUNCT
dpc-2577	67	20	.	.	PUNCT
dpc-2577	68	1	of	of	ADP
dpc-2577	68	2	the	the	DET
dpc-2577	68	3	31	31	NUM
dpc-2577	68	4	cu	cu	PROPN
dpc-2577	68	5	patients	patient	NOUN
dpc-2577	68	6	with	with	ADP
dpc-2577	68	7	a	a	DET
dpc-2577	68	8	comorbid	comorbid	NOUN
dpc-2577	68	9	autoimmune	autoimmune	ADJ
dpc-2577	68	10	disease	disease	NOUN
dpc-2577	68	11	,	,	PUNCT
dpc-2577	68	12	74.2	74.2	NUM
dpc-2577	68	13	%	%	NOUN
dpc-2577	68	14	had	have	VERB
dpc-2577	68	15	one	one	NUM
dpc-2577	68	16	,	,	PUNCT
dpc-2577	68	17	most	most	ADV
dpc-2577	68	18	often	often	ADV
dpc-2577	68	19	ht	ht	X
dpc-2577	68	20	,	,	PUNCT
dpc-2577	68	21	22.6	22.6	NUM
dpc-2577	68	22	%	%	NOUN
dpc-2577	68	23	had	have	VERB
dpc-2577	68	24	2	2	NUM
dpc-2577	68	25	,	,	PUNCT
dpc-2577	68	26	and	and	CCONJ
dpc-2577	68	27	3.2	3.2	NUM
dpc-2577	68	28	%	%	NOUN
dpc-2577	68	29	had	have	VERB
dpc-2577	68	30	3	3	NUM
dpc-2577	68	31	(	(	PUNCT
dpc-2577	68	32	table	table	NOUN
dpc-2577	68	33	2	2	NUM
dpc-2577	68	34	)	)	PUNCT
dpc-2577	68	35	.	.	PUNCT
dpc-2577	69	1	as	as	SCONJ
dpc-2577	69	2	compared	compare	VERB
dpc-2577	69	3	to	to	ADP
dpc-2577	69	4	the	the	DET
dpc-2577	69	5	patients	patient	NOUN
dpc-2577	69	6	without	without	ADP
dpc-2577	69	7	autoimmune	autoimmune	ADJ
dpc-2577	69	8	urticaria	urticaria	NOUN
dpc-2577	69	9	,	,	PUNCT
dpc-2577	69	10	many	many	ADJ
dpc-2577	69	11	more	more	ADJ
dpc-2577	69	12	with	with	ADP
dpc-2577	69	13	autoimmune	autoimmune	ADJ
dpc-2577	69	14	urticaria	urticaria	NOUN
dpc-2577	69	15	had	have	VERB
dpc-2577	69	16	a	a	DET
dpc-2577	69	17	coexisting	coexist	VERB
dpc-2577	69	18	autoimmune	autoimmune	ADJ
dpc-2577	69	19	disease	disease	NOUN
dpc-2577	69	20	(	(	PUNCT
dpc-2577	69	21	50	50	NUM
dpc-2577	69	22	%	%	NOUN
dpc-2577	69	23	vs.	vs.	ADP
dpc-2577	69	24	23.7	23.7	NUM
dpc-2577	69	25	%	%	NOUN
dpc-2577	69	26	)	)	PUNCT
dpc-2577	69	27	.	.	PUNCT
dpc-2577	70	1	interestingly	interestingly	ADV
dpc-2577	70	2	,	,	PUNCT
dpc-2577	70	3	in	in	ADP
dpc-2577	70	4	43	43	NUM
dpc-2577	70	5	patients	patient	NOUN
dpc-2577	70	6	(	(	PUNCT
dpc-2577	70	7	42.2	42.2	NUM
dpc-2577	70	8	%	%	NOUN
dpc-2577	70	9	)	)	PUNCT
dpc-2577	70	10	with	with	ADP
dpc-2577	70	11	cu	cu	PROPN
dpc-2577	70	12	there	there	PRON
dpc-2577	70	13	was	be	VERB
dpc-2577	70	14	a	a	DET
dpc-2577	70	15	familial	familial	ADJ
dpc-2577	70	16	history	history	NOUN
dpc-2577	70	17	of	of	ADP
dpc-2577	70	18	autoimmune	autoimmune	ADJ
dpc-2577	70	19	disease	disease	NOUN
dpc-2577	70	20	,	,	PUNCT
dpc-2577	70	21	in	in	ADP
dpc-2577	70	22	26	26	NUM
dpc-2577	70	23	patients	patient	NOUN
dpc-2577	70	24	(	(	PUNCT
dpc-2577	70	25	25.5	25.5	NUM
dpc-2577	70	26	%	%	NOUN
dpc-2577	70	27	)	)	PUNCT
dpc-2577	70	28	familial	familial	ADJ
dpc-2577	70	29	history	history	NOUN
dpc-2577	70	30	of	of	ADP
dpc-2577	70	31	atopy	atopy	NOUN
dpc-2577	70	32	,	,	PUNCT
dpc-2577	70	33	and	and	CCONJ
dpc-2577	70	34	in	in	ADP
dpc-2577	70	35	8	8	NUM
dpc-2577	70	36	patients	patient	NOUN
dpc-2577	70	37	(	(	PUNCT
dpc-2577	70	38	7.8	7.8	NUM
dpc-2577	70	39	%	%	NOUN
dpc-2577	70	40	)	)	PUNCT
dpc-2577	70	41	familial	familial	ADJ
dpc-2577	70	42	history	history	NOUN
dpc-2577	70	43	of	of	ADP
dpc-2577	70	44	chronic	chronic	ADJ
dpc-2577	70	45	urticaria	urticaria	NOUN
dpc-2577	70	46	.	.	PUNCT
dpc-2577	71	1	discussion	discussion	NOUN
dpc-2577	71	2	in	in	ADP
dpc-2577	71	3	line	line	NOUN
dpc-2577	71	4	with	with	ADP
dpc-2577	71	5	the	the	DET
dpc-2577	71	6	findings	finding	NOUN
dpc-2577	71	7	of	of	ADP
dpc-2577	71	8	previous	previous	ADJ
dpc-2577	71	9	studies	study	NOUN
dpc-2577	71	10	,	,	PUNCT
dpc-2577	71	11	csu	csu	PROPN
dpc-2577	71	12	occurs	occur	VERB
dpc-2577	71	13	with	with	ADP
dpc-2577	71	14	a	a	DET
dpc-2577	71	15	higher	high	ADJ
dpc-2577	71	16	frequency	frequency	NOUN
dpc-2577	71	17	than	than	ADP
dpc-2577	71	18	cindu	cindu	NOUN
dpc-2577	71	19	,	,	PUNCT
dpc-2577	71	20	with	with	ADP
dpc-2577	71	21	comorbid	comorbid	NOUN
dpc-2577	71	22	cindu	cindu	NOUN
dpc-2577	71	23	likely	likely	ADV
dpc-2577	71	24	in	in	ADP
dpc-2577	71	25	a	a	DET
dpc-2577	71	26	fifth	fifth	ADJ
dpc-2577	71	27	of	of	ADP
dpc-2577	71	28	the	the	DET
dpc-2577	71	29	cases	case	NOUN
dpc-2577	71	30	,	,	PUNCT
dpc-2577	71	31	despite	despite	SCONJ
dpc-2577	71	32	heterogeneity	heterogeneity	NOUN
dpc-2577	71	33	in	in	ADP
dpc-2577	71	34	the	the	DET
dpc-2577	71	35	regional	regional	ADJ
dpc-2577	71	36	distribution	distribution	NOUN
dpc-2577	71	37	of	of	ADP
dpc-2577	71	38	cu	cu	PROPN
dpc-2577	71	39	and	and	CCONJ
dpc-2577	71	40	its	its	PRON
dpc-2577	71	41	phenotypes	phenotype	NOUN
dpc-2577	71	42	[	[	X
dpc-2577	71	43	8	8	NUM
dpc-2577	71	44	]	]	PUNCT
dpc-2577	71	45	.	.	PUNCT
dpc-2577	72	1	symptomatic	symptomatic	ADJ
dpc-2577	72	2	dermographism	dermographism	NOUN
dpc-2577	72	3	has	have	AUX
dpc-2577	72	4	previously	previously	ADV
dpc-2577	72	5	been	be	AUX
dpc-2577	72	6	reported	report	VERB
dpc-2577	72	7	to	to	PART
dpc-2577	72	8	be	be	AUX
dpc-2577	72	9	the	the	DET
dpc-2577	72	10	most	most	ADV
dpc-2577	72	11	common	common	ADJ
dpc-2577	72	12	of	of	ADP
dpc-2577	72	13	the	the	DET
dpc-2577	72	14	physical	physical	ADJ
dpc-2577	72	15	urticarias	urticaria	NOUN
dpc-2577	73	1	[	[	X
dpc-2577	73	2	9	9	NUM
dpc-2577	73	3	]	]	PUNCT
dpc-2577	73	4	.	.	PUNCT
dpc-2577	74	1	we	we	PRON
dpc-2577	74	2	observed	observe	VERB
dpc-2577	74	3	that	that	SCONJ
dpc-2577	74	4	delayed	delay	VERB
dpc-2577	74	5	pressure	pressure	NOUN
dpc-2577	74	6	urticaria	urticaria	NOUN
dpc-2577	74	7	was	be	AUX
dpc-2577	74	8	the	the	DET
dpc-2577	74	9	most	most	ADV
dpc-2577	74	10	commonly	commonly	ADV
dpc-2577	74	11	diagnosed	diagnose	VERB
dpc-2577	74	12	cindu	cindu	NOUN
dpc-2577	74	13	subtype	subtype	NOUN
dpc-2577	74	14	.	.	PUNCT
dpc-2577	75	1	figure	figure	NOUN
dpc-2577	75	2	1	1	NUM
dpc-2577	75	3	.	.	PUNCT
dpc-2577	75	4	percentage	percentage	NOUN
dpc-2577	75	5	of	of	ADP
dpc-2577	75	6	patients	patient	NOUN
dpc-2577	75	7	with	with	ADP
dpc-2577	75	8	chronic	chronic	ADJ
dpc-2577	75	9	urticaria	urticaria	NOUN
dpc-2577	75	10	(	(	PUNCT
dpc-2577	75	11	cu	cu	PROPN
dpc-2577	75	12	)	)	PUNCT
dpc-2577	75	13	,	,	PUNCT
dpc-2577	75	14	divided	divide	VERB
dpc-2577	75	15	by	by	ADP
dpc-2577	75	16	subtype	subtype	NOUN
dpc-2577	75	17	(	(	PUNCT
dpc-2577	75	18	n=102	n=102	NUM
dpc-2577	75	19	)	)	PUNCT
dpc-2577	75	20	.	.	PUNCT
dpc-2577	76	1	figure	figure	NOUN
dpc-2577	76	2	2	2	NUM
dpc-2577	76	3	.	.	NOUN
dpc-2577	76	4	percentage	percentage	NOUN
dpc-2577	76	5	of	of	ADP
dpc-2577	76	6	patients	patient	NOUN
dpc-2577	76	7	with	with	ADP
dpc-2577	76	8	concomitant	concomitant	ADJ
dpc-2577	76	9	angioedema	angioedema	NOUN
dpc-2577	76	10	,	,	PUNCT
dpc-2577	76	11	divided	divide	VERB
dpc-2577	76	12	by	by	ADP
dpc-2577	76	13	subtype	subtype	NOUN
dpc-2577	76	14	of	of	ADP
dpc-2577	76	15	chronic	chronic	ADJ
dpc-2577	76	16	urticaria	urticaria	NOUN
dpc-2577	76	17	(	(	PUNCT
dpc-2577	76	18	cu	cu	PROPN
dpc-2577	76	19	)	)	PUNCT
dpc-2577	76	20	.	.	PUNCT
dpc-2577	77	1	4	4	NUM
dpc-2577	77	2	original	original	ADJ
dpc-2577	77	3	article	article	NOUN
dpc-2577	77	4	|	|	ADV
dpc-2577	77	5	dermatol	dermatol	ADJ
dpc-2577	77	6	pract	pract	NOUN
dpc-2577	77	7	concept	concept	NOUN
dpc-2577	77	8	.	.	PUNCT
dpc-2577	78	1	2023;13(1):e2023056	2023;13(1):e2023056	NUM
dpc-2577	78	2	table	table	NOUN
dpc-2577	78	3	1	1	NUM
dpc-2577	78	4	.	.	PUNCT
dpc-2577	79	1	the	the	DET
dpc-2577	79	2	comorbidity	comorbidity	NOUN
dpc-2577	79	3	profile	profile	NOUN
dpc-2577	79	4	of	of	ADP
dpc-2577	79	5	chronic	chronic	ADJ
dpc-2577	79	6	urticaria	urticaria	NOUN
dpc-2577	79	7	patients	patient	NOUN
dpc-2577	79	8	.	.	PUNCT
dpc-2577	80	1	diseases	disease	NOUN
dpc-2577	80	2	prevalence	prevalence	NOUN
dpc-2577	80	3	in	in	ADP
dpc-2577	80	4	all	all	DET
dpc-2577	80	5	cu	cu	NOUN
dpc-2577	80	6	patients	patient	NOUN
dpc-2577	80	7	(	(	PUNCT
dpc-2577	80	8	n=102	n=102	NUM
dpc-2577	80	9	)	)	PUNCT
dpc-2577	80	10	atopy	atopy	NOUN
dpc-2577	80	11	and	and	CCONJ
dpc-2577	80	12	allergies	allergy	NOUN
dpc-2577	80	13	drug	drug	NOUN
dpc-2577	80	14	allergy	allergy	NOUN
dpc-2577	80	15	21,6	21,6	NUM
dpc-2577	80	16	%	%	NOUN
dpc-2577	80	17	49,0	49,0	NUM
dpc-2577	80	18	%	%	NOUN
dpc-2577	80	19	allergic	allergic	ADJ
dpc-2577	80	20	rhinitis	rhinitis	NOUN
dpc-2577	80	21	20,6	20,6	NUM
dpc-2577	80	22	%	%	NOUN
dpc-2577	80	23	food	food	NOUN
dpc-2577	80	24	allergy	allergy	NOUN
dpc-2577	80	25	17,6	17,6	NUM
dpc-2577	80	26	%	%	NOUN
dpc-2577	80	27	asthma	asthma	NOUN
dpc-2577	80	28	15,7	15,7	NUM
dpc-2577	80	29	%	%	NOUN
dpc-2577	80	30	inhaled	inhale	VERB
dpc-2577	80	31	allergy	allergy	NOUN
dpc-2577	80	32	12,7	12,7	NUM
dpc-2577	80	33	%	%	NOUN
dpc-2577	80	34	atopic	atopic	NOUN
dpc-2577	80	35	dermatitis	dermatitis	NOUN
dpc-2577	80	36	10,8	10,8	NUM
dpc-2577	80	37	%	%	NOUN
dpc-2577	80	38	rhino	rhino	NOUN
dpc-2577	80	39	-	-	ADJ
dpc-2577	80	40	conjunctivitis	conjunctivitis	NOUN
dpc-2577	80	41	6,9	6,9	NUM
dpc-2577	80	42	%	%	NOUN
dpc-2577	80	43	insect	insect	NOUN
dpc-2577	80	44	venom	venom	NOUN
dpc-2577	80	45	allergy	allergy	NOUN
dpc-2577	80	46	6,9	6,9	NUM
dpc-2577	80	47	%	%	NOUN
dpc-2577	80	48	chronic	chronic	ADJ
dpc-2577	80	49	inflammation	inflammation	NOUN
dpc-2577	80	50	and	and	CCONJ
dpc-2577	80	51	infectious	infectious	ADJ
dpc-2577	80	52	sinusitis	sinusitis	NOUN
dpc-2577	80	53	17,6	17,6	NUM
dpc-2577	80	54	%	%	NOUN
dpc-2577	80	55	36,3	36,3	NUM
dpc-2577	80	56	%	%	NOUN
dpc-2577	80	57	gastritis	gastritis	NOUN
dpc-2577	80	58	10,8	10,8	NUM
dpc-2577	80	59	%	%	NOUN
dpc-2577	80	60	urinary	urinary	ADJ
dpc-2577	80	61	tract	tract	NOUN
dpc-2577	80	62	infection	infection	NOUN
dpc-2577	80	63	7,8	7,8	NUM
dpc-2577	80	64	%	%	NOUN
dpc-2577	80	65	helicobacter	helicobacter	NOUN
dpc-2577	80	66	pylori	pylori	NOUN
dpc-2577	80	67	6,9	6,9	NUM
dpc-2577	80	68	%	%	NOUN
dpc-2577	80	69	periodontitis	periodontitis	NOUN
dpc-2577	80	70	5,9	5,9	NUM
dpc-2577	80	71	%	%	NOUN
dpc-2577	80	72	otitis	otitis	NOUN
dpc-2577	80	73	media	media	NOUN
dpc-2577	80	74	2,0	2,0	NUM
dpc-2577	80	75	%	%	NOUN
dpc-2577	80	76	hepatitis	hepatitis	NOUN
dpc-2577	80	77	b	b	PROPN
dpc-2577	80	78	1,0	1,0	NUM
dpc-2577	80	79	%	%	NOUN
dpc-2577	80	80	autoimmune	autoimmune	ADJ
dpc-2577	80	81	hepatitis	hepatitis	NOUN
dpc-2577	80	82	1,0	1,0	NUM
dpc-2577	80	83	%	%	NOUN
dpc-2577	80	84	thyroid	thyroid	NOUN
dpc-2577	80	85	disorders	disorder	NOUN
dpc-2577	80	86	hashimoto	hashimoto	NOUN
dpc-2577	80	87	’s	’s	PART
dpc-2577	80	88	disease	disease	NOUN
dpc-2577	80	89	22,5	22,5	NUM
dpc-2577	80	90	%	%	NOUN
dpc-2577	80	91	36,3	36,3	NUM
dpc-2577	80	92	%	%	NOUN
dpc-2577	80	93	hypothyroidism	hypothyroidism	NOUN
dpc-2577	80	94	17,6	17,6	NUM
dpc-2577	80	95	%	%	NOUN
dpc-2577	80	96	hyperthyroidism	hyperthyroidism	NOUN
dpc-2577	80	97	2,9	2,9	NOUN
dpc-2577	80	98	%	%	NOUN
dpc-2577	80	99	graves	grave	NOUN
dpc-2577	80	100	’	'	PUNCT
dpc-2577	80	101	disease	disease	NOUN
dpc-2577	80	102	2,0	2,0	NUM
dpc-2577	80	103	%	%	NOUN
dpc-2577	80	104	goiter	goiter	NOUN
dpc-2577	80	105	1,0	1,0	NUM
dpc-2577	80	106	%	%	NOUN
dpc-2577	80	107	psychiatric	psychiatric	ADJ
dpc-2577	80	108	disorders	disorder	NOUN
dpc-2577	80	109	depression	depression	NOUN
dpc-2577	80	110	16,7	16,7	NUM
dpc-2577	80	111	%	%	NOUN
dpc-2577	80	112	25,5	25,5	NUM
dpc-2577	80	113	%	%	NOUN
dpc-2577	80	114	anxiety	anxiety	NOUN
dpc-2577	80	115	disorders	disorder	NOUN
dpc-2577	80	116	14,7	14,7	NUM
dpc-2577	80	117	%	%	NOUN
dpc-2577	80	118	skin	skin	NOUN
dpc-2577	80	119	diseases	disease	NOUN
dpc-2577	80	120	allergic	allergic	ADJ
dpc-2577	80	121	contact	contact	NOUN
dpc-2577	80	122	dermatitis	dermatitis	NOUN
dpc-2577	80	123	9,8	9,8	NUM
dpc-2577	80	124	%	%	NOUN
dpc-2577	80	125	18,6	18,6	NUM
dpc-2577	80	126	%	%	NOUN
dpc-2577	80	127	psoriasis	psoriasis	NOUN
dpc-2577	80	128	4,9	4,9	NUM
dpc-2577	80	129	%	%	NOUN
dpc-2577	80	130	vitiligo	vitiligo	VERB
dpc-2577	80	131	2,0	2,0	NUM
dpc-2577	80	132	%	%	NOUN
dpc-2577	80	133	seborrheic	seborrheic	VERB
dpc-2577	80	134	dermatitis	dermatitis	NOUN
dpc-2577	80	135	1,0	1,0	NUM
dpc-2577	80	136	%	%	NOUN
dpc-2577	80	137	alopecia	alopecia	NOUN
dpc-2577	80	138	areata	areata	ADJ
dpc-2577	80	139	1,0	1,0	NUM
dpc-2577	80	140	%	%	NOUN
dpc-2577	80	141	gastrointestinal	gastrointestinal	ADJ
dpc-2577	80	142	diseases	disease	NOUN
dpc-2577	80	143	gerd	gerd	VERB
dpc-2577	80	144	10,8	10,8	NUM
dpc-2577	80	145	%	%	NOUN
dpc-2577	80	146	18,6	18,6	NUM
dpc-2577	80	147	%	%	NOUN
dpc-2577	80	148	ibs	ib	NOUN
dpc-2577	80	149	8,8	8,8	NUM
dpc-2577	80	150	%	%	NOUN
dpc-2577	80	151	peptic	peptic	ADJ
dpc-2577	80	152	ulcer	ulcer	NOUN
dpc-2577	80	153	2,9	2,9	NUM
dpc-2577	80	154	%	%	NOUN
dpc-2577	80	155	celiac	celiac	ADJ
dpc-2577	80	156	disease	disease	NOUN
dpc-2577	80	157	1,0	1,0	NUM
dpc-2577	80	158	%	%	NOUN
dpc-2577	80	159	cardiometabolic	cardiometabolic	NOUN
dpc-2577	80	160	diseases	disease	NOUN
dpc-2577	80	161	arterial	arterial	ADJ
dpc-2577	80	162	hypertension	hypertension	NOUN
dpc-2577	80	163	8,8	8,8	NUM
dpc-2577	80	164	%	%	NOUN
dpc-2577	80	165	10,8%ischemic	10,8%ischemic	NUM
dpc-2577	80	166	stroke	stroke	NOUN
dpc-2577	80	167	2,0	2,0	NUM
dpc-2577	80	168	%	%	NOUN
dpc-2577	80	169	diabetes	diabetes	NOUN
dpc-2577	80	170	mellitus	mellitus	NOUN
dpc-2577	80	171	type	type	VERB
dpc-2577	80	172	2	2	NUM
dpc-2577	80	173	1,0	1,0	NUM
dpc-2577	80	174	%	%	NOUN
dpc-2577	80	175	connective	connective	ADJ
dpc-2577	80	176	tissue	tissue	NOUN
dpc-2577	80	177	diseases	disease	NOUN
dpc-2577	80	178	sle	sle	NOUN
dpc-2577	80	179	2,9	2,9	NUM
dpc-2577	80	180	%	%	NOUN
dpc-2577	80	181	6,9	6,9	NUM
dpc-2577	80	182	%	%	NOUN
dpc-2577	80	183	ra	ra	NOUN
dpc-2577	80	184	2,9	2,9	NUM
dpc-2577	80	185	%	%	NOUN
dpc-2577	80	186	mctd	mctd	NOUN
dpc-2577	80	187	1,0	1,0	NUM
dpc-2577	80	188	%	%	NOUN
dpc-2577	80	189	polymyositis	polymyositis	NOUN
dpc-2577	80	190	1,0	1,0	NUM
dpc-2577	80	191	%	%	NOUN
dpc-2577	80	192	neoplasm	neoplasm	ADJ
dpc-2577	80	193	melanoma	melanoma	NOUN
dpc-2577	80	194	1,0	1,0	NUM
dpc-2577	80	195	%	%	NOUN
dpc-2577	80	196	2,0	2,0	NUM
dpc-2577	80	197	%	%	NOUN
dpc-2577	80	198	carcinoid	carcinoid	NOUN
dpc-2577	80	199	tumor	tumor	NOUN
dpc-2577	80	200	1,0	1,0	NUM
dpc-2577	80	201	%	%	NOUN
dpc-2577	80	202	others	other	NOUN
dpc-2577	80	203	migraine	migraine	VERB
dpc-2577	80	204	12,7	12,7	NUM
dpc-2577	80	205	%	%	NOUN
dpc-2577	80	206	19,6	19,6	NUM
dpc-2577	80	207	%	%	NOUN
dpc-2577	80	208	endometriosis	endometriosis	NOUN
dpc-2577	80	209	5,9	5,9	NUM
dpc-2577	80	210	%	%	NOUN
dpc-2577	80	211	pernicious	pernicious	ADJ
dpc-2577	80	212	anemia	anemia	NOUN
dpc-2577	80	213	2,0	2,0	NUM
dpc-2577	80	214	%	%	NOUN
dpc-2577	80	215	epilepsy	epilepsy	NOUN
dpc-2577	80	216	1,0	1,0	NUM
dpc-2577	80	217	%	%	NOUN
dpc-2577	80	218	cu	cu	NOUN
dpc-2577	80	219	=	=	SYM
dpc-2577	80	220	chronic	chronic	ADJ
dpc-2577	80	221	urticaria	urticaria	NOUN
dpc-2577	80	222	;	;	PUNCT
dpc-2577	80	223	gerd	gerd	NOUN
dpc-2577	80	224	=	=	SYM
dpc-2577	80	225	gastroesophageal	gastroesophageal	NOUN
dpc-2577	80	226	reflux	reflux	NOUN
dpc-2577	80	227	disease	disease	NOUN
dpc-2577	80	228	;	;	PUNCT
dpc-2577	80	229	ibs	ibs	PROPN
dpc-2577	80	230	=	=	SYM
dpc-2577	80	231	irritable	irritable	ADJ
dpc-2577	80	232	bowel	bowel	NOUN
dpc-2577	80	233	syndrome	syndrome	NOUN
dpc-2577	80	234	;	;	PUNCT
dpc-2577	80	235	mctd	mctd	NOUN
dpc-2577	80	236	=	=	SYM
dpc-2577	80	237	mixed	mix	VERB
dpc-2577	80	238	connective	connective	ADJ
dpc-2577	80	239	tissue	tissue	NOUN
dpc-2577	80	240	disorder	disorder	NOUN
dpc-2577	80	241	;	;	PUNCT
dpc-2577	80	242	ra	ra	PROPN
dpc-2577	80	243	=	=	PUNCT
dpc-2577	80	244	rheumatoid	rheumatoid	VERB
dpc-2577	80	245	arthritis	arthritis	NOUN
dpc-2577	80	246	;	;	PUNCT
dpc-2577	80	247	sle	sle	PROPN
dpc-2577	80	248	=	=	PUNCT
dpc-2577	80	249	systemic	systemic	ADJ
dpc-2577	80	250	lupus	lupus	PROPN
dpc-2577	80	251	erythematosus	erythematosus	PROPN
dpc-2577	80	252	.	.	PUNCT
dpc-2577	81	1	original	original	ADJ
dpc-2577	81	2	article	article	NOUN
dpc-2577	81	3	|	|	ADV
dpc-2577	81	4	dermatol	dermatol	ADJ
dpc-2577	81	5	pract	pract	NOUN
dpc-2577	81	6	concept	concept	NOUN
dpc-2577	81	7	.	.	PUNCT
dpc-2577	82	1	2023;13(1):e2023056	2023;13(1):e2023056	NUM
dpc-2577	82	2	5	5	NUM
dpc-2577	82	3	table	table	NOUN
dpc-2577	82	4	2	2	NUM
dpc-2577	82	5	.	.	PUNCT
dpc-2577	83	1	the	the	DET
dpc-2577	83	2	number	number	NOUN
dpc-2577	83	3	and	and	CCONJ
dpc-2577	83	4	combination	combination	NOUN
dpc-2577	83	5	of	of	ADP
dpc-2577	83	6	autoimmune	autoimmune	ADJ
dpc-2577	83	7	diseases	disease	NOUN
dpc-2577	83	8	in	in	ADP
dpc-2577	83	9	chronic	chronic	ADJ
dpc-2577	83	10	urticaria	urticaria	NOUN
dpc-2577	83	11	patients	patient	NOUN
dpc-2577	83	12	.	.	PUNCT
dpc-2577	84	1	aid	aid	NOUN
dpc-2577	84	2	,	,	PUNCT
dpc-2577	84	3	no	no	INTJ
dpc-2577	84	4	.	.	PUNCT
dpc-2577	85	1	prevalence	prevalence	NOUN
dpc-2577	85	2	in	in	ADP
dpc-2577	85	3	all	all	DET
dpc-2577	85	4	cu	cu	NOUN
dpc-2577	85	5	patients	patient	NOUN
dpc-2577	85	6	with	with	ADP
dpc-2577	85	7	aid	aid	NOUN
dpc-2577	85	8	(	(	PUNCT
dpc-2577	85	9	n=31	n=31	NOUN
dpc-2577	85	10	)	)	PUNCT
dpc-2577	85	11	prevalence	prevalence	NOUN
dpc-2577	85	12	in	in	ADP
dpc-2577	85	13	all	all	DET
dpc-2577	85	14	cu	cu	NOUN
dpc-2577	85	15	patients	patient	NOUN
dpc-2577	85	16	(	(	PUNCT
dpc-2577	85	17	n=102	n=102	NUM
dpc-2577	85	18	)	)	PUNCT
dpc-2577	85	19	hashimoto	hashimoto	NOUN
dpc-2577	85	20	’s	’s	PART
dpc-2577	85	21	disease	disease	NOUN
dpc-2577	85	22	,	,	PUNCT
dpc-2577	85	23	23	23	NUM
dpc-2577	85	24	74,2	74,2	NUM
dpc-2577	85	25	%	%	NOUN
dpc-2577	85	26	22,5	22,5	NUM
dpc-2577	85	27	%	%	NOUN
dpc-2577	85	28	sle	sle	NOUN
dpc-2577	85	29	,	,	PUNCT
dpc-2577	85	30	3	3	NUM
dpc-2577	85	31	9,7	9,7	NUM
dpc-2577	85	32	%	%	NOUN
dpc-2577	85	33	2,9	2,9	NUM
dpc-2577	85	34	%	%	NOUN
dpc-2577	85	35	ra	ra	NOUN
dpc-2577	85	36	,	,	PUNCT
dpc-2577	85	37	3	3	NUM
dpc-2577	85	38	9,7	9,7	NUM
dpc-2577	85	39	%	%	NOUN
dpc-2577	85	40	2,9	2,9	NUM
dpc-2577	85	41	%	%	NOUN
dpc-2577	85	42	vitiligo	vitiligo	NOUN
dpc-2577	85	43	,	,	PUNCT
dpc-2577	85	44	2	2	NUM
dpc-2577	85	45	6,5	6,5	NUM
dpc-2577	85	46	%	%	NOUN
dpc-2577	85	47	2,0	2,0	NUM
dpc-2577	85	48	%	%	NOUN
dpc-2577	85	49	graves	grave	NOUN
dpc-2577	85	50	’	'	PUNCT
dpc-2577	85	51	disease	disease	NOUN
dpc-2577	85	52	,	,	PUNCT
dpc-2577	85	53	2	2	NUM
dpc-2577	85	54	6,5	6,5	NUM
dpc-2577	85	55	%	%	NOUN
dpc-2577	85	56	2,0	2,0	NUM
dpc-2577	85	57	%	%	NOUN
dpc-2577	85	58	pernicious	pernicious	ADJ
dpc-2577	85	59	anemia	anemia	NOUN
dpc-2577	85	60	,	,	PUNCT
dpc-2577	85	61	2	2	NUM
dpc-2577	85	62	6,5	6,5	NUM
dpc-2577	85	63	%	%	NOUN
dpc-2577	85	64	2,0	2,0	NUM
dpc-2577	85	65	%	%	NOUN
dpc-2577	85	66	autoimmune	autoimmune	ADJ
dpc-2577	85	67	hepatitis	hepatitis	NOUN
dpc-2577	85	68	,	,	PUNCT
dpc-2577	85	69	1	1	NUM
dpc-2577	85	70	3,2	3,2	NUM
dpc-2577	85	71	%	%	NOUN
dpc-2577	85	72	1,0	1,0	NUM
dpc-2577	85	73	%	%	NOUN
dpc-2577	85	74	celiac	celiac	ADJ
dpc-2577	85	75	disease	disease	NOUN
dpc-2577	85	76	,	,	PUNCT
dpc-2577	85	77	1	1	NUM
dpc-2577	85	78	3,2	3,2	NUM
dpc-2577	85	79	%	%	NOUN
dpc-2577	85	80	1,0	1,0	NUM
dpc-2577	85	81	%	%	NOUN
dpc-2577	85	82	alopecia	alopecia	NOUN
dpc-2577	85	83	areata	areata	NOUN
dpc-2577	85	84	,	,	PUNCT
dpc-2577	85	85	1	1	NUM
dpc-2577	85	86	3,2	3,2	NUM
dpc-2577	85	87	%	%	NOUN
dpc-2577	85	88	1,0	1,0	NUM
dpc-2577	85	89	%	%	NOUN
dpc-2577	85	90	mctd	mctd	NOUN
dpc-2577	85	91	,	,	PUNCT
dpc-2577	85	92	1	1	NUM
dpc-2577	85	93	3,2	3,2	NUM
dpc-2577	85	94	%	%	NOUN
dpc-2577	85	95	1,0	1,0	NUM
dpc-2577	85	96	%	%	NOUN
dpc-2577	85	97	polymyositis	polymyositis	NOUN
dpc-2577	85	98	,	,	PUNCT
dpc-2577	85	99	1	1	NUM
dpc-2577	85	100	3,2	3,2	NUM
dpc-2577	85	101	%	%	NOUN
dpc-2577	85	102	1,0	1,0	NUM
dpc-2577	85	103	%	%	NOUN
dpc-2577	85	104	number	number	NOUN
dpc-2577	85	105	of	of	ADP
dpc-2577	85	106	aid	aid	NOUN
dpc-2577	85	107	in	in	ADP
dpc-2577	85	108	cu	cu	PROPN
dpc-2577	85	109	one	one	NUM
dpc-2577	85	110	,	,	PUNCT
dpc-2577	85	111	23	23	NUM
dpc-2577	85	112	74,2	74,2	NUM
dpc-2577	85	113	%	%	NOUN
dpc-2577	85	114	22,5	22,5	NUM
dpc-2577	85	115	%	%	NOUN
dpc-2577	85	116	two	two	NUM
dpc-2577	85	117	,	,	PUNCT
dpc-2577	85	118	7	7	NUM
dpc-2577	85	119	22,6	22,6	NUM
dpc-2577	85	120	%	%	NOUN
dpc-2577	85	121	6,9	6,9	NUM
dpc-2577	85	122	%	%	NOUN
dpc-2577	85	123	three	three	NUM
dpc-2577	85	124	,	,	PUNCT
dpc-2577	85	125	1	1	NUM
dpc-2577	85	126	3,2	3,2	NUM
dpc-2577	85	127	%	%	NOUN
dpc-2577	85	128	1,0	1,0	NUM
dpc-2577	85	129	%	%	NOUN
dpc-2577	85	130	combination	combination	NOUN
dpc-2577	85	131	of	of	ADP
dpc-2577	85	132	cu	cu	PROPN
dpc-2577	85	133	of	of	ADP
dpc-2577	85	134	two	two	NUM
dpc-2577	85	135	or	or	CCONJ
dpc-2577	85	136	more	more	ADJ
dpc-2577	85	137	autoimmune	autoimmune	ADJ
dpc-2577	85	138	diseases	disease	NOUN
dpc-2577	85	139	ht	ht	X
dpc-2577	86	1	+	+	CCONJ
dpc-2577	86	2	pernicious	pernicious	ADJ
dpc-2577	86	3	anemia	anemia	NOUN
dpc-2577	86	4	,	,	PUNCT
dpc-2577	86	5	2	2	NUM
dpc-2577	86	6	6,5	6,5	NUM
dpc-2577	86	7	%	%	NOUN
dpc-2577	86	8	2,0	2,0	NUM
dpc-2577	86	9	%	%	NOUN
dpc-2577	86	10	ht	ht	PROPN
dpc-2577	86	11	+	+	CCONJ
dpc-2577	86	12	celiac	celiac	ADJ
dpc-2577	86	13	disease	disease	NOUN
dpc-2577	86	14	,	,	PUNCT
dpc-2577	86	15	1	1	NUM
dpc-2577	86	16	3,2	3,2	NUM
dpc-2577	86	17	%	%	NOUN
dpc-2577	86	18	1,0	1,0	NUM
dpc-2577	86	19	%	%	NOUN
dpc-2577	86	20	ht	ht	PROPN
dpc-2577	87	1	+	+	NUM
dpc-2577	87	2	vitiligo	vitiligo	VERB
dpc-2577	87	3	,	,	PUNCT
dpc-2577	87	4	1	1	NUM
dpc-2577	87	5	3,2	3,2	NUM
dpc-2577	87	6	%	%	NOUN
dpc-2577	87	7	1,0	1,0	NUM
dpc-2577	87	8	%	%	NOUN
dpc-2577	87	9	ht	ht	PROPN
dpc-2577	88	1	+	+	NUM
dpc-2577	88	2	ra	ra	PROPN
dpc-2577	88	3	,	,	PUNCT
dpc-2577	88	4	1	1	NUM
dpc-2577	88	5	3,2	3,2	NUM
dpc-2577	88	6	%	%	NOUN
dpc-2577	88	7	1,0	1,0	NUM
dpc-2577	88	8	%	%	NOUN
dpc-2577	88	9	ht	ht	PROPN
dpc-2577	89	1	+	+	NUM
dpc-2577	89	2	sle	sle	PROPN
dpc-2577	89	3	,	,	PUNCT
dpc-2577	89	4	1	1	NUM
dpc-2577	89	5	3,2	3,2	NUM
dpc-2577	89	6	%	%	NOUN
dpc-2577	89	7	1,0	1,0	NUM
dpc-2577	89	8	%	%	NOUN
dpc-2577	89	9	ht	ht	PROPN
dpc-2577	89	10	+	+	NUM
dpc-2577	89	11	sle	sle	PROPN
dpc-2577	90	1	+	+	CCONJ
dpc-2577	91	1	ra	ra	PROPN
dpc-2577	91	2	,	,	PUNCT
dpc-2577	91	3	1	1	NUM
dpc-2577	91	4	3,2	3,2	NUM
dpc-2577	91	5	%	%	NOUN
dpc-2577	91	6	1,0	1,0	NUM
dpc-2577	91	7	%	%	NOUN
dpc-2577	91	8	alopecia	alopecia	NOUN
dpc-2577	91	9	areata	areata	NOUN
dpc-2577	91	10	+	+	CCONJ
dpc-2577	91	11	sle	sle	PROPN
dpc-2577	91	12	,	,	PUNCT
dpc-2577	91	13	1	1	NUM
dpc-2577	91	14	3,2	3,2	NUM
dpc-2577	91	15	%	%	NOUN
dpc-2577	91	16	1,0	1,0	NUM
dpc-2577	91	17	%	%	NOUN
dpc-2577	91	18	aid	aid	NOUN
dpc-2577	91	19	=	=	SYM
dpc-2577	91	20	autoimmune	autoimmune	ADJ
dpc-2577	91	21	diseases	disease	NOUN
dpc-2577	91	22	;	;	PUNCT
dpc-2577	91	23	cu	cu	NOUN
dpc-2577	91	24	=	=	SYM
dpc-2577	91	25	chronic	chronic	ADJ
dpc-2577	91	26	urticaria	urticaria	NOUN
dpc-2577	91	27	;	;	PUNCT
dpc-2577	91	28	ht	ht	PROPN
dpc-2577	91	29	=	=	PUNCT
dpc-2577	91	30	hashimoto	hashimoto	NOUN
dpc-2577	91	31	’s	’s	PART
dpc-2577	91	32	disease	disease	NOUN
dpc-2577	91	33	;	;	PUNCT
dpc-2577	92	1	ra	ra	PROPN
dpc-2577	92	2	=	=	PUNCT
dpc-2577	92	3	rheumatoid	rheumatoid	VERB
dpc-2577	92	4	arthritis	arthritis	NOUN
dpc-2577	92	5	;	;	PUNCT
dpc-2577	92	6	sle	sle	PROPN
dpc-2577	92	7	=	=	PUNCT
dpc-2577	92	8	systemic	systemic	ADJ
dpc-2577	92	9	lupus	lupus	PROPN
dpc-2577	92	10	erythematosus	erythematosus	PROPN
dpc-2577	92	11	.	.	PUNCT
dpc-2577	93	1	the	the	DET
dpc-2577	93	2	available	available	ADJ
dpc-2577	93	3	data	datum	NOUN
dpc-2577	93	4	suggest	suggest	VERB
dpc-2577	93	5	that	that	SCONJ
dpc-2577	93	6	33–67	33–67	NUM
dpc-2577	93	7	%	%	NOUN
dpc-2577	93	8	of	of	ADP
dpc-2577	93	9	all	all	DET
dpc-2577	93	10	patients	patient	NOUN
dpc-2577	93	11	with	with	ADP
dpc-2577	93	12	cu	cu	PROPN
dpc-2577	93	13	have	have	VERB
dpc-2577	93	14	concomitant	concomitant	ADJ
dpc-2577	93	15	angioedema	angioedema	NOUN
dpc-2577	93	16	[	[	X
dpc-2577	93	17	10	10	NUM
dpc-2577	93	18	]	]	PUNCT
dpc-2577	93	19	.	.	PUNCT
dpc-2577	94	1	we	we	PRON
dpc-2577	94	2	obtained	obtain	VERB
dpc-2577	94	3	very	very	ADV
dpc-2577	94	4	similar	similar	ADJ
dpc-2577	94	5	results	result	NOUN
dpc-2577	94	6	.	.	PUNCT
dpc-2577	95	1	angioedema	angioedema	NOUN
dpc-2577	95	2	usually	usually	ADV
dpc-2577	95	3	affects	affect	VERB
dpc-2577	95	4	the	the	DET
dpc-2577	95	5	skin	skin	NOUN
dpc-2577	95	6	on	on	ADP
dpc-2577	95	7	the	the	DET
dpc-2577	95	8	face	face	NOUN
dpc-2577	95	9	,	,	PUNCT
dpc-2577	95	10	mainly	mainly	ADV
dpc-2577	95	11	the	the	DET
dpc-2577	95	12	lips	lip	NOUN
dpc-2577	95	13	and	and	CCONJ
dpc-2577	95	14	eyelids	eyelid	NOUN
dpc-2577	96	1	[	[	X
dpc-2577	96	2	11	11	NUM
dpc-2577	96	3	]	]	PUNCT
dpc-2577	96	4	.	.	PUNCT
dpc-2577	97	1	in	in	ADP
dpc-2577	97	2	contrast	contrast	NOUN
dpc-2577	97	3	,	,	PUNCT
dpc-2577	97	4	our	our	PRON
dpc-2577	97	5	results	result	NOUN
dpc-2577	97	6	showed	show	VERB
dpc-2577	97	7	that	that	SCONJ
dpc-2577	97	8	non	non	ADJ
dpc-2577	97	9	-	-	ADJ
dpc-2577	97	10	facial	facial	ADJ
dpc-2577	97	11	body	body	NOUN
dpc-2577	97	12	areas	area	NOUN
dpc-2577	97	13	were	be	AUX
dpc-2577	97	14	the	the	DET
dpc-2577	97	15	most	most	ADV
dpc-2577	97	16	frequent	frequent	ADJ
dpc-2577	97	17	locations	location	NOUN
dpc-2577	97	18	for	for	ADP
dpc-2577	97	19	angioedema	angioedema	NOUN
dpc-2577	97	20	,	,	PUNCT
dpc-2577	97	21	which	which	PRON
dpc-2577	97	22	may	may	AUX
dpc-2577	97	23	be	be	AUX
dpc-2577	97	24	related	relate	VERB
dpc-2577	97	25	to	to	ADP
dpc-2577	97	26	the	the	DET
dpc-2577	97	27	relatively	relatively	ADV
dpc-2577	97	28	high	high	ADJ
dpc-2577	97	29	percentage	percentage	NOUN
dpc-2577	97	30	of	of	ADP
dpc-2577	97	31	patients	patient	NOUN
dpc-2577	97	32	with	with	ADP
dpc-2577	97	33	delayed	delay	VERB
dpc-2577	97	34	pressure	pressure	NOUN
dpc-2577	97	35	urticaria	urticaria	NOUN
dpc-2577	97	36	in	in	ADP
dpc-2577	97	37	our	our	PRON
dpc-2577	97	38	study	study	NOUN
dpc-2577	97	39	,	,	PUNCT
dpc-2577	97	40	which	which	PRON
dpc-2577	97	41	is	be	AUX
dpc-2577	97	42	characterized	characterize	VERB
dpc-2577	97	43	by	by	ADP
dpc-2577	97	44	erythematous	erythematous	ADJ
dpc-2577	97	45	swelling	swelling	NOUN
dpc-2577	97	46	of	of	ADP
dpc-2577	97	47	the	the	DET
dpc-2577	97	48	skin	skin	NOUN
dpc-2577	97	49	4	4	NUM
dpc-2577	97	50	to	to	PART
dpc-2577	97	51	6	6	NUM
dpc-2577	97	52	hours	hour	NOUN
dpc-2577	97	53	after	after	ADP
dpc-2577	97	54	the	the	DET
dpc-2577	97	55	application	application	NOUN
dpc-2577	97	56	of	of	ADP
dpc-2577	97	57	pressure	pressure	NOUN
dpc-2577	97	58	.	.	PUNCT
dpc-2577	98	1	the	the	DET
dpc-2577	98	2	swelling	swelling	NOUN
dpc-2577	98	3	of	of	ADP
dpc-2577	98	4	the	the	DET
dpc-2577	98	5	hands	hand	NOUN
dpc-2577	98	6	and	and	CCONJ
dpc-2577	98	7	feet	foot	NOUN
dpc-2577	98	8	provoked	provoke	VERB
dpc-2577	98	9	by	by	ADP
dpc-2577	98	10	pressure	pressure	NOUN
dpc-2577	98	11	may	may	AUX
dpc-2577	98	12	be	be	AUX
dpc-2577	98	13	difficult	difficult	ADJ
dpc-2577	98	14	to	to	PART
dpc-2577	98	15	tell	tell	VERB
dpc-2577	98	16	apart	apart	ADV
dpc-2577	98	17	from	from	ADP
dpc-2577	98	18	swelling	swell	VERB
dpc-2577	98	19	caused	cause	VERB
dpc-2577	98	20	by	by	ADP
dpc-2577	98	21	angioedema	angioedema	NOUN
dpc-2577	98	22	[	[	X
dpc-2577	98	23	12	12	NUM
dpc-2577	98	24	]	]	PUNCT
dpc-2577	98	25	.	.	PUNCT
dpc-2577	99	1	most	most	ADJ
dpc-2577	99	2	publications	publication	NOUN
dpc-2577	99	3	do	do	AUX
dpc-2577	99	4	not	not	PART
dpc-2577	99	5	provide	provide	VERB
dpc-2577	99	6	information	information	NOUN
dpc-2577	99	7	on	on	ADP
dpc-2577	99	8	the	the	DET
dpc-2577	99	9	frequency	frequency	NOUN
dpc-2577	99	10	of	of	ADP
dpc-2577	99	11	episodes	episode	NOUN
dpc-2577	99	12	of	of	ADP
dpc-2577	99	13	cu	cu	PROPN
dpc-2577	99	14	.	.	PUNCT
dpc-2577	100	1	the	the	DET
dpc-2577	100	2	data	datum	NOUN
dpc-2577	100	3	mainly	mainly	ADV
dpc-2577	100	4	relate	relate	VERB
dpc-2577	100	5	to	to	ADP
dpc-2577	100	6	the	the	DET
dpc-2577	100	7	duration	duration	NOUN
dpc-2577	100	8	of	of	ADP
dpc-2577	100	9	the	the	DET
dpc-2577	100	10	disease	disease	NOUN
dpc-2577	100	11	,	,	PUNCT
dpc-2577	100	12	which	which	PRON
dpc-2577	100	13	is	be	AUX
dpc-2577	100	14	estimated	estimate	VERB
dpc-2577	100	15	at	at	ADP
dpc-2577	100	16	generally	generally	ADV
dpc-2577	100	17	1	1	NUM
dpc-2577	100	18	-	-	SYM
dpc-2577	100	19	5	5	NUM
dpc-2577	100	20	years	year	NOUN
dpc-2577	100	21	[	[	X
dpc-2577	100	22	10	10	NUM
dpc-2577	100	23	]	]	PUNCT
dpc-2577	100	24	.	.	PUNCT
dpc-2577	101	1	the	the	DET
dpc-2577	101	2	frequency	frequency	NOUN
dpc-2577	101	3	of	of	ADP
dpc-2577	101	4	urticaria	urticaria	NOUN
dpc-2577	101	5	symptoms	symptom	NOUN
dpc-2577	101	6	in	in	ADP
dpc-2577	101	7	this	this	DET
dpc-2577	101	8	study	study	NOUN
dpc-2577	101	9	was	be	AUX
dpc-2577	101	10	estimated	estimate	VERB
dpc-2577	101	11	as	as	ADP
dpc-2577	101	12	:	:	PUNCT
dpc-2577	101	13	59.8	59.8	NUM
dpc-2577	101	14	%	%	NOUN
dpc-2577	101	15	daily	daily	ADV
dpc-2577	101	16	,	,	PUNCT
dpc-2577	101	17	16.7	16.7	NUM
dpc-2577	101	18	%	%	NOUN
dpc-2577	101	19	several	several	ADJ
dpc-2577	101	20	times	time	NOUN
dpc-2577	101	21	a	a	DET
dpc-2577	101	22	week	week	NOUN
dpc-2577	101	23	,	,	PUNCT
dpc-2577	101	24	8.8	8.8	NUM
dpc-2577	101	25	%	%	NOUN
dpc-2577	101	26	several	several	ADJ
dpc-2577	101	27	times	time	NOUN
dpc-2577	101	28	a	a	DET
dpc-2577	101	29	month	month	NOUN
dpc-2577	101	30	,	,	PUNCT
dpc-2577	101	31	and	and	CCONJ
dpc-2577	101	32	14.7	14.7	NUM
dpc-2577	101	33	%	%	NOUN
dpc-2577	101	34	irregularly	irregularly	ADV
dpc-2577	101	35	.	.	PUNCT
dpc-2577	102	1	many	many	ADJ
dpc-2577	102	2	researchers	researcher	NOUN
dpc-2577	102	3	analyzed	analyze	VERB
dpc-2577	102	4	mainly	mainly	ADV
dpc-2577	102	5	allergic	allergic	ADJ
dpc-2577	102	6	diseases	disease	NOUN
dpc-2577	102	7	accompanying	accompany	VERB
dpc-2577	102	8	urticaria	urticaria	NOUN
dpc-2577	102	9	.	.	PUNCT
dpc-2577	103	1	shalom	shalom	PROPN
dpc-2577	103	2	et	et	PROPN
dpc-2577	103	3	al	al	PROPN
dpc-2577	103	4	.	.	PUNCT
dpc-2577	104	1	[	[	X
dpc-2577	104	2	13	13	NUM
dpc-2577	104	3	]	]	PUNCT
dpc-2577	104	4	reported	report	VERB
dpc-2577	104	5	that	that	SCONJ
dpc-2577	104	6	the	the	DET
dpc-2577	104	7	most	most	ADV
dpc-2577	104	8	common	common	ADJ
dpc-2577	104	9	were	be	AUX
dpc-2577	104	10	allergic	allergic	ADJ
dpc-2577	104	11	rhinitis	rhinitis	NOUN
dpc-2577	104	12	(	(	PUNCT
dpc-2577	104	13	19.9	19.9	NUM
dpc-2577	104	14	%	%	NOUN
dpc-2577	104	15	)	)	PUNCT
dpc-2577	104	16	and	and	CCONJ
dpc-2577	104	17	asthma	asthma	NOUN
dpc-2577	104	18	(	(	PUNCT
dpc-2577	104	19	10.8	10.8	NUM
dpc-2577	104	20	%	%	NOUN
dpc-2577	104	21	)	)	PUNCT
dpc-2577	104	22	.	.	PUNCT
dpc-2577	105	1	zuberbier	zuberbier	PROPN
dpc-2577	105	2	et	et	PROPN
dpc-2577	105	3	al	al	PROPN
dpc-2577	105	4	.	.	PUNCT
dpc-2577	106	1	[	[	X
dpc-2577	106	2	14	14	NUM
dpc-2577	106	3	]	]	PUNCT
dpc-2577	106	4	also	also	ADV
dpc-2577	106	5	concluded	conclude	VERB
dpc-2577	106	6	that	that	SCONJ
dpc-2577	106	7	atopy	atopy	NOUN
dpc-2577	106	8	,	,	PUNCT
dpc-2577	106	9	mainly	mainly	ADV
dpc-2577	106	10	allergic	allergic	ADJ
dpc-2577	106	11	rhinitis	rhinitis	NOUN
dpc-2577	106	12	(	(	PUNCT
dpc-2577	106	13	41.9	41.9	NUM
dpc-2577	106	14	%	%	NOUN
dpc-2577	106	15	)	)	PUNCT
dpc-2577	106	16	,	,	PUNCT
dpc-2577	106	17	and	and	CCONJ
dpc-2577	106	18	atopic	atopic	NOUN
dpc-2577	106	19	dermatitis	dermatitis	NOUN
dpc-2577	106	20	(	(	PUNCT
dpc-2577	106	21	18.9	18.9	NUM
dpc-2577	106	22	%	%	NOUN
dpc-2577	106	23	)	)	PUNCT
dpc-2577	106	24	were	be	AUX
dpc-2577	106	25	the	the	DET
dpc-2577	106	26	most	most	ADV
dpc-2577	106	27	common	common	ADJ
dpc-2577	106	28	.	.	PUNCT
dpc-2577	107	1	a	a	DET
dpc-2577	107	2	korean	korean	ADJ
dpc-2577	107	3	study	study	NOUN
dpc-2577	107	4	also	also	ADV
dpc-2577	107	5	highlighted	highlight	VERB
dpc-2577	107	6	the	the	DET
dpc-2577	107	7	high	high	ADJ
dpc-2577	107	8	burden	burden	NOUN
dpc-2577	107	9	of	of	ADP
dpc-2577	107	10	allergic	allergic	ADJ
dpc-2577	107	11	rhinitis	rhinitis	NOUN
dpc-2577	107	12	,	,	PUNCT
dpc-2577	107	13	drug	drug	NOUN
dpc-2577	107	14	allergies	allergy	NOUN
dpc-2577	107	15	,	,	PUNCT
dpc-2577	107	16	and	and	CCONJ
dpc-2577	107	17	asthma	asthma	NOUN
dpc-2577	108	1	[	[	X
dpc-2577	108	2	15	15	NUM
dpc-2577	108	3	]	]	PUNCT
dpc-2577	108	4	.	.	PUNCT
dpc-2577	109	1	in	in	ADP
dpc-2577	109	2	the	the	DET
dpc-2577	109	3	scandinavian	scandinavian	ADJ
dpc-2577	109	4	aware	aware	ADJ
dpc-2577	109	5	study	study	NOUN
dpc-2577	109	6	,	,	PUNCT
dpc-2577	109	7	a	a	DET
dpc-2577	109	8	follow	follow	VERB
dpc-2577	109	9	up	up	ADP
dpc-2577	109	10	-	-	PUNCT
dpc-2577	109	11	study	study	NOUN
dpc-2577	109	12	of	of	ADP
dpc-2577	109	13	patients	patient	NOUN
dpc-2577	109	14	with	with	ADP
dpc-2577	109	15	cu	cu	PROPN
dpc-2577	109	16	refractory	refractory	NOUN
dpc-2577	109	17	to	to	ADP
dpc-2577	109	18	antihistamine	antihistamine	PROPN
dpc-2577	109	19	treatment	treatment	NOUN
dpc-2577	109	20	,	,	PUNCT
dpc-2577	109	21	the	the	DET
dpc-2577	109	22	most	most	ADV
dpc-2577	109	23	common	common	ADJ
dpc-2577	109	24	comorbidities	comorbiditie	NOUN
dpc-2577	109	25	were	be	AUX
dpc-2577	109	26	atopic	atopic	NOUN
dpc-2577	109	27	diseases	disease	NOUN
dpc-2577	109	28	including	include	VERB
dpc-2577	109	29	asthma	asthma	NOUN
dpc-2577	109	30	,	,	PUNCT
dpc-2577	109	31	allergic	allergic	ADJ
dpc-2577	109	32	rhinitis	rhinitis	NOUN
dpc-2577	109	33	,	,	PUNCT
dpc-2577	109	34	food	food	NOUN
dpc-2577	109	35	allergies	allergy	NOUN
dpc-2577	109	36	,	,	PUNCT
dpc-2577	109	37	and	and	CCONJ
dpc-2577	109	38	atopic	atopic	NOUN
dpc-2577	109	39	dermatitis	dermatitis	NOUN
dpc-2577	109	40	.	.	PUNCT
dpc-2577	110	1	[	[	X
dpc-2577	110	2	16	16	NUM
dpc-2577	110	3	]	]	PUNCT
dpc-2577	110	4	.	.	PUNCT
dpc-2577	111	1	our	our	PRON
dpc-2577	111	2	results	result	NOUN
dpc-2577	111	3	are	be	AUX
dpc-2577	111	4	similar	similar	ADJ
dpc-2577	111	5	to	to	ADP
dpc-2577	111	6	these	these	DET
dpc-2577	111	7	past	past	ADJ
dpc-2577	111	8	findings	finding	NOUN
dpc-2577	111	9	.	.	PUNCT
dpc-2577	112	1	type	type	NOUN
dpc-2577	112	2	-	-	PUNCT
dpc-2577	112	3	i	i	PRON
dpc-2577	112	4	auto	auto	NOUN
dpc-2577	112	5	-	-	PUNCT
dpc-2577	112	6	allergic	allergic	NOUN
dpc-2577	112	7	csu	csu	NOUN
dpc-2577	112	8	is	be	AUX
dpc-2577	112	9	quite	quite	ADV
dpc-2577	112	10	common	common	ADJ
dpc-2577	112	11	and	and	CCONJ
dpc-2577	112	12	possibly	possibly	ADV
dpc-2577	112	13	more	more	ADV
dpc-2577	112	14	likely	likely	ADV
dpc-2577	112	15	associated	associate	VERB
dpc-2577	112	16	with	with	ADP
dpc-2577	112	17	atopic	atopic	NOUN
dpc-2577	112	18	comorbidities	comorbiditie	NOUN
dpc-2577	112	19	than	than	ADP
dpc-2577	112	20	typeiib	typeiib	ADJ
dpc-2577	112	21	auto	auto	NOUN
dpc-2577	112	22	-	-	PUNCT
dpc-2577	112	23	immune	immune	NOUN
dpc-2577	112	24	driven	drive	VERB
dpc-2577	112	25	csu	csu	PROPN
dpc-2577	112	26	,	,	PUNCT
dpc-2577	112	27	which	which	PRON
dpc-2577	112	28	seemingly	seemingly	ADV
dpc-2577	112	29	be	be	VERB
dpc-2577	112	30	the	the	DET
dpc-2577	112	31	reason	reason	NOUN
dpc-2577	112	32	for	for	ADP
dpc-2577	112	33	the	the	DET
dpc-2577	112	34	high	high	ADJ
dpc-2577	112	35	frequency	frequency	NOUN
dpc-2577	112	36	of	of	ADP
dpc-2577	112	37	atopic	atopic	NOUN
dpc-2577	112	38	comorbidities	comorbiditie	NOUN
dpc-2577	112	39	observed	observe	VERB
dpc-2577	112	40	in	in	ADP
dpc-2577	112	41	the	the	DET
dpc-2577	112	42	overall	overall	ADJ
dpc-2577	112	43	cu	cu	PROPN
dpc-2577	112	44	population	population	NOUN
dpc-2577	113	1	[	[	X
dpc-2577	113	2	17	17	NUM
dpc-2577	113	3	]	]	PUNCT
dpc-2577	113	4	.	.	PUNCT
dpc-2577	114	1	on	on	ADP
dpc-2577	114	2	the	the	DET
dpc-2577	114	3	other	other	ADJ
dpc-2577	114	4	hand	hand	NOUN
dpc-2577	114	5	,	,	PUNCT
dpc-2577	114	6	the	the	DET
dpc-2577	114	7	large	large	ADJ
dpc-2577	114	8	registry	registry	NOUN
dpc-2577	114	9	study	study	NOUN
dpc-2577	114	10	from	from	ADP
dpc-2577	114	11	germany	germany	PROPN
dpc-2577	114	12	demonstrated	demonstrate	VERB
dpc-2577	114	13	hypertensive	hypertensive	ADJ
dpc-2577	114	14	diseases	disease	NOUN
dpc-2577	114	15	(	(	PUNCT
dpc-2577	114	16	43.5	43.5	NUM
dpc-2577	114	17	%	%	NOUN
dpc-2577	114	18	)	)	PUNCT
dpc-2577	114	19	,	,	PUNCT
dpc-2577	114	20	lipoprotein	lipoprotein	ADJ
dpc-2577	114	21	metabolism	metabolism	NOUN
dpc-2577	114	22	disorders	disorder	NOUN
dpc-2577	114	23	(	(	PUNCT
dpc-2577	114	24	32.1	32.1	NUM
dpc-2577	114	25	%	%	NOUN
dpc-2577	114	26	)	)	PUNCT
dpc-2577	114	27	,	,	PUNCT
dpc-2577	114	28	and	and	CCONJ
dpc-2577	114	29	affective	affective	ADJ
dpc-2577	114	30	disorders	disorder	NOUN
dpc-2577	114	31	(	(	PUNCT
dpc-2577	114	32	26.0	26.0	NUM
dpc-2577	114	33	%	%	NOUN
dpc-2577	114	34	)	)	PUNCT
dpc-2577	114	35	as	as	ADP
dpc-2577	114	36	the	the	DET
dpc-2577	114	37	most	most	ADV
dpc-2577	114	38	frequently	frequently	ADV
dpc-2577	114	39	reported	report	VERB
dpc-2577	114	40	comorbidities	comorbiditie	NOUN
dpc-2577	114	41	of	of	ADP
dpc-2577	114	42	6	6	NUM
dpc-2577	114	43	original	original	ADJ
dpc-2577	114	44	article	article	NOUN
dpc-2577	114	45	|	|	ADV
dpc-2577	114	46	dermatol	dermatol	ADJ
dpc-2577	114	47	pract	pract	NOUN
dpc-2577	114	48	concept	concept	NOUN
dpc-2577	114	49	.	.	PUNCT
dpc-2577	115	1	2023;13(1):e2023056	2023;13(1):e2023056	NUM
dpc-2577	115	2	patients	patient	NOUN
dpc-2577	115	3	.	.	PUNCT
dpc-2577	116	1	we	we	PRON
dpc-2577	116	2	found	find	VERB
dpc-2577	116	3	the	the	DET
dpc-2577	116	4	prevalence	prevalence	NOUN
dpc-2577	116	5	of	of	ADP
dpc-2577	116	6	thyroid	thyroid	NOUN
dpc-2577	116	7	diseases	disease	NOUN
dpc-2577	116	8	among	among	ADP
dpc-2577	116	9	cu	cu	PROPN
dpc-2577	116	10	patients	patient	NOUN
dpc-2577	116	11	was	be	AUX
dpc-2577	116	12	about	about	ADV
dpc-2577	116	13	36.3	36.3	NUM
dpc-2577	116	14	%	%	NOUN
dpc-2577	116	15	.	.	PUNCT
dpc-2577	117	1	hashimoto	hashimoto	NOUN
dpc-2577	117	2	’s	’s	PART
dpc-2577	117	3	thyroiditis	thyroiditis	NOUN
dpc-2577	117	4	was	be	AUX
dpc-2577	117	5	the	the	DET
dpc-2577	117	6	most	most	ADV
dpc-2577	117	7	prevalent	prevalent	ADJ
dpc-2577	117	8	thyroid	thyroid	NOUN
dpc-2577	117	9	disease	disease	NOUN
dpc-2577	117	10	(	(	PUNCT
dpc-2577	117	11	22.5	22.5	NUM
dpc-2577	117	12	%	%	NOUN
dpc-2577	117	13	)	)	PUNCT
dpc-2577	117	14	,	,	PUNCT
dpc-2577	117	15	followed	follow	VERB
dpc-2577	117	16	by	by	ADP
dpc-2577	117	17	hypothyroidism	hypothyroidism	NOUN
dpc-2577	117	18	(	(	PUNCT
dpc-2577	117	19	17.6	17.6	NUM
dpc-2577	117	20	%	%	NOUN
dpc-2577	117	21	)	)	PUNCT
dpc-2577	117	22	,	,	PUNCT
dpc-2577	117	23	hyperthyroidism	hyperthyroidism	NOUN
dpc-2577	117	24	(	(	PUNCT
dpc-2577	117	25	2.9	2.9	NUM
dpc-2577	117	26	%	%	NOUN
dpc-2577	117	27	)	)	PUNCT
dpc-2577	117	28	,	,	PUNCT
dpc-2577	117	29	and	and	CCONJ
dpc-2577	117	30	graves	grave	VERB
dpc-2577	117	31	’	'	PUNCT
dpc-2577	117	32	disease	disease	NOUN
dpc-2577	117	33	(	(	PUNCT
dpc-2577	117	34	2.0	2.0	NUM
dpc-2577	117	35	%	%	NOUN
dpc-2577	117	36	)	)	PUNCT
dpc-2577	117	37	.	.	PUNCT
dpc-2577	118	1	the	the	DET
dpc-2577	118	2	relationship	relationship	NOUN
dpc-2577	118	3	of	of	ADP
dpc-2577	118	4	cu	cu	PROPN
dpc-2577	118	5	with	with	ADP
dpc-2577	118	6	autoimmune	autoimmune	ADJ
dpc-2577	118	7	thyroid	thyroid	NOUN
dpc-2577	118	8	diseases	disease	NOUN
dpc-2577	118	9	has	have	AUX
dpc-2577	118	10	been	be	AUX
dpc-2577	118	11	underlined	underline	VERB
dpc-2577	118	12	for	for	ADP
dpc-2577	118	13	many	many	ADJ
dpc-2577	118	14	years	year	NOUN
dpc-2577	118	15	and	and	CCONJ
dpc-2577	118	16	a	a	DET
dpc-2577	118	17	large	large	ADJ
dpc-2577	118	18	number	number	NOUN
dpc-2577	118	19	of	of	ADP
dpc-2577	118	20	studies	study	NOUN
dpc-2577	118	21	have	have	AUX
dpc-2577	118	22	been	be	AUX
dpc-2577	118	23	conducted	conduct	VERB
dpc-2577	118	24	worldwide	worldwide	ADV
dpc-2577	119	1	[	[	X
dpc-2577	119	2	27	27	NUM
dpc-2577	119	3	]	]	PUNCT
dpc-2577	119	4	.	.	PUNCT
dpc-2577	120	1	it	it	PRON
dpc-2577	120	2	is	be	AUX
dpc-2577	120	3	worth	worth	ADJ
dpc-2577	120	4	noting	note	VERB
dpc-2577	120	5	that	that	SCONJ
dpc-2577	120	6	most	most	ADJ
dpc-2577	120	7	of	of	ADP
dpc-2577	120	8	the	the	DET
dpc-2577	120	9	studies	study	NOUN
dpc-2577	120	10	have	have	AUX
dpc-2577	120	11	analyzed	analyze	VERB
dpc-2577	120	12	the	the	DET
dpc-2577	120	13	relationship	relationship	NOUN
dpc-2577	120	14	between	between	ADP
dpc-2577	120	15	csu	csu	PROPN
dpc-2577	120	16	and	and	CCONJ
dpc-2577	120	17	thyroid	thyroid	VERB
dpc-2577	120	18	autoimmunity	autoimmunity	NOUN
dpc-2577	120	19	.	.	PUNCT
dpc-2577	121	1	little	little	ADJ
dpc-2577	121	2	is	be	AUX
dpc-2577	121	3	known	know	VERB
dpc-2577	121	4	about	about	ADP
dpc-2577	121	5	whether	whether	SCONJ
dpc-2577	121	6	cindu	cindu	NOUN
dpc-2577	121	7	is	be	AUX
dpc-2577	121	8	also	also	ADV
dpc-2577	121	9	linked	link	VERB
dpc-2577	121	10	to	to	PART
dpc-2577	121	11	thyroid	thyroid	VERB
dpc-2577	121	12	autoimmunity	autoimmunity	NOUN
dpc-2577	121	13	.	.	PUNCT
dpc-2577	122	1	our	our	PRON
dpc-2577	122	2	data	datum	NOUN
dpc-2577	122	3	showed	show	VERB
dpc-2577	122	4	that	that	SCONJ
dpc-2577	122	5	26,3	26,3	NUM
dpc-2577	122	6	%	%	NOUN
dpc-2577	122	7	of	of	ADP
dpc-2577	122	8	patients	patient	NOUN
dpc-2577	122	9	with	with	ADP
dpc-2577	122	10	isolated	isolated	ADJ
dpc-2577	122	11	csu	csu	PROPN
dpc-2577	122	12	had	have	VERB
dpc-2577	122	13	autoimmune	autoimmune	ADJ
dpc-2577	122	14	thyroid	thyroid	NOUN
dpc-2577	122	15	disease	disease	NOUN
dpc-2577	122	16	,	,	PUNCT
dpc-2577	122	17	while	while	SCONJ
dpc-2577	122	18	with	with	ADP
dpc-2577	122	19	isolated	isolated	ADJ
dpc-2577	122	20	cindu	cindu	NOUN
dpc-2577	122	21	only	only	ADV
dpc-2577	122	22	13,6	13,6	NUM
dpc-2577	122	23	%	%	NOUN
dpc-2577	122	24	.	.	PUNCT
dpc-2577	123	1	the	the	DET
dpc-2577	123	2	guidelines	guideline	NOUN
dpc-2577	123	3	of	of	ADP
dpc-2577	123	4	the	the	DET
dpc-2577	123	5	eaaci	eaaci	NOUN
dpc-2577	123	6	/	/	SYM
dpc-2577	123	7	ga2len	ga2len	PROPN
dpc-2577	123	8	/	/	SYM
dpc-2577	123	9	edf	edf	PROPN
dpc-2577	123	10	/	/	SYM
dpc-2577	123	11	wao	wao	PROPN
dpc-2577	123	12	recommend	recommend	VERB
dpc-2577	123	13	that	that	SCONJ
dpc-2577	123	14	physicians	physician	NOUN
dpc-2577	123	15	assess	assess	VERB
dpc-2577	123	16	cu	cu	NOUN
dpc-2577	123	17	patients	patient	NOUN
dpc-2577	123	18	for	for	ADP
dpc-2577	123	19	family	family	NOUN
dpc-2577	123	20	history	history	NOUN
dpc-2577	123	21	of	of	ADP
dpc-2577	123	22	urticaria	urticaria	NOUN
dpc-2577	123	23	and	and	CCONJ
dpc-2577	123	24	atopy	atopy	VERB
dpc-2577	123	25	[	[	X
dpc-2577	123	26	1	1	NUM
dpc-2577	123	27	]	]	PUNCT
dpc-2577	123	28	.	.	PUNCT
dpc-2577	124	1	in	in	ADP
dpc-2577	124	2	our	our	PRON
dpc-2577	124	3	study	study	NOUN
dpc-2577	124	4	,	,	PUNCT
dpc-2577	124	5	family	family	NOUN
dpc-2577	124	6	history	history	NOUN
dpc-2577	124	7	of	of	ADP
dpc-2577	124	8	urticaria	urticaria	NOUN
dpc-2577	124	9	and	and	CCONJ
dpc-2577	124	10	atopy	atopy	NOUN
dpc-2577	124	11	was	be	AUX
dpc-2577	124	12	negative	negative	ADJ
dpc-2577	124	13	in	in	ADP
dpc-2577	124	14	the	the	DET
dpc-2577	124	15	majority	majority	NOUN
dpc-2577	124	16	of	of	ADP
dpc-2577	124	17	patients	patient	NOUN
dpc-2577	124	18	,	,	PUNCT
dpc-2577	124	19	92.2	92.2	NUM
dpc-2577	124	20	%	%	NOUN
dpc-2577	124	21	in	in	ADP
dpc-2577	124	22	urticaria	urticaria	NOUN
dpc-2577	124	23	and	and	CCONJ
dpc-2577	124	24	74.5	74.5	NUM
dpc-2577	124	25	%	%	NOUN
dpc-2577	124	26	in	in	ADP
dpc-2577	124	27	atopy	atopy	NOUN
dpc-2577	124	28	.	.	PUNCT
dpc-2577	125	1	on	on	ADP
dpc-2577	125	2	the	the	DET
dpc-2577	125	3	other	other	ADJ
dpc-2577	125	4	hand	hand	NOUN
dpc-2577	125	5	,	,	PUNCT
dpc-2577	125	6	autoimmune	autoimmune	ADJ
dpc-2577	125	7	disorders	disorder	NOUN
dpc-2577	125	8	were	be	AUX
dpc-2577	125	9	common	common	ADJ
dpc-2577	125	10	in	in	ADP
dpc-2577	125	11	family	family	NOUN
dpc-2577	125	12	members	member	NOUN
dpc-2577	125	13	.	.	PUNCT
dpc-2577	126	1	our	our	PRON
dpc-2577	126	2	study	study	NOUN
dpc-2577	126	3	has	have	VERB
dpc-2577	126	4	some	some	DET
dpc-2577	126	5	limitations	limitation	NOUN
dpc-2577	126	6	.	.	PUNCT
dpc-2577	127	1	first	first	ADV
dpc-2577	127	2	,	,	PUNCT
dpc-2577	127	3	respondents	respondent	NOUN
dpc-2577	127	4	were	be	AUX
dpc-2577	127	5	recruited	recruit	VERB
dpc-2577	127	6	through	through	ADP
dpc-2577	127	7	facebook	facebook	NOUN
dpc-2577	127	8	groups	group	NOUN
dpc-2577	127	9	and	and	CCONJ
dpc-2577	127	10	there	there	PRON
dpc-2577	127	11	is	be	VERB
dpc-2577	127	12	a	a	DET
dpc-2577	127	13	potential	potential	ADJ
dpc-2577	127	14	sample	sample	NOUN
dpc-2577	127	15	selection	selection	NOUN
dpc-2577	127	16	bias	bias	NOUN
dpc-2577	127	17	.	.	PUNCT
dpc-2577	128	1	our	our	PRON
dpc-2577	128	2	study	study	NOUN
dpc-2577	128	3	population	population	NOUN
dpc-2577	128	4	can	can	AUX
dpc-2577	128	5	not	not	PART
dpc-2577	128	6	be	be	AUX
dpc-2577	128	7	representative	representative	ADJ
dpc-2577	128	8	of	of	ADP
dpc-2577	128	9	all	all	DET
dpc-2577	128	10	chronic	chronic	ADJ
dpc-2577	128	11	urticaria	urticaria	NOUN
dpc-2577	128	12	patients	patient	NOUN
dpc-2577	128	13	as	as	ADP
dpc-2577	128	14	the	the	DET
dpc-2577	128	15	participation	participation	NOUN
dpc-2577	128	16	of	of	ADP
dpc-2577	128	17	men	man	NOUN
dpc-2577	128	18	has	have	AUX
dpc-2577	128	19	been	be	AUX
dpc-2577	128	20	unrepresentative	unrepresentative	ADJ
dpc-2577	128	21	.	.	PUNCT
dpc-2577	129	1	we	we	PRON
dpc-2577	129	2	did	do	AUX
dpc-2577	129	3	not	not	PART
dpc-2577	129	4	use	use	VERB
dpc-2577	129	5	any	any	DET
dpc-2577	129	6	instrument	instrument	NOUN
dpc-2577	129	7	for	for	ADP
dpc-2577	129	8	assessing	assess	VERB
dpc-2577	129	9	urticaria	urticaria	NOUN
dpc-2577	129	10	severity	severity	NOUN
dpc-2577	129	11	therefore	therefore	ADV
dpc-2577	129	12	we	we	PRON
dpc-2577	129	13	do	do	AUX
dpc-2577	129	14	not	not	PART
dpc-2577	129	15	know	know	VERB
dpc-2577	129	16	the	the	DET
dpc-2577	129	17	severity	severity	NOUN
dpc-2577	129	18	of	of	ADP
dpc-2577	129	19	the	the	DET
dpc-2577	129	20	disease	disease	NOUN
dpc-2577	129	21	in	in	ADP
dpc-2577	129	22	the	the	DET
dpc-2577	129	23	respondents	respondent	NOUN
dpc-2577	129	24	.	.	PUNCT
dpc-2577	130	1	however	however	ADV
dpc-2577	130	2	,	,	PUNCT
dpc-2577	130	3	patients	patient	NOUN
dpc-2577	130	4	participating	participate	VERB
dpc-2577	130	5	in	in	ADP
dpc-2577	130	6	urticaria	urticaria	ADJ
dpc-2577	130	7	groups	group	NOUN
dpc-2577	130	8	typically	typically	ADV
dpc-2577	130	9	have	have	VERB
dpc-2577	130	10	more	more	ADV
dpc-2577	130	11	severe	severe	ADJ
dpc-2577	130	12	and	and	CCONJ
dpc-2577	130	13	uncontrolled	uncontrolled	ADJ
dpc-2577	130	14	symptoms	symptom	NOUN
dpc-2577	130	15	of	of	ADP
dpc-2577	130	16	the	the	DET
dpc-2577	130	17	disease	disease	NOUN
dpc-2577	130	18	.	.	PUNCT
dpc-2577	131	1	in	in	ADP
dpc-2577	131	2	addition	addition	NOUN
dpc-2577	131	3	,	,	PUNCT
dpc-2577	131	4	women	woman	NOUN
dpc-2577	131	5	participate	participate	VERB
dpc-2577	131	6	more	more	ADV
dpc-2577	131	7	actively	actively	ADV
dpc-2577	131	8	in	in	ADP
dpc-2577	131	9	social	social	ADJ
dpc-2577	131	10	networks	network	NOUN
dpc-2577	131	11	and	and	CCONJ
dpc-2577	131	12	are	be	AUX
dpc-2577	131	13	looking	look	VERB
dpc-2577	131	14	for	for	ADP
dpc-2577	131	15	more	more	ADJ
dpc-2577	131	16	information	information	NOUN
dpc-2577	131	17	about	about	ADP
dpc-2577	131	18	the	the	DET
dpc-2577	131	19	diseases	disease	NOUN
dpc-2577	131	20	they	they	PRON
dpc-2577	131	21	suffer	suffer	VERB
dpc-2577	131	22	from	from	ADP
dpc-2577	131	23	.	.	PUNCT
dpc-2577	132	1	another	another	DET
dpc-2577	132	2	limitation	limitation	NOUN
dpc-2577	132	3	is	be	AUX
dpc-2577	132	4	the	the	DET
dpc-2577	132	5	fact	fact	NOUN
dpc-2577	132	6	that	that	SCONJ
dpc-2577	132	7	middle	middle	ADJ
dpc-2577	132	8	-	-	PUNCT
dpc-2577	132	9	aged	aged	ADJ
dpc-2577	132	10	patients	patient	NOUN
dpc-2577	132	11	are	be	AUX
dpc-2577	132	12	more	more	ADV
dpc-2577	132	13	likely	likely	ADJ
dpc-2577	132	14	to	to	PART
dpc-2577	132	15	participate	participate	VERB
dpc-2577	132	16	actively	actively	ADV
dpc-2577	132	17	in	in	ADP
dpc-2577	132	18	social	social	ADJ
dpc-2577	132	19	networks	network	NOUN
dpc-2577	132	20	and	and	CCONJ
dpc-2577	132	21	online	online	ADJ
dpc-2577	132	22	survey	survey	NOUN
dpc-2577	132	23	studies	study	NOUN
dpc-2577	132	24	thus	thus	ADV
dpc-2577	132	25	the	the	DET
dpc-2577	132	26	obtained	obtain	VERB
dpc-2577	132	27	data	datum	NOUN
dpc-2577	132	28	may	may	AUX
dpc-2577	132	29	not	not	PART
dpc-2577	132	30	be	be	AUX
dpc-2577	132	31	representative	representative	ADJ
dpc-2577	132	32	of	of	ADP
dpc-2577	132	33	all	all	DET
dpc-2577	132	34	age	age	NOUN
dpc-2577	132	35	groups	group	NOUN
dpc-2577	132	36	.	.	PUNCT
dpc-2577	133	1	most	most	ADJ
dpc-2577	133	2	of	of	ADP
dpc-2577	133	3	our	our	PRON
dpc-2577	133	4	study	study	NOUN
dpc-2577	133	5	population	population	NOUN
dpc-2577	133	6	were	be	AUX
dpc-2577	133	7	patients	patient	NOUN
dpc-2577	133	8	between	between	ADP
dpc-2577	133	9	the	the	DET
dpc-2577	133	10	ages	age	NOUN
dpc-2577	133	11	of	of	ADP
dpc-2577	133	12	19	19	NUM
dpc-2577	133	13	and	and	CCONJ
dpc-2577	133	14	39	39	NUM
dpc-2577	133	15	.	.	PUNCT
dpc-2577	134	1	taking	take	VERB
dpc-2577	134	2	into	into	ADP
dpc-2577	134	3	account	account	NOUN
dpc-2577	134	4	all	all	PRON
dpc-2577	134	5	of	of	ADP
dpc-2577	134	6	this	this	PRON
dpc-2577	134	7	,	,	PUNCT
dpc-2577	134	8	our	our	PRON
dpc-2577	134	9	data	datum	NOUN
dpc-2577	134	10	have	have	VERB
dpc-2577	134	11	over	over	ADV
dpc-2577	134	12	-	-	PUNCT
dpc-2577	134	13	represented	represent	VERB
dpc-2577	134	14	young	young	ADJ
dpc-2577	134	15	women	woman	NOUN
dpc-2577	134	16	and	and	CCONJ
dpc-2577	134	17	those	those	PRON
dpc-2577	134	18	who	who	PRON
dpc-2577	134	19	have	have	VERB
dpc-2577	134	20	more	more	ADV
dpc-2577	134	21	severe	severe	ADJ
dpc-2577	134	22	chronic	chronic	ADJ
dpc-2577	134	23	urticaria	urticaria	NOUN
dpc-2577	134	24	.	.	PUNCT
dpc-2577	135	1	as	as	SCONJ
dpc-2577	135	2	mentioned	mention	VERB
dpc-2577	135	3	above	above	ADV
dpc-2577	135	4	,	,	PUNCT
dpc-2577	135	5	young	young	ADJ
dpc-2577	135	6	women	woman	NOUN
dpc-2577	135	7	and	and	CCONJ
dpc-2577	135	8	patients	patient	NOUN
dpc-2577	135	9	with	with	ADP
dpc-2577	135	10	severe	severe	ADJ
dpc-2577	135	11	diseases	disease	NOUN
dpc-2577	135	12	seek	seek	VERB
dpc-2577	135	13	more	more	ADJ
dpc-2577	135	14	information	information	NOUN
dpc-2577	135	15	about	about	ADP
dpc-2577	135	16	the	the	DET
dpc-2577	135	17	disease	disease	NOUN
dpc-2577	135	18	they	they	PRON
dpc-2577	135	19	suffer	suffer	VERB
dpc-2577	135	20	from	from	ADP
dpc-2577	135	21	and	and	CCONJ
dpc-2577	135	22	are	be	AUX
dpc-2577	135	23	more	more	ADV
dpc-2577	135	24	active	active	ADJ
dpc-2577	135	25	on	on	ADP
dpc-2577	135	26	social	social	ADJ
dpc-2577	135	27	media	medium	NOUN
dpc-2577	135	28	.	.	PUNCT
dpc-2577	136	1	such	such	DET
dpc-2577	136	2	a	a	DET
dpc-2577	136	3	profile	profile	NOUN
dpc-2577	136	4	of	of	ADP
dpc-2577	136	5	patients	patient	NOUN
dpc-2577	136	6	participating	participate	VERB
dpc-2577	136	7	in	in	ADP
dpc-2577	136	8	our	our	PRON
dpc-2577	136	9	study	study	NOUN
dpc-2577	136	10	may	may	AUX
dpc-2577	136	11	affect	affect	VERB
dpc-2577	136	12	the	the	DET
dpc-2577	136	13	percentage	percentage	NOUN
dpc-2577	136	14	of	of	ADP
dpc-2577	136	15	comorbidities	comorbiditie	NOUN
dpc-2577	136	16	which	which	PRON
dpc-2577	136	17	is	be	AUX
dpc-2577	136	18	relatively	relatively	ADV
dpc-2577	136	19	high	high	ADJ
dpc-2577	136	20	compared	compare	VERB
dpc-2577	136	21	to	to	ADP
dpc-2577	136	22	other	other	ADJ
dpc-2577	136	23	reported	report	VERB
dpc-2577	136	24	publications	publication	NOUN
dpc-2577	136	25	.	.	PUNCT
dpc-2577	137	1	finally	finally	ADV
dpc-2577	137	2	,	,	PUNCT
dpc-2577	137	3	the	the	DET
dpc-2577	137	4	high	high	ADJ
dpc-2577	137	5	registration	registration	NOUN
dpc-2577	137	6	percentage	percentage	NOUN
dpc-2577	137	7	of	of	ADP
dpc-2577	137	8	delayed	delay	VERB
dpc-2577	137	9	pressure	pressure	NOUN
dpc-2577	137	10	urticaria	urticaria	NOUN
dpc-2577	137	11	in	in	ADP
dpc-2577	137	12	our	our	PRON
dpc-2577	137	13	study	study	NOUN
dpc-2577	137	14	may	may	AUX
dpc-2577	137	15	be	be	AUX
dpc-2577	137	16	a	a	DET
dpc-2577	137	17	result	result	NOUN
dpc-2577	137	18	of	of	ADP
dpc-2577	137	19	the	the	DET
dpc-2577	137	20	percentage	percentage	NOUN
dpc-2577	137	21	of	of	ADP
dpc-2577	137	22	angioedema	angioedema	NOUN
dpc-2577	137	23	.	.	PUNCT
dpc-2577	138	1	regarding	regard	VERB
dpc-2577	138	2	the	the	DET
dpc-2577	138	3	fact	fact	NOUN
dpc-2577	138	4	that	that	SCONJ
dpc-2577	138	5	it	it	PRON
dpc-2577	138	6	can	can	AUX
dpc-2577	138	7	be	be	AUX
dpc-2577	138	8	difficult	difficult	ADJ
dpc-2577	138	9	for	for	SCONJ
dpc-2577	138	10	patients	patient	NOUN
dpc-2577	138	11	to	to	PART
dpc-2577	138	12	distinguish	distinguish	VERB
dpc-2577	138	13	between	between	ADP
dpc-2577	138	14	swelling	swelling	NOUN
dpc-2577	138	15	caused	cause	VERB
dpc-2577	138	16	by	by	ADP
dpc-2577	138	17	pressure	pressure	NOUN
dpc-2577	138	18	from	from	ADP
dpc-2577	138	19	swelling	swell	VERB
dpc-2577	138	20	caused	cause	VERB
dpc-2577	138	21	by	by	ADP
dpc-2577	138	22	angioedema	angioedema	NOUN
dpc-2577	138	23	they	they	PRON
dpc-2577	138	24	often	often	ADV
dpc-2577	138	25	confuse	confuse	VERB
dpc-2577	138	26	the	the	DET
dpc-2577	138	27	two	two	NUM
dpc-2577	138	28	entities	entity	NOUN
dpc-2577	138	29	or	or	CCONJ
dpc-2577	138	30	report	report	VERB
dpc-2577	138	31	them	they	PRON
dpc-2577	138	32	in	in	ADP
dpc-2577	138	33	the	the	DET
dpc-2577	138	34	same	same	ADJ
dpc-2577	138	35	way	way	NOUN
dpc-2577	138	36	.	.	PUNCT
dpc-2577	139	1	special	special	ADJ
dpc-2577	139	2	interest	interest	NOUN
dpc-2577	139	3	[	[	X
dpc-2577	139	4	18	18	NUM
dpc-2577	139	5	]	]	PUNCT
dpc-2577	139	6	.	.	PUNCT
dpc-2577	140	1	this	this	PRON
dpc-2577	140	2	is	be	AUX
dpc-2577	140	3	in	in	ADP
dpc-2577	140	4	contrast	contrast	NOUN
dpc-2577	140	5	to	to	ADP
dpc-2577	140	6	our	our	PRON
dpc-2577	140	7	findings	finding	NOUN
dpc-2577	140	8	where	where	SCONJ
dpc-2577	140	9	coexisting	coexist	VERB
dpc-2577	140	10	hypertension	hypertension	NOUN
dpc-2577	140	11	was	be	AUX
dpc-2577	140	12	reported	report	VERB
dpc-2577	140	13	by	by	ADP
dpc-2577	140	14	only	only	ADV
dpc-2577	140	15	8.8	8.8	NUM
dpc-2577	140	16	%	%	NOUN
dpc-2577	140	17	of	of	ADP
dpc-2577	140	18	patients	patient	NOUN
dpc-2577	140	19	.	.	PUNCT
dpc-2577	141	1	a	a	DET
dpc-2577	141	2	retrospective	retrospective	ADJ
dpc-2577	141	3	danish	danish	ADJ
dpc-2577	141	4	cohort	cohort	NOUN
dpc-2577	141	5	study	study	NOUN
dpc-2577	141	6	that	that	PRON
dpc-2577	141	7	examined	examine	VERB
dpc-2577	141	8	the	the	DET
dpc-2577	141	9	prevalence	prevalence	NOUN
dpc-2577	141	10	of	of	ADP
dpc-2577	141	11	cardiovascular	cardiovascular	ADJ
dpc-2577	141	12	diseases	disease	NOUN
dpc-2577	141	13	did	do	AUX
dpc-2577	141	14	not	not	PART
dpc-2577	141	15	find	find	VERB
dpc-2577	141	16	any	any	DET
dpc-2577	141	17	increased	increase	VERB
dpc-2577	141	18	risk	risk	NOUN
dpc-2577	141	19	of	of	ADP
dpc-2577	141	20	these	these	PRON
dpc-2577	141	21	in	in	ADP
dpc-2577	141	22	cu	cu	PROPN
dpc-2577	141	23	patients	patient	NOUN
dpc-2577	141	24	compared	compare	VERB
dpc-2577	141	25	to	to	ADP
dpc-2577	141	26	the	the	DET
dpc-2577	141	27	general	general	ADJ
dpc-2577	141	28	population	population	NOUN
dpc-2577	142	1	[	[	X
dpc-2577	142	2	19	19	NUM
dpc-2577	142	3	]	]	PUNCT
dpc-2577	142	4	.	.	PUNCT
dpc-2577	143	1	however	however	ADV
dpc-2577	143	2	,	,	PUNCT
dpc-2577	143	3	an	an	DET
dpc-2577	143	4	extended	extended	ADJ
dpc-2577	143	5	duration	duration	NOUN
dpc-2577	143	6	of	of	ADP
dpc-2577	143	7	csu	csu	PROPN
dpc-2577	143	8	is	be	AUX
dpc-2577	143	9	more	more	ADV
dpc-2577	143	10	likely	likely	ADJ
dpc-2577	143	11	in	in	ADP
dpc-2577	143	12	patients	patient	NOUN
dpc-2577	143	13	with	with	ADP
dpc-2577	143	14	arterial	arterial	ADJ
dpc-2577	143	15	hypertension	hypertension	NOUN
dpc-2577	143	16	[	[	X
dpc-2577	143	17	5	5	NUM
dpc-2577	143	18	]	]	PUNCT
dpc-2577	143	19	.	.	PUNCT
dpc-2577	144	1	in	in	ADP
dpc-2577	144	2	the	the	DET
dpc-2577	144	3	taiwan	taiwan	PROPN
dpc-2577	144	4	study	study	NOUN
dpc-2577	144	5	,	,	PUNCT
dpc-2577	144	6	among	among	ADP
dpc-2577	144	7	the	the	DET
dpc-2577	144	8	four	four	NUM
dpc-2577	144	9	categories	category	NOUN
dpc-2577	144	10	of	of	ADP
dpc-2577	144	11	comorbidities	comorbiditie	NOUN
dpc-2577	144	12	that	that	PRON
dpc-2577	144	13	were	be	AUX
dpc-2577	144	14	examined	examine	VERB
dpc-2577	144	15	,	,	PUNCT
dpc-2577	144	16	inflammatory	inflammatory	ADJ
dpc-2577	144	17	diseases	disease	NOUN
dpc-2577	144	18	(	(	PUNCT
dpc-2577	144	19	9.78	9.78	NUM
dpc-2577	144	20	%	%	NOUN
dpc-2577	144	21	)	)	PUNCT
dpc-2577	144	22	were	be	AUX
dpc-2577	144	23	the	the	DET
dpc-2577	144	24	most	most	ADV
dpc-2577	144	25	prevalent	prevalent	ADJ
dpc-2577	144	26	,	,	PUNCT
dpc-2577	144	27	followed	follow	VERB
dpc-2577	144	28	by	by	ADP
dpc-2577	144	29	psychiatric	psychiatric	ADJ
dpc-2577	144	30	disorders	disorder	NOUN
dpc-2577	144	31	(	(	PUNCT
dpc-2577	144	32	8.53	8.53	NUM
dpc-2577	144	33	%	%	NOUN
dpc-2577	144	34	)	)	PUNCT
dpc-2577	144	35	,	,	PUNCT
dpc-2577	145	1	rheumatic	rheumatic	ADJ
dpc-2577	145	2	diseases	disease	NOUN
dpc-2577	145	3	(	(	PUNCT
dpc-2577	145	4	2.48	2.48	NUM
dpc-2577	145	5	%	%	NOUN
dpc-2577	145	6	)	)	PUNCT
dpc-2577	145	7	,	,	PUNCT
dpc-2577	145	8	and	and	CCONJ
dpc-2577	145	9	thyroid	thyroid	NOUN
dpc-2577	145	10	disorders	disorder	NOUN
dpc-2577	145	11	(	(	PUNCT
dpc-2577	145	12	1.78	1.78	NUM
dpc-2577	145	13	%	%	NOUN
dpc-2577	145	14	)	)	PUNCT
dpc-2577	146	1	[	[	X
dpc-2577	146	2	20	20	NUM
dpc-2577	146	3	]	]	PUNCT
dpc-2577	146	4	.	.	PUNCT
dpc-2577	147	1	other	other	ADJ
dpc-2577	147	2	studies	study	NOUN
dpc-2577	147	3	have	have	AUX
dpc-2577	147	4	found	find	VERB
dpc-2577	147	5	that	that	SCONJ
dpc-2577	147	6	psychiatric	psychiatric	ADJ
dpc-2577	147	7	comorbidities	comorbiditie	NOUN
dpc-2577	147	8	were	be	AUX
dpc-2577	147	9	the	the	DET
dpc-2577	147	10	most	most	ADV
dpc-2577	147	11	commonly	commonly	ADV
dpc-2577	147	12	recognized	recognize	VERB
dpc-2577	147	13	in	in	ADP
dpc-2577	147	14	cu	cu	PROPN
dpc-2577	147	15	patients	patient	NOUN
dpc-2577	147	16	,	,	PUNCT
dpc-2577	147	17	ranging	range	VERB
dpc-2577	147	18	up	up	ADP
dpc-2577	147	19	to	to	PART
dpc-2577	147	20	60	60	NUM
dpc-2577	147	21	%	%	NOUN
dpc-2577	147	22	.	.	PUNCT
dpc-2577	148	1	anxiety	anxiety	NOUN
dpc-2577	148	2	,	,	PUNCT
dpc-2577	148	3	depression	depression	NOUN
dpc-2577	148	4	,	,	PUNCT
dpc-2577	148	5	and	and	CCONJ
dpc-2577	148	6	somatoform	somatoform	NOUN
dpc-2577	148	7	disorders	disorder	NOUN
dpc-2577	148	8	have	have	AUX
dpc-2577	148	9	been	be	AUX
dpc-2577	148	10	reported	report	VERB
dpc-2577	148	11	to	to	PART
dpc-2577	148	12	be	be	AUX
dpc-2577	148	13	the	the	DET
dpc-2577	148	14	most	most	ADV
dpc-2577	148	15	prevalent	prevalent	ADJ
dpc-2577	148	16	mental	mental	ADJ
dpc-2577	148	17	disorders	disorder	NOUN
dpc-2577	148	18	in	in	ADP
dpc-2577	148	19	cu	cu	PROPN
dpc-2577	148	20	patients	patient	NOUN
dpc-2577	148	21	[	[	X
dpc-2577	148	22	21	21	NUM
dpc-2577	148	23	]	]	PUNCT
dpc-2577	148	24	.	.	PUNCT
dpc-2577	149	1	in	in	ADP
dpc-2577	149	2	our	our	PRON
dpc-2577	149	3	study	study	NOUN
dpc-2577	149	4	,	,	PUNCT
dpc-2577	149	5	almost	almost	ADV
dpc-2577	149	6	26	26	NUM
dpc-2577	149	7	%	%	NOUN
dpc-2577	149	8	of	of	ADP
dpc-2577	149	9	patients	patient	NOUN
dpc-2577	149	10	reported	report	VERB
dpc-2577	149	11	psychiatric	psychiatric	ADJ
dpc-2577	149	12	disorders	disorder	NOUN
dpc-2577	149	13	,	,	PUNCT
dpc-2577	149	14	most	most	ADV
dpc-2577	149	15	often	often	ADV
dpc-2577	149	16	depression	depression	NOUN
dpc-2577	149	17	.	.	PUNCT
dpc-2577	150	1	many	many	ADJ
dpc-2577	150	2	authors	author	NOUN
dpc-2577	150	3	emphasize	emphasize	VERB
dpc-2577	150	4	the	the	DET
dpc-2577	150	5	possible	possible	ADJ
dpc-2577	150	6	role	role	NOUN
dpc-2577	150	7	of	of	ADP
dpc-2577	150	8	parasitic	parasitic	ADJ
dpc-2577	150	9	infestations	infestation	NOUN
dpc-2577	150	10	and	and	CCONJ
dpc-2577	150	11	inflammation	inflammation	NOUN
dpc-2577	150	12	in	in	ADP
dpc-2577	150	13	chronic	chronic	ADJ
dpc-2577	150	14	urticaria	urticaria	NOUN
dpc-2577	150	15	[	[	X
dpc-2577	150	16	22	22	NUM
dpc-2577	150	17	]	]	PUNCT
dpc-2577	150	18	.	.	PUNCT
dpc-2577	151	1	in	in	ADP
dpc-2577	151	2	our	our	PRON
dpc-2577	151	3	analysis	analysis	NOUN
dpc-2577	151	4	,	,	PUNCT
dpc-2577	151	5	none	none	NOUN
dpc-2577	151	6	of	of	ADP
dpc-2577	151	7	the	the	DET
dpc-2577	151	8	respondents	respondent	NOUN
dpc-2577	151	9	reported	report	VERB
dpc-2577	151	10	parasitic	parasitic	ADJ
dpc-2577	151	11	infestations	infestation	NOUN
dpc-2577	151	12	.	.	PUNCT
dpc-2577	152	1	whereas	whereas	SCONJ
dpc-2577	152	2	among	among	ADP
dpc-2577	152	3	inflammatory	inflammatory	ADJ
dpc-2577	152	4	diseases	disease	NOUN
dpc-2577	152	5	,	,	PUNCT
dpc-2577	152	6	the	the	DET
dpc-2577	152	7	most	most	ADV
dpc-2577	152	8	common	common	ADJ
dpc-2577	152	9	were	be	AUX
dpc-2577	152	10	sinusitis	sinusitis	NOUN
dpc-2577	152	11	(	(	PUNCT
dpc-2577	152	12	17.6	17.6	NUM
dpc-2577	152	13	%	%	NOUN
dpc-2577	152	14	)	)	PUNCT
dpc-2577	152	15	,	,	PUNCT
dpc-2577	152	16	gastritis	gastritis	NOUN
dpc-2577	152	17	(	(	PUNCT
dpc-2577	152	18	10.8	10.8	NUM
dpc-2577	152	19	%	%	NOUN
dpc-2577	152	20	)	)	PUNCT
dpc-2577	152	21	,	,	PUNCT
dpc-2577	152	22	and	and	CCONJ
dpc-2577	152	23	urinary	urinary	ADJ
dpc-2577	152	24	tract	tract	NOUN
dpc-2577	152	25	infection	infection	NOUN
dpc-2577	152	26	(	(	PUNCT
dpc-2577	152	27	7.8	7.8	NUM
dpc-2577	152	28	%	%	NOUN
dpc-2577	152	29	)	)	PUNCT
dpc-2577	152	30	.	.	PUNCT
dpc-2577	153	1	authors	author	NOUN
dpc-2577	153	2	from	from	ADP
dpc-2577	153	3	taiwan	taiwan	PROPN
dpc-2577	153	4	found	find	VERB
dpc-2577	153	5	peptic	peptic	ADJ
dpc-2577	153	6	ulcer	ulcer	NOUN
dpc-2577	153	7	was	be	AUX
dpc-2577	153	8	the	the	DET
dpc-2577	153	9	most	most	ADV
dpc-2577	153	10	prevalent	prevalent	ADJ
dpc-2577	153	11	inflammatory	inflammatory	ADJ
dpc-2577	153	12	disease	disease	NOUN
dpc-2577	153	13	(	(	PUNCT
dpc-2577	153	14	4.83	4.83	NUM
dpc-2577	153	15	%	%	NOUN
dpc-2577	153	16	)	)	PUNCT
dpc-2577	153	17	,	,	PUNCT
dpc-2577	153	18	followed	follow	VERB
dpc-2577	153	19	by	by	ADP
dpc-2577	153	20	hepatitis	hepatitis	PROPN
dpc-2577	153	21	b	b	PROPN
dpc-2577	153	22	/	/	SYM
dpc-2577	153	23	hepatitis	hepatitis	NOUN
dpc-2577	153	24	c	c	NOUN
dpc-2577	153	25	(	(	PUNCT
dpc-2577	153	26	1.64	1.64	NUM
dpc-2577	153	27	%	%	NOUN
dpc-2577	153	28	)	)	PUNCT
dpc-2577	153	29	and	and	CCONJ
dpc-2577	153	30	periodontitis	periodontitis	NOUN
dpc-2577	153	31	(	(	PUNCT
dpc-2577	153	32	2.82	2.82	NUM
dpc-2577	153	33	%	%	NOUN
dpc-2577	153	34	)	)	PUNCT
dpc-2577	154	1	[	[	X
dpc-2577	154	2	20	20	NUM
dpc-2577	154	3	]	]	PUNCT
dpc-2577	154	4	.	.	PUNCT
dpc-2577	155	1	the	the	DET
dpc-2577	155	2	association	association	NOUN
dpc-2577	155	3	between	between	ADP
dpc-2577	155	4	cu	cu	PROPN
dpc-2577	155	5	and	and	CCONJ
dpc-2577	155	6	neoplasm	neoplasm	NOUN
dpc-2577	155	7	diseases	disease	NOUN
dpc-2577	155	8	is	be	AUX
dpc-2577	155	9	still	still	ADV
dpc-2577	155	10	controversial	controversial	ADJ
dpc-2577	155	11	.	.	PUNCT
dpc-2577	156	1	one	one	NUM
dpc-2577	156	2	population	population	NOUN
dpc-2577	156	3	-	-	PUNCT
dpc-2577	156	4	based	base	VERB
dpc-2577	156	5	study	study	NOUN
dpc-2577	156	6	reported	report	VERB
dpc-2577	156	7	no	no	DET
dpc-2577	156	8	association	association	NOUN
dpc-2577	156	9	between	between	ADP
dpc-2577	156	10	cu	cu	PROPN
dpc-2577	156	11	and	and	CCONJ
dpc-2577	156	12	cancer	cancer	NOUN
dpc-2577	156	13	[	[	X
dpc-2577	156	14	23	23	NUM
dpc-2577	156	15	]	]	PUNCT
dpc-2577	156	16	.	.	PUNCT
dpc-2577	157	1	a	a	DET
dpc-2577	157	2	study	study	NOUN
dpc-2577	157	3	from	from	ADP
dpc-2577	157	4	taiwan	taiwan	PROPN
dpc-2577	157	5	demonstrated	demonstrate	VERB
dpc-2577	157	6	an	an	DET
dpc-2577	157	7	increased	increased	ADJ
dpc-2577	157	8	risk	risk	NOUN
dpc-2577	157	9	of	of	ADP
dpc-2577	157	10	hematological	hematological	ADJ
dpc-2577	157	11	malignant	malignant	ADJ
dpc-2577	157	12	tumors	tumor	NOUN
dpc-2577	157	13	,	,	PUNCT
dpc-2577	157	14	especially	especially	ADV
dpc-2577	157	15	non	non	ADJ
dpc-2577	157	16	-	-	ADJ
dpc-2577	157	17	hodgkin	hodgkin	ADJ
dpc-2577	157	18	lymphoma	lymphoma	NOUN
dpc-2577	157	19	,	,	PUNCT
dpc-2577	157	20	in	in	ADP
dpc-2577	157	21	patients	patient	NOUN
dpc-2577	157	22	with	with	ADP
dpc-2577	157	23	cu	cu	PROPN
dpc-2577	157	24	[	[	X
dpc-2577	157	25	24	24	NUM
dpc-2577	157	26	]	]	PUNCT
dpc-2577	157	27	.	.	PUNCT
dpc-2577	158	1	a	a	DET
dpc-2577	158	2	korean	korean	ADJ
dpc-2577	158	3	study	study	NOUN
dpc-2577	158	4	showed	show	VERB
dpc-2577	158	5	an	an	DET
dpc-2577	158	6	increased	increased	ADJ
dpc-2577	158	7	risk	risk	NOUN
dpc-2577	158	8	of	of	ADP
dpc-2577	158	9	nonhematological	nonhematological	ADJ
dpc-2577	158	10	tumors	tumor	NOUN
dpc-2577	158	11	,	,	PUNCT
dpc-2577	158	12	especially	especially	ADV
dpc-2577	158	13	stomach	stomach	NOUN
dpc-2577	158	14	,	,	PUNCT
dpc-2577	158	15	thyroid	thyroid	NOUN
dpc-2577	158	16	,	,	PUNCT
dpc-2577	158	17	and	and	CCONJ
dpc-2577	158	18	liver	liver	NOUN
dpc-2577	158	19	cancers	cancer	NOUN
dpc-2577	158	20	in	in	ADP
dpc-2577	158	21	the	the	DET
dpc-2577	158	22	case	case	NOUN
dpc-2577	158	23	of	of	ADP
dpc-2577	158	24	cu	cu	PROPN
dpc-2577	158	25	,	,	PUNCT
dpc-2577	158	26	and	and	CCONJ
dpc-2577	158	27	thyroid	thyroid	NOUN
dpc-2577	158	28	,	,	PUNCT
dpc-2577	158	29	liver	liver	NOUN
dpc-2577	158	30	,	,	PUNCT
dpc-2577	158	31	and	and	CCONJ
dpc-2577	158	32	prostate	prostate	NOUN
dpc-2577	158	33	cancers	cancer	NOUN
dpc-2577	158	34	in	in	ADP
dpc-2577	158	35	the	the	DET
dpc-2577	158	36	case	case	NOUN
dpc-2577	158	37	of	of	ADP
dpc-2577	158	38	csu	csu	PROPN
dpc-2577	158	39	[	[	X
dpc-2577	158	40	15	15	NUM
dpc-2577	158	41	]	]	PUNCT
dpc-2577	158	42	.	.	PUNCT
dpc-2577	159	1	in	in	ADP
dpc-2577	159	2	our	our	PRON
dpc-2577	159	3	study	study	NOUN
dpc-2577	159	4	,	,	PUNCT
dpc-2577	159	5	two	two	NUM
dpc-2577	159	6	patients	patient	NOUN
dpc-2577	159	7	reported	report	VERB
dpc-2577	159	8	the	the	DET
dpc-2577	159	9	presence	presence	NOUN
dpc-2577	159	10	of	of	ADP
dpc-2577	159	11	melanoma	melanoma	NOUN
dpc-2577	159	12	and	and	CCONJ
dpc-2577	159	13	carcinoid	carcinoid	NOUN
dpc-2577	159	14	tumor	tumor	NOUN
dpc-2577	159	15	.	.	PUNCT
dpc-2577	160	1	a	a	DET
dpc-2577	160	2	systematic	systematic	ADJ
dpc-2577	160	3	review	review	NOUN
dpc-2577	160	4	of	of	ADP
dpc-2577	160	5	the	the	DET
dpc-2577	160	6	literature	literature	NOUN
dpc-2577	160	7	on	on	ADP
dpc-2577	160	8	autoimmune	autoimmune	ADJ
dpc-2577	160	9	comorbidities	comorbiditie	NOUN
dpc-2577	160	10	in	in	ADP
dpc-2577	160	11	patients	patient	NOUN
dpc-2577	160	12	with	with	ADP
dpc-2577	160	13	cu	cu	PROPN
dpc-2577	160	14	showed	show	VERB
dpc-2577	160	15	that	that	SCONJ
dpc-2577	160	16	the	the	DET
dpc-2577	160	17	most	most	ADV
dpc-2577	160	18	common	common	ADJ
dpc-2577	160	19	autoimmune	autoimmune	ADJ
dpc-2577	160	20	comorbidities	comorbiditie	NOUN
dpc-2577	160	21	were	be	AUX
dpc-2577	160	22	autoimmune	autoimmune	ADJ
dpc-2577	160	23	thyroid	thyroid	NOUN
dpc-2577	160	24	diseases	disease	NOUN
dpc-2577	160	25	and	and	CCONJ
dpc-2577	160	26	vitiligo	vitiligo	VERB
dpc-2577	160	27	[	[	X
dpc-2577	160	28	25	25	NUM
dpc-2577	160	29	]	]	PUNCT
dpc-2577	160	30	.	.	PUNCT
dpc-2577	161	1	our	our	PRON
dpc-2577	161	2	results	result	NOUN
dpc-2577	161	3	are	be	AUX
dpc-2577	161	4	similar	similar	ADJ
dpc-2577	161	5	,	,	PUNCT
dpc-2577	161	6	except	except	SCONJ
dpc-2577	161	7	that	that	SCONJ
dpc-2577	161	8	the	the	DET
dpc-2577	161	9	next	next	ADJ
dpc-2577	161	10	most	most	ADV
dpc-2577	161	11	common	common	ADJ
dpc-2577	161	12	diseases	disease	NOUN
dpc-2577	161	13	after	after	ADP
dpc-2577	161	14	autoimmune	autoimmune	ADJ
dpc-2577	161	15	thyroid	thyroid	NOUN
dpc-2577	161	16	diseases	disease	NOUN
dpc-2577	161	17	(	(	PUNCT
dpc-2577	161	18	24.5	24.5	NUM
dpc-2577	161	19	%	%	NOUN
dpc-2577	161	20	)	)	PUNCT
dpc-2577	161	21	were	be	AUX
dpc-2577	161	22	rheumatoid	rheumatoid	VERB
dpc-2577	161	23	arthritis	arthritis	NOUN
dpc-2577	161	24	(	(	PUNCT
dpc-2577	161	25	2.9	2.9	NUM
dpc-2577	161	26	%	%	NOUN
dpc-2577	161	27	)	)	PUNCT
dpc-2577	161	28	and	and	CCONJ
dpc-2577	161	29	systemic	systemic	ADJ
dpc-2577	161	30	lupus	lupus	PROPN
dpc-2577	161	31	erythematosus	erythematosus	NOUN
dpc-2577	161	32	(	(	PUNCT
dpc-2577	161	33	2.9	2.9	NUM
dpc-2577	161	34	%	%	NOUN
dpc-2577	161	35	)	)	PUNCT
dpc-2577	161	36	.	.	PUNCT
dpc-2577	162	1	thyroid	thyroid	NOUN
dpc-2577	162	2	dysfunctions	dysfunction	NOUN
dpc-2577	162	3	,	,	PUNCT
dpc-2577	162	4	especially	especially	ADV
dpc-2577	162	5	autoimmunity	autoimmunity	NOUN
dpc-2577	162	6	,	,	PUNCT
dpc-2577	162	7	have	have	AUX
dpc-2577	162	8	been	be	AUX
dpc-2577	162	9	most	most	ADV
dpc-2577	162	10	commonly	commonly	ADV
dpc-2577	162	11	found	find	VERB
dpc-2577	162	12	among	among	ADP
dpc-2577	162	13	cu	cu	PROPN
dpc-2577	162	14	patients	patient	NOUN
dpc-2577	162	15	,	,	PUNCT
dpc-2577	162	16	with	with	ADP
dpc-2577	162	17	the	the	DET
dpc-2577	162	18	reported	report	VERB
dpc-2577	162	19	prevalence	prevalence	NOUN
dpc-2577	162	20	ranging	range	VERB
dpc-2577	162	21	up	up	ADP
dpc-2577	162	22	to	to	ADP
dpc-2577	162	23	more	more	ADJ
dpc-2577	162	24	than	than	ADP
dpc-2577	162	25	50	50	NUM
dpc-2577	162	26	%	%	NOUN
dpc-2577	162	27	depending	depend	VERB
dpc-2577	162	28	on	on	ADP
dpc-2577	162	29	the	the	DET
dpc-2577	162	30	inclusion	inclusion	NOUN
dpc-2577	162	31	criteria	criterion	NOUN
dpc-2577	162	32	.	.	PUNCT
dpc-2577	163	1	association	association	NOUN
dpc-2577	163	2	studies	study	NOUN
dpc-2577	163	3	using	use	VERB
dpc-2577	163	4	the	the	DET
dpc-2577	163	5	presence	presence	NOUN
dpc-2577	163	6	of	of	ADP
dpc-2577	163	7	anti	anti	ADJ
dpc-2577	163	8	-	-	ADJ
dpc-2577	163	9	thyroid	thyroid	ADJ
dpc-2577	163	10	antibodies	antibodie	VERB
dpc-2577	163	11	as	as	SCONJ
dpc-2577	163	12	the	the	DET
dpc-2577	163	13	criteria	criterion	NOUN
dpc-2577	163	14	usually	usually	ADV
dpc-2577	163	15	obtained	obtain	VERB
dpc-2577	163	16	higher	high	ADJ
dpc-2577	163	17	frequencies	frequency	NOUN
dpc-2577	163	18	[	[	X
dpc-2577	163	19	26	26	NUM
dpc-2577	163	20	]	]	PUNCT
dpc-2577	163	21	.	.	PUNCT
dpc-2577	164	1	in	in	ADP
dpc-2577	164	2	this	this	DET
dpc-2577	164	3	study	study	NOUN
dpc-2577	164	4	,	,	PUNCT
dpc-2577	164	5	we	we	PRON
dpc-2577	164	6	defined	define	VERB
dpc-2577	164	7	the	the	DET
dpc-2577	164	8	presence	presence	NOUN
dpc-2577	164	9	of	of	ADP
dpc-2577	164	10	thyroid	thyroid	NOUN
dpc-2577	164	11	disorders	disorder	NOUN
dpc-2577	164	12	based	base	VERB
dpc-2577	164	13	on	on	ADP
dpc-2577	164	14	self	self	NOUN
dpc-2577	164	15	-	-	PUNCT
dpc-2577	164	16	reports	report	NOUN
dpc-2577	164	17	by	by	ADP
dpc-2577	164	18	original	original	ADJ
dpc-2577	164	19	article	article	NOUN
dpc-2577	164	20	|	|	ADV
dpc-2577	164	21	dermatol	dermatol	ADJ
dpc-2577	164	22	pract	pract	NOUN
dpc-2577	164	23	concept	concept	NOUN
dpc-2577	164	24	.	.	PUNCT
dpc-2577	165	1	2023;13(1):e2023056	2023;13(1):e2023056	NUM
dpc-2577	165	2	7	7	NUM
dpc-2577	165	3	allergy	allergy	NOUN
dpc-2577	165	4	organ	organ	NOUN
dpc-2577	165	5	j.	j.	PROPN
dpc-2577	165	6	2018;11(1):32	2018;11(1):32	PROPN
dpc-2577	165	7	.	.	PUNCT
dpc-2577	165	8	published	publish	VERB
dpc-2577	165	9	2018	2018	NUM
dpc-2577	165	10	nov	nov	PROPN
dpc-2577	165	11	16	16	NUM
dpc-2577	165	12	.	.	PUNCT
dpc-2577	166	1	doi:10.1186	doi:10.1186	PROPN
dpc-2577	166	2	/	/	SYM
dpc-2577	166	3	s40413	s40413	PROPN
dpc-2577	166	4	-	-	PUNCT
dpc-2577	166	5	018	018	NUM
dpc-2577	166	6	-	-	PUNCT
dpc-2577	166	7	0216	0216	NUM
dpc-2577	166	8	-	-	SYM
dpc-2577	166	9	1	1	NUM
dpc-2577	166	10	9	9	NUM
dpc-2577	166	11	.	.	PUNCT
dpc-2577	167	1	sánchez	sánchez	PROPN
dpc-2577	167	2	j	j	PROPN
dpc-2577	167	3	,	,	PUNCT
dpc-2577	167	4	amaya	amaya	PROPN
dpc-2577	167	5	e	e	PROPN
dpc-2577	167	6	,	,	PUNCT
dpc-2577	167	7	acevedo	acevedo	PROPN
dpc-2577	167	8	a	a	PROPN
dpc-2577	167	9	,	,	PUNCT
dpc-2577	167	10	celis	celis	PROPN
dpc-2577	167	11	a	a	PRON
dpc-2577	167	12	,	,	PUNCT
dpc-2577	167	13	caraballo	caraballo	PROPN
dpc-2577	167	14	d	d	PROPN
dpc-2577	167	15	,	,	PUNCT
dpc-2577	167	16	cardona	cardona	PROPN
dpc-2577	167	17	r.	r.	PROPN
dpc-2577	167	18	prevalence	prevalence	NOUN
dpc-2577	167	19	of	of	ADP
dpc-2577	167	20	inducible	inducible	ADJ
dpc-2577	167	21	urticaria	urticaria	NOUN
dpc-2577	167	22	in	in	ADP
dpc-2577	167	23	patients	patient	NOUN
dpc-2577	167	24	with	with	ADP
dpc-2577	167	25	chronic	chronic	ADJ
dpc-2577	167	26	spontaneous	spontaneous	ADJ
dpc-2577	167	27	urticaria	urticaria	NOUN
dpc-2577	167	28	:	:	PUNCT
dpc-2577	167	29	associated	associated	ADJ
dpc-2577	167	30	risk	risk	NOUN
dpc-2577	167	31	factors	factor	NOUN
dpc-2577	167	32	.	.	PUNCT
dpc-2577	167	33	 	 	SPACE
dpc-2577	168	1	j	j	PROPN
dpc-2577	168	2	allergy	allergy	PROPN
dpc-2577	168	3	clin	clin	PROPN
dpc-2577	168	4	immunol	immunol	PROPN
dpc-2577	168	5	pract	pract	PROPN
dpc-2577	168	6	.	.	PUNCT
dpc-2577	169	1	2017;5(2):464	2017;5(2):464	NUM
dpc-2577	169	2	-	-	PUNCT
dpc-2577	169	3	470	470	NUM
dpc-2577	169	4	.	.	PUNCT
dpc-2577	170	1	doi:10.1016	doi:10.1016	PROPN
dpc-2577	170	2	/	/	SYM
dpc-2577	170	3	j.jaip.2016.09.029	j.jaip.2016.09.029	PROPN
dpc-2577	170	4	10	10	NUM
dpc-2577	170	5	.	.	PUNCT
dpc-2577	171	1	maurer	maurer	PROPN
dpc-2577	171	2	m	m	PROPN
dpc-2577	171	3	,	,	PUNCT
dpc-2577	171	4	weller	weller	PROPN
dpc-2577	171	5	k	k	PROPN
dpc-2577	171	6	,	,	PUNCT
dpc-2577	171	7	bindslev	bindslev	NOUN
dpc-2577	171	8	-	-	PUNCT
dpc-2577	171	9	jensen	jensen	PROPN
dpc-2577	171	10	c	c	PROPN
dpc-2577	171	11	,	,	PUNCT
dpc-2577	171	12	et	et	PROPN
dpc-2577	171	13	al	al	PROPN
dpc-2577	171	14	.	.	PUNCT
dpc-2577	171	15	unmet	unmet	PROPN
dpc-2577	171	16	clinical	clinical	ADJ
dpc-2577	171	17	needs	need	NOUN
dpc-2577	171	18	in	in	ADP
dpc-2577	171	19	chronic	chronic	ADJ
dpc-2577	171	20	spontaneous	spontaneous	ADJ
dpc-2577	171	21	urticaria	urticaria	NOUN
dpc-2577	171	22	.	.	PUNCT
dpc-2577	172	1	a	a	DET
dpc-2577	172	2	ga²len	ga²len	PROPN
dpc-2577	172	3	task	task	NOUN
dpc-2577	172	4	force	force	NOUN
dpc-2577	172	5	report	report	NOUN
dpc-2577	172	6	.	.	PUNCT
dpc-2577	172	7	  	  	SPACE
dpc-2577	172	8	allergy	allergy	NOUN
dpc-2577	172	9	.	.	PUNCT
dpc-2577	173	1	2011;66(3):317	2011;66(3):317	NUM
dpc-2577	173	2	-	-	SYM
dpc-2577	173	3	330	330	NUM
dpc-2577	173	4	.	.	PUNCT
dpc-2577	174	1	doi:10.1111	doi:10.1111	ADJ
dpc-2577	174	2	/	/	SYM
dpc-2577	174	3	j.1398	j.1398	PROPN
dpc-2577	174	4	-	-	PUNCT
dpc-2577	174	5	9995	9995	NUM
dpc-2577	174	6	.2010.02496.x	.2010.02496.x	NUM
dpc-2577	174	7	11	11	NUM
dpc-2577	174	8	.	.	PUNCT
dpc-2577	175	1	nowicki	nowicki	PROPN
dpc-2577	175	2	rj	rj	PROPN
dpc-2577	175	3	,	,	PUNCT
dpc-2577	175	4	grubska	grubska	ADJ
dpc-2577	175	5	-	-	PUNCT
dpc-2577	175	6	suchanek	suchanek	NOUN
dpc-2577	175	7	e	e	NOUN
dpc-2577	175	8	,	,	PUNCT
dpc-2577	175	9	porêbski	porêbski	VERB
dpc-2577	175	10	g	g	ADP
dpc-2577	175	11	,	,	PUNCT
dpc-2577	175	12	et	et	PROPN
dpc-2577	175	13	al	al	PROPN
dpc-2577	175	14	.	.	PROPN
dpc-2577	175	15	angioedema	angioedema	VERB
dpc-2577	175	16	.	.	PUNCT
dpc-2577	176	1	interdisciplinary	interdisciplinary	ADJ
dpc-2577	176	2	diagnostic	diagnostic	ADJ
dpc-2577	176	3	and	and	CCONJ
dpc-2577	176	4	therapeutic	therapeutic	ADJ
dpc-2577	176	5	recommendations	recommendation	NOUN
dpc-2577	176	6	of	of	ADP
dpc-2577	176	7	the	the	DET
dpc-2577	176	8	polish	polish	ADJ
dpc-2577	176	9	dermatological	dermatological	ADJ
dpc-2577	176	10	society	society	NOUN
dpc-2577	176	11	(	(	PUNCT
dpc-2577	176	12	ptd	ptd	NOUN
dpc-2577	176	13	)	)	PUNCT
dpc-2577	176	14	and	and	CCONJ
dpc-2577	176	15	polish	polish	ADJ
dpc-2577	176	16	society	society	NOUN
dpc-2577	176	17	of	of	ADP
dpc-2577	176	18	allergology	allergology	NOUN
dpc-2577	176	19	(	(	PUNCT
dpc-2577	176	20	pta	pta	PROPN
dpc-2577	176	21	)	)	PUNCT
dpc-2577	176	22	.	.	PUNCT
dpc-2577	176	23	 	 	SPACE
dpc-2577	177	1	postepy	postepy	ADJ
dpc-2577	177	2	dermatol	dermatol	NOUN
dpc-2577	177	3	alergol	alergol	NOUN
dpc-2577	177	4	.	.	PUNCT
dpc-2577	178	1	2020;37(4):445	2020;37(4):445	NUM
dpc-2577	178	2	-	-	PUNCT
dpc-2577	178	3	451	451	NUM
dpc-2577	178	4	.	.	PUNCT
dpc-2577	179	1	doi:10.5114	doi:10.5114	PROPN
dpc-2577	179	2	/	/	SYM
dpc-2577	179	3	ada.2020.98226	ada.2020.98226	PROPN
dpc-2577	179	4	12	12	NUM
dpc-2577	179	5	.	.	PUNCT
dpc-2577	180	1	lawlor	lawlor	PROPN
dpc-2577	180	2	f	f	PROPN
dpc-2577	180	3	,	,	PUNCT
dpc-2577	180	4	black	black	PROPN
dpc-2577	180	5	ak	ak	PROPN
dpc-2577	180	6	.	.	PROPN
dpc-2577	180	7	delayed	delay	VERB
dpc-2577	180	8	pressure	pressure	NOUN
dpc-2577	180	9	urticaria	urticaria	NOUN
dpc-2577	180	10	.	.	PUNCT
dpc-2577	180	11	  	  	SPACE
dpc-2577	181	1	immunol	immunol	NOUN
dpc-2577	181	2	allergy	allergy	PROPN
dpc-2577	181	3	clin	clin	PROPN
dpc-2577	181	4	north	north	PROPN
dpc-2577	181	5	am	be	AUX
dpc-2577	181	6	.	.	PUNCT
dpc-2577	182	1	2004;24(2):247	2004;24(2):247	PROPN
dpc-2577	182	2	-	-	PUNCT
dpc-2577	182	3	vii	vii	PROPN
dpc-2577	182	4	.	.	PUNCT
dpc-2577	182	5	doi:10.1016	doi:10.1016	PROPN
dpc-2577	182	6	/	/	SYM
dpc-2577	182	7	j.	j.	PROPN
dpc-2577	182	8	iac.2004.01.006	iac.2004.01.006	PROPN
dpc-2577	182	9	13	13	NUM
dpc-2577	182	10	.	.	PUNCT
dpc-2577	183	1	shalom	shalom	PROPN
dpc-2577	183	2	g	g	PROPN
dpc-2577	183	3	,	,	PUNCT
dpc-2577	183	4	magen	magen	PROPN
dpc-2577	183	5	e	e	PROPN
dpc-2577	183	6	,	,	PUNCT
dpc-2577	183	7	dreiher	dreiher	PROPN
dpc-2577	183	8	j	j	PROPN
dpc-2577	183	9	,	,	PUNCT
dpc-2577	183	10	et	et	PROPN
dpc-2577	183	11	al	al	PROPN
dpc-2577	183	12	.	.	PROPN
dpc-2577	184	1	chronic	chronic	ADJ
dpc-2577	184	2	urticaria	urticaria	NOUN
dpc-2577	184	3	and	and	CCONJ
dpc-2577	184	4	atopic	atopic	NOUN
dpc-2577	184	5	disorders	disorder	NOUN
dpc-2577	184	6	:	:	PUNCT
dpc-2577	184	7	a	a	DET
dpc-2577	184	8	cross	cross	ADJ
dpc-2577	184	9	-	-	ADJ
dpc-2577	184	10	sectional	sectional	ADJ
dpc-2577	184	11	study	study	NOUN
dpc-2577	184	12	of	of	ADP
dpc-2577	184	13	11	11	NUM
dpc-2577	184	14	271	271	NUM
dpc-2577	184	15	patients	patient	NOUN
dpc-2577	184	16	.	.	PUNCT
dpc-2577	184	17	 	 	SPACE
dpc-2577	185	1	br	br	PROPN
dpc-2577	185	2	j	j	PROPN
dpc-2577	185	3	dermatol	dermatol	NOUN
dpc-2577	185	4	.	.	PUNCT
dpc-2577	186	1	2017;177(4):e96	2017;177(4):e96	NOUN
dpc-2577	186	2	-	-	PUNCT
dpc-2577	186	3	e97	e97	NUM
dpc-2577	186	4	.	.	PUNCT
dpc-2577	187	1	doi:10.1111	doi:10.1111	PROPN
dpc-2577	187	2	/	/	SYM
dpc-2577	187	3	bjd.15347	bjd.15347	NUM
dpc-2577	187	4	14	14	NUM
dpc-2577	187	5	.	.	PUNCT
dpc-2577	188	1	zuberbier	zuberbier	PROPN
dpc-2577	188	2	t	t	PROPN
dpc-2577	188	3	,	,	PUNCT
dpc-2577	188	4	balke	balke	PROPN
dpc-2577	188	5	m	m	PROPN
dpc-2577	188	6	,	,	PUNCT
dpc-2577	188	7	worm	worm	PROPN
dpc-2577	188	8	m	m	PROPN
dpc-2577	188	9	,	,	PUNCT
dpc-2577	188	10	edenharter	edenharter	NOUN
dpc-2577	188	11	g	g	PROPN
dpc-2577	188	12	,	,	PUNCT
dpc-2577	188	13	maurer	maurer	PROPN
dpc-2577	188	14	m.	m.	PROPN
dpc-2577	188	15	epidemiology	epidemiology	NOUN
dpc-2577	188	16	of	of	ADP
dpc-2577	188	17	urticaria	urticaria	NOUN
dpc-2577	188	18	:	:	PUNCT
dpc-2577	188	19	a	a	DET
dpc-2577	188	20	representative	representative	ADJ
dpc-2577	188	21	cross	cross	ADJ
dpc-2577	188	22	-	-	ADJ
dpc-2577	188	23	sectional	sectional	ADJ
dpc-2577	188	24	population	population	NOUN
dpc-2577	188	25	survey	survey	NOUN
dpc-2577	188	26	.	.	PUNCT
dpc-2577	188	27	  	  	SPACE
dpc-2577	189	1	clin	clin	PROPN
dpc-2577	189	2	exp	exp	NOUN
dpc-2577	189	3	dermatol	dermatol	NOUN
dpc-2577	189	4	.	.	PUNCT
dpc-2577	190	1	2010;35(8):869	2010;35(8):869	NUM
dpc-2577	190	2	-	-	PUNCT
dpc-2577	190	3	873	873	NUM
dpc-2577	190	4	.	.	PUNCT
dpc-2577	191	1	doi:10.1111	doi:10.1111	ADJ
dpc-2577	191	2	/	/	SYM
dpc-2577	191	3	j.1365	j.1365	NOUN
dpc-2577	191	4	-	-	PUNCT
dpc-2577	191	5	2230.2010.03840.x	2230.2010.03840.x	NUM
dpc-2577	191	6	15	15	NUM
dpc-2577	191	7	.	.	PUNCT
dpc-2577	192	1	kim	kim	PROPN
dpc-2577	192	2	br	br	PROPN
dpc-2577	192	3	,	,	PUNCT
dpc-2577	192	4	yang	yang	PROPN
dpc-2577	192	5	s	s	PROPN
dpc-2577	192	6	,	,	PUNCT
dpc-2577	192	7	choi	choi	PROPN
dpc-2577	192	8	jw	jw	PROPN
dpc-2577	192	9	,	,	PUNCT
dpc-2577	192	10	choi	choi	PROPN
dpc-2577	192	11	cw	cw	PROPN
dpc-2577	192	12	,	,	PUNCT
dpc-2577	192	13	youn	youn	PROPN
dpc-2577	192	14	sw	sw	PROPN
dpc-2577	192	15	.	.	PUNCT
dpc-2577	193	1	epidemiology	epidemiology	NOUN
dpc-2577	193	2	and	and	CCONJ
dpc-2577	193	3	comorbidities	comorbiditie	NOUN
dpc-2577	193	4	of	of	ADP
dpc-2577	193	5	patients	patient	NOUN
dpc-2577	193	6	with	with	ADP
dpc-2577	193	7	chronic	chronic	ADJ
dpc-2577	193	8	urticaria	urticaria	NOUN
dpc-2577	193	9	in	in	ADP
dpc-2577	193	10	korea	korea	PROPN
dpc-2577	193	11	:	:	PUNCT
dpc-2577	193	12	a	a	DET
dpc-2577	193	13	nationwide	nationwide	ADJ
dpc-2577	193	14	population	population	NOUN
dpc-2577	193	15	-	-	PUNCT
dpc-2577	193	16	based	base	VERB
dpc-2577	193	17	study	study	NOUN
dpc-2577	193	18	.	.	PUNCT
dpc-2577	193	19	 	 	SPACE
dpc-2577	194	1	j	j	PROPN
dpc-2577	194	2	dermatol	dermatol	NOUN
dpc-2577	194	3	.	.	PUNCT
dpc-2577	195	1	2018;45(1):10	2018;45(1):10	PROPN
dpc-2577	195	2	-	-	PUNCT
dpc-2577	195	3	16	16	NUM
dpc-2577	195	4	.	.	PUNCT
dpc-2577	196	1	doi:10.1111/1346	doi:10.1111/1346	VERB
dpc-2577	196	2	-	-	PUNCT
dpc-2577	196	3	8138.14075	8138.14075	PROPN
dpc-2577	196	4	16	16	NUM
dpc-2577	196	5	.	.	PUNCT
dpc-2577	197	1	thomsen	thomsen	PROPN
dpc-2577	197	2	sf	sf	PROPN
dpc-2577	197	3	,	,	PUNCT
dpc-2577	197	4	pritzier	pritzier	X
dpc-2577	197	5	ec	ec	PROPN
dpc-2577	197	6	,	,	PUNCT
dpc-2577	197	7	anderson	anderson	PROPN
dpc-2577	197	8	cd	cd	PROPN
dpc-2577	197	9	,	,	PUNCT
dpc-2577	197	10	et	et	PROPN
dpc-2577	197	11	al	al	PROPN
dpc-2577	197	12	.	.	PUNCT
dpc-2577	198	1	chronic	chronic	ADJ
dpc-2577	198	2	urticaria	urticaria	NOUN
dpc-2577	198	3	in	in	ADP
dpc-2577	198	4	the	the	DET
dpc-2577	198	5	real	real	ADJ
dpc-2577	198	6	-	-	PUNCT
dpc-2577	198	7	life	life	NOUN
dpc-2577	198	8	clinical	clinical	ADJ
dpc-2577	198	9	practice	practice	NOUN
dpc-2577	198	10	setting	set	VERB
dpc-2577	198	11	in	in	ADP
dpc-2577	198	12	sweden	sweden	PROPN
dpc-2577	198	13	,	,	PUNCT
dpc-2577	198	14	norway	norway	PROPN
dpc-2577	198	15	,	,	PUNCT
dpc-2577	198	16	and	and	CCONJ
dpc-2577	198	17	denmark	denmark	PROPN
dpc-2577	198	18	:	:	PUNCT
dpc-2577	198	19	baseline	baseline	NOUN
dpc-2577	198	20	results	result	NOUN
dpc-2577	198	21	from	from	ADP
dpc-2577	198	22	the	the	DET
dpc-2577	198	23	non	non	ADJ
dpc-2577	198	24	-	-	ADJ
dpc-2577	198	25	interventional	interventional	ADJ
dpc-2577	198	26	multicentre	multicentre	NOUN
dpc-2577	198	27	aware	aware	ADJ
dpc-2577	198	28	study	study	NOUN
dpc-2577	198	29	.	.	PUNCT
dpc-2577	198	30	  	  	SPACE
dpc-2577	199	1	j	j	PROPN
dpc-2577	199	2	eur	eur	PROPN
dpc-2577	199	3	acad	acad	PROPN
dpc-2577	199	4	dermatol	dermatol	NOUN
dpc-2577	199	5	venereol	venereol	NOUN
dpc-2577	199	6	.	.	PUNCT
dpc-2577	200	1	2017;31(6	2017;31(6	NUM
dpc-2577	200	2	):	):	PUNCT
dpc-2577	200	3	1048	1048	NUM
dpc-2577	200	4	-	-	SYM
dpc-2577	200	5	1055	1055	NUM
dpc-2577	200	6	.	.	PUNCT
dpc-2577	201	1	doi:10.1111	doi:10.1111	ADJ
dpc-2577	201	2	/	/	SYM
dpc-2577	201	3	jdv.14210	jdv.14210	PROPN
dpc-2577	201	4	17	17	NUM
dpc-2577	201	5	.	.	PUNCT
dpc-2577	202	1	maurer	maurer	PROPN
dpc-2577	202	2	m	m	PROPN
dpc-2577	202	3	,	,	PUNCT
dpc-2577	202	4	eyerich	eyerich	PROPN
dpc-2577	202	5	k	k	NOUN
dpc-2577	202	6	,	,	PUNCT
dpc-2577	202	7	eyerich	eyerich	PROPN
dpc-2577	202	8	s	s	VERB
dpc-2577	202	9	,	,	PUNCT
dpc-2577	202	10	et	et	PROPN
dpc-2577	202	11	al	al	PROPN
dpc-2577	202	12	.	.	PUNCT
dpc-2577	203	1	urticaria	urticaria	PROPN
dpc-2577	203	2	:	:	PUNCT
dpc-2577	203	3	collegium	collegium	NOUN
dpc-2577	203	4	internationale	internationale	NOUN
dpc-2577	203	5	allergologicum	allergologicum	NOUN
dpc-2577	203	6	(	(	PUNCT
dpc-2577	203	7	cia	cia	PROPN
dpc-2577	203	8	)	)	PUNCT
dpc-2577	203	9	update	update	NOUN
dpc-2577	203	10	2020	2020	NUM
dpc-2577	203	11	.	.	PUNCT
dpc-2577	203	12	 	 	SPACE
dpc-2577	204	1	int	int	PROPN
dpc-2577	204	2	arch	arch	ADJ
dpc-2577	204	3	allergy	allergy	NOUN
dpc-2577	204	4	immunol	immunol	NOUN
dpc-2577	204	5	.	.	PUNCT
dpc-2577	205	1	2020;181(5):321	2020;181(5):321	NUM
dpc-2577	205	2	-	-	SYM
dpc-2577	205	3	333	333	NUM
dpc-2577	205	4	.	.	PUNCT
dpc-2577	205	5	doi:10.1159/000507218	doi:10.1159/000507218	NOUN
dpc-2577	205	6	18	18	NUM
dpc-2577	205	7	.	.	PUNCT
dpc-2577	206	1	weller	weller	PROPN
dpc-2577	206	2	k	k	PROPN
dpc-2577	206	3	,	,	PUNCT
dpc-2577	206	4	maurer	maurer	PROPN
dpc-2577	206	5	m	m	PROPN
dpc-2577	206	6	,	,	PUNCT
dpc-2577	206	7	bauer	bauer	PROPN
dpc-2577	206	8	a	a	PROPN
dpc-2577	206	9	,	,	PUNCT
dpc-2577	206	10	et	et	PROPN
dpc-2577	206	11	al	al	PROPN
dpc-2577	206	12	.	.	PUNCT
dpc-2577	206	13	epidemiology	epidemiology	NOUN
dpc-2577	206	14	,	,	PUNCT
dpc-2577	206	15	comorbidities	comorbiditie	NOUN
dpc-2577	206	16	,	,	PUNCT
dpc-2577	206	17	and	and	CCONJ
dpc-2577	206	18	healthcare	healthcare	NOUN
dpc-2577	206	19	utilization	utilization	NOUN
dpc-2577	206	20	of	of	ADP
dpc-2577	206	21	patients	patient	NOUN
dpc-2577	206	22	with	with	ADP
dpc-2577	206	23	chronic	chronic	ADJ
dpc-2577	206	24	urticaria	urticaria	NOUN
dpc-2577	206	25	in	in	ADP
dpc-2577	206	26	germany	germany	PROPN
dpc-2577	206	27	.	.	PUNCT
dpc-2577	206	28	 	 	SPACE
dpc-2577	207	1	j	j	PROPN
dpc-2577	207	2	eur	eur	PROPN
dpc-2577	207	3	acad	acad	PROPN
dpc-2577	207	4	dermatol	dermatol	NOUN
dpc-2577	207	5	venereol	venereol	NOUN
dpc-2577	207	6	.	.	PUNCT
dpc-2577	208	1	2022;36(1):91	2022;36(1):91	NUM
dpc-2577	208	2	-	-	SYM
dpc-2577	208	3	99	99	NUM
dpc-2577	208	4	.	.	PUNCT
dpc-2577	209	1	doi:10.1111	doi:10.1111	NOUN
dpc-2577	209	2	/	/	SYM
dpc-2577	209	3	jdv.17724	jdv.17724	NUM
dpc-2577	209	4	19	19	NUM
dpc-2577	209	5	.	.	PUNCT
dpc-2577	210	1	egeberg	egeberg	PROPN
dpc-2577	210	2	a	a	PROPN
dpc-2577	210	3	,	,	PUNCT
dpc-2577	210	4	kofoed	kofoed	PROPN
dpc-2577	210	5	k	k	NOUN
dpc-2577	210	6	,	,	PUNCT
dpc-2577	210	7	gislason	gislason	PROPN
dpc-2577	210	8	gh	gh	PROPN
dpc-2577	210	9	,	,	PUNCT
dpc-2577	210	10	vestergaard	vestergaard	PROPN
dpc-2577	210	11	c	c	NOUN
dpc-2577	210	12	,	,	PUNCT
dpc-2577	210	13	thyssen	thyssen	PROPN
dpc-2577	210	14	jp	jp	PROPN
dpc-2577	210	15	.	.	PUNCT
dpc-2577	211	1	cardiovascular	cardiovascular	ADJ
dpc-2577	211	2	risk	risk	NOUN
dpc-2577	211	3	is	be	AUX
dpc-2577	211	4	not	not	PART
dpc-2577	211	5	increased	increase	VERB
dpc-2577	211	6	in	in	ADP
dpc-2577	211	7	patients	patient	NOUN
dpc-2577	211	8	with	with	ADP
dpc-2577	211	9	chronic	chronic	ADJ
dpc-2577	211	10	urticaria	urticaria	NOUN
dpc-2577	211	11	:	:	PUNCT
dpc-2577	211	12	a	a	DET
dpc-2577	211	13	retrospective	retrospective	ADJ
dpc-2577	211	14	population	population	NOUN
dpc-2577	211	15	-	-	PUNCT
dpc-2577	211	16	based	base	VERB
dpc-2577	211	17	cohort	cohort	NOUN
dpc-2577	211	18	study	study	NOUN
dpc-2577	211	19	.	.	PUNCT
dpc-2577	211	20	  	  	SPACE
dpc-2577	212	1	acta	acta	PROPN
dpc-2577	212	2	derm	derm	PROPN
dpc-2577	212	3	venereol	venereol	NOUN
dpc-2577	212	4	.	.	PUNCT
dpc-2577	213	1	2017;97(2):261	2017;97(2):261	NUM
dpc-2577	213	2	-	-	PUNCT
dpc-2577	213	3	262	262	NUM
dpc-2577	213	4	.	.	PUNCT
dpc-2577	214	1	doi:10.2340/00015555	doi:10.2340/00015555	VERB
dpc-2577	214	2	-	-	PUNCT
dpc-2577	214	3	2516	2516	NUM
dpc-2577	214	4	20	20	NUM
dpc-2577	214	5	.	.	PUNCT
dpc-2577	215	1	chu	chu	PROPN
dpc-2577	215	2	cy	cy	PROPN
dpc-2577	215	3	,	,	PUNCT
dpc-2577	215	4	cho	cho	PROPN
dpc-2577	215	5	yt	yt	PROPN
dpc-2577	215	6	,	,	PUNCT
dpc-2577	215	7	jiang	jiang	PROPN
dpc-2577	215	8	jh	jh	PROPN
dpc-2577	215	9	,	,	PUNCT
dpc-2577	215	10	lin	lin	PROPN
dpc-2577	215	11	ei	ei	PROPN
dpc-2577	215	12	,	,	PUNCT
dpc-2577	215	13	tang	tang	PROPN
dpc-2577	215	14	ch	ch	PROPN
dpc-2577	215	15	.	.	PUNCT
dpc-2577	215	16	epidemiology	epidemiology	NOUN
dpc-2577	215	17	and	and	CCONJ
dpc-2577	215	18	comorbidities	comorbiditie	NOUN
dpc-2577	215	19	of	of	ADP
dpc-2577	215	20	patients	patient	NOUN
dpc-2577	215	21	with	with	ADP
dpc-2577	215	22	chronic	chronic	ADJ
dpc-2577	215	23	urticaria	urticaria	NOUN
dpc-2577	215	24	in	in	ADP
dpc-2577	215	25	taiwan	taiwan	PROPN
dpc-2577	215	26	:	:	PUNCT
dpc-2577	215	27	a	a	DET
dpc-2577	215	28	nationwide	nationwide	ADJ
dpc-2577	215	29	population	population	NOUN
dpc-2577	215	30	-	-	PUNCT
dpc-2577	215	31	based	base	VERB
dpc-2577	215	32	study	study	NOUN
dpc-2577	215	33	.	.	PUNCT
dpc-2577	215	34	 	 	SPACE
dpc-2577	216	1	j	j	PROPN
dpc-2577	216	2	dermatol	dermatol	NOUN
dpc-2577	216	3	sci	sci	PROPN
dpc-2577	216	4	.	.	PUNCT
dpc-2577	217	1	2017;88(2):192	2017;88(2):192	NUM
dpc-2577	217	2	-	-	SYM
dpc-2577	217	3	198	198	NUM
dpc-2577	217	4	.	.	PUNCT
dpc-2577	218	1	doi:10.1016	doi:10.1016	PROPN
dpc-2577	218	2	/	/	SYM
dpc-2577	218	3	j.jdermsci.2017.07.006	j.jdermsci.2017.07.006	PROPN
dpc-2577	218	4	21	21	NUM
dpc-2577	218	5	.	.	PUNCT
dpc-2577	219	1	konstantinou	konstantinou	PROPN
dpc-2577	219	2	gn	gn	PROPN
dpc-2577	219	3	,	,	PUNCT
dpc-2577	219	4	konstantinou	konstantinou	PROPN
dpc-2577	219	5	gn	gn	PROPN
dpc-2577	219	6	.	.	PROPN
dpc-2577	219	7	psychiatric	psychiatric	ADJ
dpc-2577	219	8	comorbidity	comorbidity	NOUN
dpc-2577	219	9	in	in	ADP
dpc-2577	219	10	chronic	chronic	ADJ
dpc-2577	219	11	urticaria	urticaria	NOUN
dpc-2577	219	12	patients	patient	NOUN
dpc-2577	219	13	:	:	PUNCT
dpc-2577	219	14	a	a	DET
dpc-2577	219	15	systematic	systematic	ADJ
dpc-2577	219	16	review	review	NOUN
dpc-2577	219	17	and	and	CCONJ
dpc-2577	219	18	meta	meta	ADJ
dpc-2577	219	19	-	-	PUNCT
dpc-2577	219	20	analysis	analysis	NOUN
dpc-2577	219	21	.	.	PUNCT
dpc-2577	219	22	  	  	SPACE
dpc-2577	219	23	clin	clin	PROPN
dpc-2577	219	24	transl	transl	PROPN
dpc-2577	219	25	allergy	allergy	PROPN
dpc-2577	219	26	.	.	PUNCT
dpc-2577	220	1	2019;9:42	2019;9:42	PROPN
dpc-2577	220	2	.	.	PUNCT
dpc-2577	221	1	published	publish	VERB
dpc-2577	221	2	2019	2019	NUM
dpc-2577	221	3	aug	aug	PROPN
dpc-2577	221	4	23	23	NUM
dpc-2577	221	5	.	.	PUNCT
dpc-2577	222	1	doi:10.1186	doi:10.1186	PROPN
dpc-2577	222	2	/	/	SYM
dpc-2577	222	3	s13601	s13601	NOUN
dpc-2577	222	4	-	-	PUNCT
dpc-2577	222	5	019	019	NUM
dpc-2577	222	6	-	-	PUNCT
dpc-2577	222	7	0278	0278	NUM
dpc-2577	222	8	-	-	SYM
dpc-2577	222	9	3	3	NUM
dpc-2577	222	10	22	22	NUM
dpc-2577	222	11	.	.	PUNCT
dpc-2577	223	1	bansal	bansal	PROPN
dpc-2577	223	2	cj	cj	PROPN
dpc-2577	223	3	,	,	PUNCT
dpc-2577	223	4	bansal	bansal	NOUN
dpc-2577	223	5	as	as	ADP
dpc-2577	223	6	.	.	PROPN
dpc-2577	223	7	stress	stress	PROPN
dpc-2577	223	8	,	,	PUNCT
dpc-2577	223	9	pseudoallergens	pseudoallergen	NOUN
dpc-2577	223	10	,	,	PUNCT
dpc-2577	223	11	autoimmunity	autoimmunity	NOUN
dpc-2577	223	12	,	,	PUNCT
dpc-2577	223	13	infection	infection	NOUN
dpc-2577	223	14	and	and	CCONJ
dpc-2577	223	15	inflammation	inflammation	NOUN
dpc-2577	223	16	in	in	ADP
dpc-2577	223	17	chronic	chronic	ADJ
dpc-2577	223	18	spontaneous	spontaneous	ADJ
dpc-2577	223	19	urticaria	urticaria	NOUN
dpc-2577	223	20	.	.	PUNCT
dpc-2577	223	21	  	  	SPACE
dpc-2577	224	1	allergy	allergy	NOUN
dpc-2577	224	2	asthma	asthma	PROPN
dpc-2577	224	3	clin	clin	PROPN
dpc-2577	224	4	immunol	immunol	NOUN
dpc-2577	224	5	.	.	PUNCT
dpc-2577	225	1	2019;15:56	2019;15:56	NUM
dpc-2577	225	2	.	.	PUNCT
dpc-2577	225	3	published	publish	VERB
dpc-2577	225	4	2019	2019	NUM
dpc-2577	225	5	sep	sep	PROPN
dpc-2577	225	6	11	11	NUM
dpc-2577	225	7	.	.	PUNCT
dpc-2577	226	1	doi:10.1186	doi:10.1186	PROPN
dpc-2577	226	2	/	/	SYM
dpc-2577	226	3	s13223	s13223	NOUN
dpc-2577	226	4	-	-	PUNCT
dpc-2577	226	5	019	019	NUM
dpc-2577	226	6	-	-	PUNCT
dpc-2577	226	7	0372	0372	NUM
dpc-2577	226	8	-	-	PUNCT
dpc-2577	226	9	z	z	NOUN
dpc-2577	226	10	23	23	NUM
dpc-2577	226	11	.	.	PUNCT
dpc-2577	227	1	lindelöf	lindelöf	PROPN
dpc-2577	227	2	b	b	PROPN
dpc-2577	227	3	,	,	PUNCT
dpc-2577	227	4	sigurgeirsson	sigurgeirsson	NOUN
dpc-2577	227	5	b	b	NOUN
dpc-2577	227	6	,	,	PUNCT
dpc-2577	227	7	wahlgren	wahlgren	PROPN
dpc-2577	227	8	cf	cf	PROPN
dpc-2577	227	9	,	,	PUNCT
dpc-2577	227	10	eklund	eklund	PROPN
dpc-2577	227	11	g.	g.	PROPN
dpc-2577	227	12	chronic	chronic	PROPN
dpc-2577	227	13	urticaria	urticaria	NOUN
dpc-2577	227	14	and	and	CCONJ
dpc-2577	227	15	cancer	cancer	NOUN
dpc-2577	227	16	:	:	PUNCT
dpc-2577	227	17	an	an	DET
dpc-2577	227	18	epidemiological	epidemiological	ADJ
dpc-2577	227	19	study	study	NOUN
dpc-2577	227	20	of	of	ADP
dpc-2577	227	21	1155	1155	NUM
dpc-2577	227	22	patients	patient	NOUN
dpc-2577	227	23	.	.	PUNCT
dpc-2577	227	24	 	 	SPACE
dpc-2577	228	1	br	br	PROPN
dpc-2577	228	2	conclusions	conclusion	NOUN
dpc-2577	228	3	in	in	ADP
dpc-2577	228	4	conclusion	conclusion	NOUN
dpc-2577	228	5	,	,	PUNCT
dpc-2577	228	6	cu	cu	PROPN
dpc-2577	228	7	significantly	significantly	ADV
dpc-2577	228	8	influences	influence	VERB
dpc-2577	228	9	the	the	DET
dpc-2577	228	10	quality	quality	NOUN
dpc-2577	228	11	of	of	ADP
dpc-2577	228	12	patients	patient	NOUN
dpc-2577	228	13	’	'	PUNCT
dpc-2577	228	14	lives	life	NOUN
dpc-2577	228	15	,	,	PUNCT
dpc-2577	228	16	which	which	PRON
dpc-2577	228	17	may	may	AUX
dpc-2577	228	18	be	be	AUX
dpc-2577	228	19	negatively	negatively	ADV
dpc-2577	228	20	affected	affect	VERB
dpc-2577	228	21	by	by	ADP
dpc-2577	228	22	the	the	DET
dpc-2577	228	23	association	association	NOUN
dpc-2577	228	24	with	with	ADP
dpc-2577	228	25	a	a	DET
dpc-2577	228	26	wide	wide	ADJ
dpc-2577	228	27	range	range	NOUN
dpc-2577	228	28	of	of	ADP
dpc-2577	228	29	comorbidities	comorbiditie	NOUN
dpc-2577	228	30	.	.	PUNCT
dpc-2577	229	1	our	our	PRON
dpc-2577	229	2	study	study	NOUN
dpc-2577	229	3	found	find	VERB
dpc-2577	229	4	that	that	SCONJ
dpc-2577	229	5	the	the	DET
dpc-2577	229	6	most	most	ADV
dpc-2577	229	7	common	common	ADJ
dpc-2577	229	8	comorbidities	comorbiditie	NOUN
dpc-2577	229	9	in	in	ADP
dpc-2577	229	10	cu	cu	PROPN
dpc-2577	229	11	include	include	VERB
dpc-2577	229	12	atopic	atopic	NOUN
dpc-2577	229	13	and	and	CCONJ
dpc-2577	229	14	allergic	allergic	ADJ
dpc-2577	229	15	diseases	disease	NOUN
dpc-2577	229	16	,	,	PUNCT
dpc-2577	229	17	chronic	chronic	ADJ
dpc-2577	229	18	inflammations	inflammation	NOUN
dpc-2577	229	19	,	,	PUNCT
dpc-2577	229	20	thyroid	thyroid	NOUN
dpc-2577	229	21	,	,	PUNCT
dpc-2577	229	22	and	and	CCONJ
dpc-2577	229	23	psychiatric	psychiatric	ADJ
dpc-2577	229	24	disorders	disorder	NOUN
dpc-2577	229	25	.	.	PUNCT
dpc-2577	230	1	this	this	DET
dpc-2577	230	2	pattern	pattern	NOUN
dpc-2577	230	3	of	of	ADP
dpc-2577	230	4	comorbidities	comorbiditie	NOUN
dpc-2577	230	5	seems	seem	VERB
dpc-2577	230	6	to	to	PART
dpc-2577	230	7	be	be	AUX
dpc-2577	230	8	specific	specific	ADJ
dpc-2577	230	9	to	to	ADP
dpc-2577	230	10	cu	cu	PROPN
dpc-2577	230	11	.	.	PUNCT
dpc-2577	231	1	our	our	PRON
dpc-2577	231	2	data	datum	NOUN
dpc-2577	231	3	suggest	suggest	VERB
dpc-2577	231	4	that	that	SCONJ
dpc-2577	231	5	patients	patient	NOUN
dpc-2577	231	6	with	with	ADP
dpc-2577	231	7	autoimmune	autoimmune	ADJ
dpc-2577	231	8	urticaria	urticaria	NOUN
dpc-2577	231	9	are	be	AUX
dpc-2577	231	10	more	more	ADV
dpc-2577	231	11	likely	likely	ADJ
dpc-2577	231	12	to	to	PART
dpc-2577	231	13	have	have	VERB
dpc-2577	231	14	autoimmune	autoimmune	ADJ
dpc-2577	231	15	comorbidities	comorbiditie	NOUN
dpc-2577	231	16	than	than	ADP
dpc-2577	231	17	patients	patient	NOUN
dpc-2577	231	18	without	without	ADP
dpc-2577	231	19	this	this	DET
dpc-2577	231	20	subtype	subtype	NOUN
dpc-2577	231	21	of	of	ADP
dpc-2577	231	22	csu	csu	PROPN
dpc-2577	231	23	.	.	PUNCT
dpc-2577	232	1	this	this	PRON
dpc-2577	232	2	may	may	AUX
dpc-2577	232	3	be	be	AUX
dpc-2577	232	4	explained	explain	VERB
dpc-2577	232	5	by	by	ADP
dpc-2577	232	6	the	the	DET
dpc-2577	232	7	known	know	VERB
dpc-2577	232	8	co	co	NOUN
dpc-2577	232	9	-	-	NOUN
dpc-2577	232	10	occurrence	occurrence	NOUN
dpc-2577	232	11	of	of	ADP
dpc-2577	232	12	multiple	multiple	ADJ
dpc-2577	232	13	autoimmune	autoimmune	ADJ
dpc-2577	232	14	phenomena	phenomenon	NOUN
dpc-2577	232	15	and	and	CCONJ
dpc-2577	232	16	autoimmune	autoimmune	ADJ
dpc-2577	232	17	diseases	disease	NOUN
dpc-2577	232	18	.	.	PUNCT
dpc-2577	233	1	therefore	therefore	ADV
dpc-2577	233	2	,	,	PUNCT
dpc-2577	233	3	autoimmune	autoimmune	ADJ
dpc-2577	233	4	comorbidities	comorbiditie	NOUN
dpc-2577	233	5	in	in	ADP
dpc-2577	233	6	patients	patient	NOUN
dpc-2577	233	7	with	with	ADP
dpc-2577	233	8	chronic	chronic	ADJ
dpc-2577	233	9	urticaria	urticaria	NOUN
dpc-2577	233	10	may	may	AUX
dpc-2577	233	11	suggest	suggest	VERB
dpc-2577	233	12	the	the	DET
dpc-2577	233	13	presence	presence	NOUN
dpc-2577	233	14	of	of	ADP
dpc-2577	233	15	an	an	DET
dpc-2577	233	16	autoimmunological	autoimmunological	ADJ
dpc-2577	233	17	subtype	subtype	NOUN
dpc-2577	233	18	of	of	ADP
dpc-2577	233	19	csu	csu	PROPN
dpc-2577	233	20	,	,	PUNCT
dpc-2577	233	21	which	which	PRON
dpc-2577	233	22	is	be	AUX
dpc-2577	233	23	usually	usually	ADV
dpc-2577	233	24	more	more	ADV
dpc-2577	233	25	severe	severe	ADJ
dpc-2577	233	26	and	and	CCONJ
dpc-2577	233	27	has	have	VERB
dpc-2577	233	28	a	a	DET
dpc-2577	233	29	significantly	significantly	ADV
dpc-2577	233	30	worse	bad	ADJ
dpc-2577	233	31	response	response	NOUN
dpc-2577	233	32	to	to	ADP
dpc-2577	233	33	omalizumab	omalizumab	NOUN
dpc-2577	233	34	treatment	treatment	NOUN
dpc-2577	233	35	[	[	X
dpc-2577	233	36	28	28	NUM
dpc-2577	233	37	]	]	PUNCT
dpc-2577	233	38	.	.	PUNCT
dpc-2577	234	1	knowledge	knowledge	NOUN
dpc-2577	234	2	of	of	ADP
dpc-2577	234	3	the	the	DET
dpc-2577	234	4	comorbidities	comorbiditie	NOUN
dpc-2577	234	5	of	of	ADP
dpc-2577	234	6	cu	cu	PROPN
dpc-2577	234	7	may	may	AUX
dpc-2577	234	8	support	support	VERB
dpc-2577	234	9	clinicians	clinician	NOUN
dpc-2577	234	10	in	in	ADP
dpc-2577	234	11	appropriately	appropriately	ADV
dpc-2577	234	12	managing	manage	VERB
dpc-2577	234	13	and	and	CCONJ
dpc-2577	234	14	treating	treat	VERB
dpc-2577	234	15	this	this	DET
dpc-2577	234	16	condition	condition	NOUN
dpc-2577	234	17	.	.	PUNCT
dpc-2577	235	1	acknowledgments	acknowledgment	NOUN
dpc-2577	235	2	we	we	PRON
dpc-2577	235	3	would	would	AUX
dpc-2577	235	4	like	like	VERB
dpc-2577	235	5	to	to	PART
dpc-2577	235	6	express	express	VERB
dpc-2577	235	7	our	our	PRON
dpc-2577	235	8	gratitude	gratitude	NOUN
dpc-2577	235	9	to	to	ADP
dpc-2577	235	10	the	the	DET
dpc-2577	235	11	patients	patient	NOUN
dpc-2577	235	12	who	who	PRON
dpc-2577	235	13	complete	complete	VERB
dpc-2577	235	14	our	our	PRON
dpc-2577	235	15	survey	survey	NOUN
dpc-2577	235	16	.	.	PUNCT
dpc-2577	236	1	references	reference	NOUN
dpc-2577	236	2	1	1	NUM
dpc-2577	236	3	.	.	PUNCT
dpc-2577	236	4	zuberbier	zuberbier	PROPN
dpc-2577	236	5	t	t	PROPN
dpc-2577	236	6	,	,	PUNCT
dpc-2577	236	7	aberer	aberer	PROPN
dpc-2577	236	8	w	w	PROPN
dpc-2577	236	9	,	,	PUNCT
dpc-2577	236	10	asero	asero	NOUN
dpc-2577	236	11	r	r	NOUN
dpc-2577	236	12	,	,	PUNCT
dpc-2577	236	13	et	et	PROPN
dpc-2577	236	14	al	al	PROPN
dpc-2577	236	15	.	.	PUNCT
dpc-2577	237	1	the	the	DET
dpc-2577	237	2	eaaci	eaaci	PROPN
dpc-2577	237	3	/	/	SYM
dpc-2577	237	4	ga²len/	ga²len/	PROPN
dpc-2577	237	5	edf	edf	PROPN
dpc-2577	237	6	/	/	SYM
dpc-2577	237	7	wao	wao	PROPN
dpc-2577	237	8	guideline	guideline	NOUN
dpc-2577	237	9	for	for	ADP
dpc-2577	237	10	the	the	DET
dpc-2577	237	11	definition	definition	NOUN
dpc-2577	237	12	,	,	PUNCT
dpc-2577	237	13	classification	classification	NOUN
dpc-2577	237	14	,	,	PUNCT
dpc-2577	237	15	diagnosis	diagnosis	NOUN
dpc-2577	237	16	,	,	PUNCT
dpc-2577	237	17	and	and	CCONJ
dpc-2577	237	18	management	management	NOUN
dpc-2577	237	19	of	of	ADP
dpc-2577	237	20	urticaria	urticaria	NOUN
dpc-2577	237	21	.	.	PUNCT
dpc-2577	237	22	  	  	SPACE
dpc-2577	237	23	allergy	allergy	NOUN
dpc-2577	237	24	.	.	PUNCT
dpc-2577	238	1	2018;73(7):1393	2018;73(7):1393	NUM
dpc-2577	238	2	-	-	SYM
dpc-2577	238	3	1414	1414	NUM
dpc-2577	238	4	.	.	PUNCT
dpc-2577	239	1	doi:10.1111	doi:10.1111	ADJ
dpc-2577	239	2	/	/	SYM
dpc-2577	239	3	all.13397	all.13397	PROPN
dpc-2577	239	4	2	2	NUM
dpc-2577	239	5	.	.	PUNCT
dpc-2577	239	6	saini	saini	PROPN
dpc-2577	239	7	ss	ss	PROPN
dpc-2577	239	8	.	.	PUNCT
dpc-2577	239	9	chronic	chronic	ADJ
dpc-2577	239	10	spontaneous	spontaneous	ADJ
dpc-2577	239	11	urticaria	urticaria	NOUN
dpc-2577	239	12	:	:	PUNCT
dpc-2577	239	13	etiology	etiology	NOUN
dpc-2577	239	14	and	and	CCONJ
dpc-2577	239	15	pathogenesis	pathogenesis	NOUN
dpc-2577	239	16	.	.	PUNCT
dpc-2577	239	17	  	  	SPACE
dpc-2577	240	1	immunol	immunol	NOUN
dpc-2577	240	2	allergy	allergy	PROPN
dpc-2577	240	3	clin	clin	PROPN
dpc-2577	240	4	north	north	PROPN
dpc-2577	240	5	am	am	PROPN
dpc-2577	240	6	.	.	PUNCT
dpc-2577	241	1	2014;34(1):33	2014;34(1):33	NUM
dpc-2577	241	2	-	-	SYM
dpc-2577	241	3	52	52	NUM
dpc-2577	241	4	.	.	PUNCT
dpc-2577	242	1	doi:10.1016	doi:10.1016	PROPN
dpc-2577	242	2	/	/	SYM
dpc-2577	242	3	j.iac.2013.09.012	j.iac.2013.09.012	PROPN
dpc-2577	242	4	3	3	NUM
dpc-2577	242	5	.	.	PUNCT
dpc-2577	243	1	staubach	staubach	PROPN
dpc-2577	243	2	p	p	X
dpc-2577	243	3	,	,	PUNCT
dpc-2577	243	4	dechene	dechene	PROPN
dpc-2577	243	5	m	m	PROPN
dpc-2577	243	6	,	,	PUNCT
dpc-2577	243	7	metz	metz	PROPN
dpc-2577	243	8	m	m	PROPN
dpc-2577	243	9	,	,	PUNCT
dpc-2577	243	10	et	et	PROPN
dpc-2577	243	11	al	al	PROPN
dpc-2577	243	12	.	.	PROPN
dpc-2577	243	13	high	high	ADJ
dpc-2577	243	14	prevalence	prevalence	NOUN
dpc-2577	243	15	of	of	ADP
dpc-2577	243	16	mental	mental	ADJ
dpc-2577	243	17	disorders	disorder	NOUN
dpc-2577	243	18	and	and	CCONJ
dpc-2577	243	19	emotional	emotional	ADJ
dpc-2577	243	20	distress	distress	NOUN
dpc-2577	243	21	in	in	ADP
dpc-2577	243	22	patients	patient	NOUN
dpc-2577	243	23	with	with	ADP
dpc-2577	243	24	chronic	chronic	ADJ
dpc-2577	243	25	spontaneous	spontaneous	ADJ
dpc-2577	243	26	urticaria	urticaria	NOUN
dpc-2577	243	27	.	.	PUNCT
dpc-2577	243	28	  	  	SPACE
dpc-2577	243	29	acta	acta	PROPN
dpc-2577	243	30	derm	derm	NOUN
dpc-2577	243	31	venereol	venereol	NOUN
dpc-2577	243	32	.	.	PUNCT
dpc-2577	244	1	2011;91(5):557	2011;91(5):557	NUM
dpc-2577	244	2	-	-	SYM
dpc-2577	244	3	561	561	NUM
dpc-2577	244	4	.	.	PUNCT
dpc-2577	245	1	doi:10.2340/00015555	doi:10.2340/00015555	NOUN
dpc-2577	245	2	-	-	PUNCT
dpc-2577	245	3	1109	1109	NUM
dpc-2577	245	4	4	4	NUM
dpc-2577	245	5	.	.	PUNCT
dpc-2577	245	6	chiu	chiu	PROPN
dpc-2577	245	7	hy	hy	PROPN
dpc-2577	245	8	,	,	PUNCT
dpc-2577	245	9	muo	muo	PROPN
dpc-2577	245	10	ch	ch	PROPN
dpc-2577	245	11	,	,	PUNCT
dpc-2577	245	12	sung	sung	PROPN
dpc-2577	245	13	fc	fc	PROPN
dpc-2577	245	14	.	.	PUNCT
dpc-2577	246	1	associations	association	NOUN
dpc-2577	246	2	of	of	ADP
dpc-2577	246	3	chronic	chronic	ADJ
dpc-2577	246	4	urticaria	urticaria	NOUN
dpc-2577	246	5	with	with	ADP
dpc-2577	246	6	atopic	atopic	NOUN
dpc-2577	246	7	and	and	CCONJ
dpc-2577	246	8	autoimmune	autoimmune	ADJ
dpc-2577	246	9	comorbidities	comorbiditie	NOUN
dpc-2577	246	10	:	:	PUNCT
dpc-2577	246	11	a	a	DET
dpc-2577	246	12	nationwide	nationwide	ADJ
dpc-2577	246	13	population	population	NOUN
dpc-2577	246	14	-	-	PUNCT
dpc-2577	246	15	based	base	VERB
dpc-2577	246	16	study	study	NOUN
dpc-2577	246	17	.	.	PUNCT
dpc-2577	246	18	  	  	SPACE
dpc-2577	247	1	int	int	PROPN
dpc-2577	247	2	j	j	PROPN
dpc-2577	247	3	dermatol	dermatol	NOUN
dpc-2577	247	4	.	.	PUNCT
dpc-2577	248	1	2018;57(7):822	2018;57(7):822	NOUN
dpc-2577	248	2	-	-	PUNCT
dpc-2577	248	3	829	829	NUM
dpc-2577	248	4	.	.	PUNCT
dpc-2577	249	1	doi:10.1111	doi:10.1111	NOUN
dpc-2577	249	2	/	/	SYM
dpc-2577	249	3	ijd.14000	ijd.14000	NUM
dpc-2577	249	4	5	5	NUM
dpc-2577	249	5	.	.	PUNCT
dpc-2577	249	6	nebiolo	nebiolo	PROPN
dpc-2577	249	7	f	f	PROPN
dpc-2577	249	8	,	,	PUNCT
dpc-2577	249	9	bergia	bergia	NOUN
dpc-2577	249	10	r	r	NOUN
dpc-2577	249	11	,	,	PUNCT
dpc-2577	249	12	bommarito	bommarito	ADJ
dpc-2577	249	13	l	l	NOUN
dpc-2577	249	14	,	,	PUNCT
dpc-2577	249	15	et	et	PROPN
dpc-2577	249	16	al	al	PROPN
dpc-2577	249	17	.	.	PROPN
dpc-2577	249	18	effect	effect	NOUN
dpc-2577	249	19	of	of	ADP
dpc-2577	249	20	arterial	arterial	ADJ
dpc-2577	249	21	hypertension	hypertension	NOUN
dpc-2577	249	22	on	on	ADP
dpc-2577	249	23	chronic	chronic	ADJ
dpc-2577	249	24	urticaria	urticaria	NOUN
dpc-2577	249	25	duration	duration	NOUN
dpc-2577	249	26	.	.	PUNCT
dpc-2577	249	27	 	 	SPACE
dpc-2577	250	1	ann	ann	PROPN
dpc-2577	250	2	allergy	allergy	PROPN
dpc-2577	250	3	asthma	asthma	PROPN
dpc-2577	250	4	immunol	immunol	PROPN
dpc-2577	250	5	.	.	PUNCT
dpc-2577	251	1	2009;103(5):407	2009;103(5):407	X
dpc-2577	251	2	-	-	PUNCT
dpc-2577	251	3	410	410	NUM
dpc-2577	251	4	.	.	PUNCT
dpc-2577	252	1	doi:10.1016	doi:10.1016	PROPN
dpc-2577	252	2	/	/	SYM
dpc-2577	252	3	s1081	s1081	PROPN
dpc-2577	252	4	-	-	PUNCT
dpc-2577	252	5	1206(10)60360	1206(10)60360	NUM
dpc-2577	252	6	-	-	SYM
dpc-2577	252	7	2	2	NUM
dpc-2577	252	8	6	6	NUM
dpc-2577	252	9	.	.	PUNCT
dpc-2577	253	1	shalom	shalom	PROPN
dpc-2577	253	2	g	g	PROPN
dpc-2577	253	3	,	,	PUNCT
dpc-2577	253	4	kridin	kridin	VERB
dpc-2577	253	5	k	k	PROPN
dpc-2577	253	6	,	,	PUNCT
dpc-2577	253	7	babaev	babaev	NOUN
dpc-2577	253	8	m	m	PROPN
dpc-2577	253	9	,	,	PUNCT
dpc-2577	253	10	et	et	PROPN
dpc-2577	253	11	al	al	PROPN
dpc-2577	253	12	.	.	PUNCT
dpc-2577	253	13	chronic	chronic	ADJ
dpc-2577	253	14	urticaria	urticaria	NOUN
dpc-2577	253	15	and	and	CCONJ
dpc-2577	253	16	osteoporosis	osteoporosis	NOUN
dpc-2577	253	17	:	:	PUNCT
dpc-2577	253	18	a	a	DET
dpc-2577	253	19	longitudinal	longitudinal	ADJ
dpc-2577	253	20	,	,	PUNCT
dpc-2577	253	21	community	community	NOUN
dpc-2577	253	22	-	-	PUNCT
dpc-2577	253	23	based	base	VERB
dpc-2577	253	24	cohort	cohort	NOUN
dpc-2577	253	25	study	study	NOUN
dpc-2577	253	26	of	of	ADP
dpc-2577	253	27	11	11	NUM
dpc-2577	253	28	944	944	NUM
dpc-2577	253	29	patients	patient	NOUN
dpc-2577	253	30	.	.	PUNCT
dpc-2577	253	31	  	  	SPACE
dpc-2577	254	1	br	br	PROPN
dpc-2577	254	2	j	j	PROPN
dpc-2577	254	3	dermatol	dermatol	NOUN
dpc-2577	254	4	.	.	PUNCT
dpc-2577	255	1	2019;180(5):1077	2019;180(5):1077	NUM
dpc-2577	255	2	-	-	SYM
dpc-2577	255	3	1082	1082	NUM
dpc-2577	255	4	.	.	PUNCT
dpc-2577	256	1	doi:10.1111	doi:10.1111	ADJ
dpc-2577	256	2	/	/	SYM
dpc-2577	256	3	bjd.17528	bjd.17528	PROPN
dpc-2577	256	4	7	7	NUM
dpc-2577	256	5	.	.	PUNCT
dpc-2577	256	6	kolkhir	kolkhir	PROPN
dpc-2577	256	7	p	p	NOUN
dpc-2577	256	8	,	,	PUNCT
dpc-2577	256	9	pereverzina	pereverzina	NOUN
dpc-2577	256	10	n	n	CCONJ
dpc-2577	256	11	,	,	PUNCT
dpc-2577	256	12	olisova	olisova	X
dpc-2577	256	13	o	o	NOUN
dpc-2577	256	14	,	,	PUNCT
dpc-2577	256	15	maurer	maurer	PROPN
dpc-2577	256	16	m.	m.	PROPN
dpc-2577	256	17	comorbidity	comorbidity	NOUN
dpc-2577	256	18	of	of	ADP
dpc-2577	256	19	viral	viral	ADJ
dpc-2577	256	20	hepatitis	hepatitis	NOUN
dpc-2577	256	21	and	and	CCONJ
dpc-2577	256	22	chronic	chronic	ADJ
dpc-2577	256	23	spontaneous	spontaneous	ADJ
dpc-2577	256	24	urticaria	urticaria	NOUN
dpc-2577	256	25	:	:	PUNCT
dpc-2577	256	26	a	a	DET
dpc-2577	256	27	systematic	systematic	ADJ
dpc-2577	256	28	review	review	NOUN
dpc-2577	256	29	.	.	PUNCT
dpc-2577	256	30	 	 	SPACE
dpc-2577	256	31	allergy	allergy	NOUN
dpc-2577	256	32	.	.	PUNCT
dpc-2577	257	1	2018;73(10):1946	2018;73(10):1946	X
dpc-2577	257	2	-	-	SYM
dpc-2577	257	3	1953	1953	NUM
dpc-2577	257	4	.	.	PUNCT
dpc-2577	258	1	doi:10.1111	doi:10.1111	NOUN
dpc-2577	258	2	/	/	SYM
dpc-2577	258	3	all.13482	all.13482	PROPN
dpc-2577	258	4	8	8	NUM
dpc-2577	258	5	.	.	PUNCT
dpc-2577	259	1	maurer	maurer	PROPN
dpc-2577	259	2	m	m	PROPN
dpc-2577	259	3	,	,	PUNCT
dpc-2577	259	4	houghton	houghton	PROPN
dpc-2577	259	5	k	k	PROPN
dpc-2577	259	6	,	,	PUNCT
dpc-2577	259	7	costa	costa	PROPN
dpc-2577	259	8	c	c	NOUN
dpc-2577	259	9	,	,	PUNCT
dpc-2577	259	10	et	et	PROPN
dpc-2577	259	11	al	al	PROPN
dpc-2577	259	12	.	.	PROPN
dpc-2577	259	13	differences	difference	NOUN
dpc-2577	259	14	in	in	ADP
dpc-2577	259	15	chronic	chronic	ADJ
dpc-2577	259	16	spontaneous	spontaneous	ADJ
dpc-2577	259	17	urticaria	urticaria	NOUN
dpc-2577	259	18	between	between	ADP
dpc-2577	259	19	europe	europe	PROPN
dpc-2577	259	20	and	and	CCONJ
dpc-2577	259	21	central	central	ADJ
dpc-2577	259	22	/	/	SYM
dpc-2577	259	23	south	south	PROPN
dpc-2577	259	24	america	america	PROPN
dpc-2577	259	25	:	:	PUNCT
dpc-2577	259	26	results	result	NOUN
dpc-2577	259	27	of	of	ADP
dpc-2577	259	28	the	the	DET
dpc-2577	259	29	multi	multi	ADJ
dpc-2577	259	30	-	-	ADJ
dpc-2577	259	31	center	center	ADJ
dpc-2577	259	32	real	real	ADJ
dpc-2577	259	33	world	world	NOUN
dpc-2577	259	34	aware	aware	ADJ
dpc-2577	259	35	study	study	NOUN
dpc-2577	259	36	.	.	PUNCT
dpc-2577	259	37	 	 	SPACE
dpc-2577	259	38	world	world	NOUN
dpc-2577	259	39	8	8	NUM
dpc-2577	259	40	original	original	ADJ
dpc-2577	259	41	article	article	NOUN
dpc-2577	259	42	|	|	ADV
dpc-2577	259	43	dermatol	dermatol	ADJ
dpc-2577	259	44	pract	pract	NOUN
dpc-2577	259	45	concept	concept	NOUN
dpc-2577	259	46	.	.	PUNCT
dpc-2577	260	1	2023;13(1):e2023056	2023;13(1):e2023056	NUM
dpc-2577	260	2	diseases	disease	NOUN
dpc-2577	260	3	:	:	PUNCT
dpc-2577	260	4	a	a	DET
dpc-2577	260	5	systematic	systematic	ADJ
dpc-2577	260	6	review	review	NOUN
dpc-2577	260	7	.	.	PUNCT
dpc-2577	260	8	 	 	SPACE
dpc-2577	260	9	allergy	allergy	NOUN
dpc-2577	260	10	.	.	PUNCT
dpc-2577	261	1	2017;72(10):1440	2017;72(10):1440	NUM
dpc-2577	261	2	-	-	SYM
dpc-2577	261	3	1460	1460	NUM
dpc-2577	261	4	.	.	PUNCT
dpc-2577	262	1	doi:10.1111	doi:10.1111	PROPN
dpc-2577	262	2	/	/	SYM
dpc-2577	262	3	all.13182	all.13182	PROPN
dpc-2577	262	4	27	27	NUM
dpc-2577	262	5	.	.	PUNCT
dpc-2577	263	1	gonzalez	gonzalez	PROPN
dpc-2577	263	2	-	-	PUNCT
dpc-2577	263	3	diaz	diaz	PROPN
dpc-2577	263	4	sn	sn	PROPN
dpc-2577	263	5	,	,	PUNCT
dpc-2577	263	6	sanchez	sanchez	PROPN
dpc-2577	263	7	-	-	PUNCT
dpc-2577	263	8	borges	borges	PROPN
dpc-2577	263	9	m	m	PROPN
dpc-2577	263	10	,	,	PUNCT
dpc-2577	263	11	rangel	rangel	PROPN
dpc-2577	263	12	-	-	PUNCT
dpc-2577	263	13	gonzalez	gonzalez	PROPN
dpc-2577	263	14	dm	dm	PROPN
dpc-2577	263	15	,	,	PUNCT
dpc-2577	263	16	guzman	guzman	NOUN
dpc-2577	263	17	-	-	PUNCT
dpc-2577	263	18	avilan	avilan	PROPN
dpc-2577	263	19	ri	ri	PROPN
dpc-2577	263	20	,	,	PUNCT
dpc-2577	263	21	canseco	canseco	PROPN
dpc-2577	263	22	-	-	PUNCT
dpc-2577	263	23	villarreal	villarreal	PROPN
dpc-2577	263	24	ji	ji	PROPN
dpc-2577	263	25	,	,	PUNCT
dpc-2577	263	26	arias	arias	PROPN
dpc-2577	263	27	-	-	PUNCT
dpc-2577	263	28	cruz	cruz	PROPN
dpc-2577	263	29	a.	a.	NOUN
dpc-2577	263	30	chronic	chronic	PROPN
dpc-2577	263	31	urticaria	urticaria	NOUN
dpc-2577	263	32	and	and	CCONJ
dpc-2577	263	33	thyroid	thyroid	VERB
dpc-2577	263	34	pathology	pathology	NOUN
dpc-2577	263	35	.	.	PUNCT
dpc-2577	263	36	 	 	SPACE
dpc-2577	263	37	world	world	NOUN
dpc-2577	263	38	allergy	allergy	PROPN
dpc-2577	263	39	organ	organ	PROPN
dpc-2577	263	40	j.	j.	PROPN
dpc-2577	263	41	2020;13(3):100101	2020;13(3):100101	PROPN
dpc-2577	263	42	.	.	PUNCT
dpc-2577	264	1	published	publish	VERB
dpc-2577	264	2	2020	2020	NUM
dpc-2577	264	3	mar	mar	PROPN
dpc-2577	264	4	6	6	NUM
dpc-2577	264	5	.	.	PUNCT
dpc-2577	264	6	doi:10.1016	doi:10.1016	PROPN
dpc-2577	264	7	/	/	SYM
dpc-2577	264	8	j.	j.	PROPN
dpc-2577	264	9	waojou.2020.100101	waojou.2020.100101	PROPN
dpc-2577	264	10	28	28	NUM
dpc-2577	264	11	.	.	PUNCT
dpc-2577	265	1	gericke	gericke	PROPN
dpc-2577	265	2	j	j	PROPN
dpc-2577	265	3	,	,	PUNCT
dpc-2577	265	4	metz	metz	PROPN
dpc-2577	265	5	m	m	PROPN
dpc-2577	265	6	,	,	PUNCT
dpc-2577	265	7	ohanyan	ohanyan	PROPN
dpc-2577	265	8	t	t	PROPN
dpc-2577	265	9	,	,	PUNCT
dpc-2577	265	10	et	et	PROPN
dpc-2577	265	11	al	al	PROPN
dpc-2577	265	12	.	.	PROPN
dpc-2577	265	13	serum	serum	PROPN
dpc-2577	265	14	autoreactivity	autoreactivity	PROPN
dpc-2577	265	15	predicts	predict	VERB
dpc-2577	265	16	time	time	NOUN
dpc-2577	265	17	to	to	PART
dpc-2577	265	18	response	response	VERB
dpc-2577	265	19	to	to	ADP
dpc-2577	265	20	omalizumab	omalizumab	NOUN
dpc-2577	265	21	therapy	therapy	NOUN
dpc-2577	265	22	in	in	ADP
dpc-2577	265	23	chronic	chronic	ADJ
dpc-2577	265	24	spontaneous	spontaneous	ADJ
dpc-2577	265	25	urticaria	urticaria	NOUN
dpc-2577	265	26	.	.	PUNCT
dpc-2577	265	27	  	  	SPACE
dpc-2577	266	1	j	j	PROPN
dpc-2577	266	2	allergy	allergy	PROPN
dpc-2577	266	3	clin	clin	PROPN
dpc-2577	266	4	immunol	immunol	NOUN
dpc-2577	266	5	.	.	PUNCT
dpc-2577	267	1	2017;139(3):1059	2017;139(3):1059	PROPN
dpc-2577	267	2	-	-	SYM
dpc-2577	267	3	1061.e1	1061.e1	NUM
dpc-2577	267	4	.	.	PUNCT
dpc-2577	267	5	doi:10.1016	doi:10.1016	PROPN
dpc-2577	267	6	/	/	SYM
dpc-2577	267	7	j.jaci.2016.07.047	j.jaci.2016.07.047	PROPN
dpc-2577	267	8	j	j	PROPN
dpc-2577	267	9	dermatol	dermatol	NOUN
dpc-2577	267	10	.	.	PUNCT
dpc-2577	268	1	1990;123(4):453	1990;123(4):453	NUM
dpc-2577	268	2	-	-	SYM
dpc-2577	268	3	456	456	NUM
dpc-2577	268	4	.	.	PUNCT
dpc-2577	269	1	doi:10.1111	doi:10.1111	ADJ
dpc-2577	269	2	/	/	SYM
dpc-2577	269	3	j.1365	j.1365	NOUN
dpc-2577	269	4	-	-	PUNCT
dpc-2577	269	5	2133	2133	NUM
dpc-2577	269	6	.1990.tb01449.x	.1990.tb01449.x	PUNCT
dpc-2577	269	7	24	24	NUM
dpc-2577	269	8	.	.	PUNCT
dpc-2577	270	1	chen	chen	PROPN
dpc-2577	270	2	yj	yj	PROPN
dpc-2577	270	3	,	,	PUNCT
dpc-2577	270	4	wu	wu	PROPN
dpc-2577	270	5	cy	cy	PROPN
dpc-2577	270	6	,	,	PUNCT
dpc-2577	270	7	shen	shen	PROPN
dpc-2577	270	8	jl	jl	PROPN
dpc-2577	270	9	,	,	PUNCT
dpc-2577	270	10	chen	chen	PROPN
dpc-2577	270	11	tt	tt	PROPN
dpc-2577	270	12	,	,	PUNCT
dpc-2577	270	13	chang	chang	PROPN
dpc-2577	270	14	yt	yt	PROPN
dpc-2577	270	15	.	.	PUNCT
dpc-2577	270	16	cancer	cancer	NOUN
dpc-2577	270	17	risk	risk	NOUN
dpc-2577	270	18	in	in	ADP
dpc-2577	270	19	patients	patient	NOUN
dpc-2577	270	20	  	  	SPACE
dpc-2577	270	21	with	with	ADP
dpc-2577	270	22	chronic	chronic	ADJ
dpc-2577	270	23	urticaria	urticaria	NOUN
dpc-2577	270	24	:	:	PUNCT
dpc-2577	270	25	a	a	DET
dpc-2577	270	26	population	population	NOUN
dpc-2577	270	27	-	-	PUNCT
dpc-2577	270	28	based	base	VERB
dpc-2577	270	29	cohort	cohort	NOUN
dpc-2577	270	30	study	study	NOUN
dpc-2577	270	31	.	.	PUNCT
dpc-2577	270	32	  	  	SPACE
dpc-2577	270	33	arch	arch	ADJ
dpc-2577	270	34	dermatol	dermatol	NOUN
dpc-2577	270	35	.	.	PUNCT
dpc-2577	271	1	2012;148(1):103	2012;148(1):103	NUM
dpc-2577	271	2	-	-	SYM
dpc-2577	271	3	108	108	NUM
dpc-2577	271	4	.	.	PUNCT
dpc-2577	272	1	doi:10.1001/	doi:10.1001/	NOUN
dpc-2577	272	2	archdermatol.2011.682	archdermatol.2011.682	ADV
dpc-2577	272	3	25	25	NUM
dpc-2577	272	4	.	.	PUNCT
dpc-2577	273	1	kolkhir	kolkhir	PROPN
dpc-2577	273	2	p	p	NOUN
dpc-2577	273	3	,	,	PUNCT
dpc-2577	273	4	borzova	borzova	X
dpc-2577	273	5	e	e	NOUN
dpc-2577	273	6	,	,	PUNCT
dpc-2577	273	7	grattan	grattan	PROPN
dpc-2577	273	8	c	c	PROPN
dpc-2577	273	9	,	,	PUNCT
dpc-2577	273	10	asero	asero	NOUN
dpc-2577	273	11	r	r	NOUN
dpc-2577	273	12	,	,	PUNCT
dpc-2577	273	13	pogorelov	pogorelov	NOUN
dpc-2577	273	14	d	d	PROPN
dpc-2577	273	15	,	,	PUNCT
dpc-2577	273	16	maurer	maurer	PROPN
dpc-2577	273	17	m.	m.	PROPN
dpc-2577	273	18	autoimmune	autoimmune	PROPN
dpc-2577	273	19	comorbidity	comorbidity	NOUN
dpc-2577	273	20	in	in	ADP
dpc-2577	273	21	chronic	chronic	ADJ
dpc-2577	273	22	spontaneous	spontaneous	ADJ
dpc-2577	273	23	urticaria	urticaria	NOUN
dpc-2577	273	24	:	:	PUNCT
dpc-2577	273	25	a	a	DET
dpc-2577	273	26	systematic	systematic	ADJ
dpc-2577	273	27	review	review	NOUN
dpc-2577	273	28	.	.	PUNCT
dpc-2577	273	29	 	 	SPACE
dpc-2577	274	1	autoimmun	autoimmun	PROPN
dpc-2577	274	2	rev	rev	PROPN
dpc-2577	274	3	.	.	PROPN
dpc-2577	274	4	2017;16(12):1196	2017;16(12):1196	NUM
dpc-2577	274	5	-	-	PROPN
dpc-2577	274	6	1208	1208	NUM
dpc-2577	274	7	.	.	PUNCT
dpc-2577	275	1	doi:10.1016	doi:10.1016	PROPN
dpc-2577	275	2	/	/	SYM
dpc-2577	275	3	j.autrev.2017.10.003	j.autrev.2017.10.003	PROPN
dpc-2577	275	4	26	26	NUM
dpc-2577	275	5	.	.	PUNCT
dpc-2577	276	1	kolkhir	kolkhir	PROPN
dpc-2577	276	2	p	p	NOUN
dpc-2577	276	3	,	,	PUNCT
dpc-2577	276	4	metz	metz	PROPN
dpc-2577	276	5	m	m	PROPN
dpc-2577	276	6	,	,	PUNCT
dpc-2577	276	7	altrichter	altrichter	PROPN
dpc-2577	276	8	s	s	PROPN
dpc-2577	276	9	,	,	PUNCT
dpc-2577	276	10	maurer	maurer	PROPN
dpc-2577	276	11	m.	m.	PROPN
dpc-2577	276	12	comorbidity	comorbidity	NOUN
dpc-2577	276	13	of	of	ADP
dpc-2577	276	14	chronic	chronic	ADJ
dpc-2577	276	15	spontaneous	spontaneous	ADJ
dpc-2577	276	16	urticaria	urticaria	NOUN
dpc-2577	276	17	and	and	CCONJ
dpc-2577	276	18	autoimmune	autoimmune	ADJ
dpc-2577	276	19	thyroid	thyroid	NOUN